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Retinitis Pigmentosa (RP) is a disease of the retina, which causes progressive retinal 
degeneration. X-linked RP is one of the most severe subtypes with an estimated 15% 
of cases caused by mutations in RP2. RP2 functions as a GTPase Activating Protein 
(GAP) for the small G protein ARL3, which is proposed to regulate the traffic of lipid-
modified proteins within photoreceptors. It is hypothesised that mutations in RP2 
result in dysregulation of ARL3 and therefore protein mis-trafficking. In order to 
elucidate the contribution of ARL3 dysregulation to the pathogenesis of RP, I have 
established new mouse models by CRISPR-mediated genome editing.  These include 
an Rp2h knockout line and a line, which harbours a human pathogenic missense 
mutation, E135G, which abolishes interaction with ARL3.  
Furthermore, I have generated mice carrying a Q71L missense mutation in Arl3. This 
mutation locks ARL3 in the active GTP-bound state, and hence is predicted to 
phenocopy Rp2h knockout. Histological examination has revealed that Rp2h 
knockout, Rp2h E135G and Arl3 Q71L/+ mutant animals display progressive retinal 
degeneration evident from age 6 months. Arl3 Q71L/Q71L animals display retinal 
degeneration at age 3 months demonstrating that elevated levels of ARL3-GTP is a 
driver of retinal degeneration in mice. Immunofluorescence analysis has shown ARL3 
Q71L mice, Rp2h knockout mice and Rp2h E135G/Y mice show mislocalisation of 
lipid modified proteins likely driving retinal degeneration, however further analysis has 
shown that these mice do not completely phenocopy each other suggesting that levels 
of ARL3-GTP may not be the only mechanism contributing to retinal degeneration in 
Rp2h mutant mice.  
The mechanisms of RP2 regulation are not well understood; therefore to identify 
potential interactors of RP2 a BIO-ID proximity labelling assay in RPE-1 cells was 
performed. A top hit from this assay was palmitoyltransferase ZDHHC5. I confirmed 
this interaction in cells and using a click chemistry based approach demonstrated that 
it is unlikely that this enzyme functions to palmitoylate RP2. Using 
immunofluorescence in HeLa cells I have shown that overexpression of ZDHHC5 can 
rescue the localisation of human pathogenic RP2 mutants C3S and G2A, which are 
normally mislocalised in vivo, independent of its catalytic activity. SiRNA knockdown 
of ZDHHC5 in cells leads to mislocalisation of RP2 demonstrating ZDHHC5 has a role 
in trafficking RP2. Results from these studies have provided new knowledge 
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regarding the mechanisms that cause retinal degeneration and new insights into the 










The retina is the part of the eye that is responsible for detecting light and sending 
signals to the brain. Within the retina, the specialised cells which detect light, are 
called photoreceptors. Inherited Retinal Degenerations are a group of diseases that 
lead to death of these photoreceptor cells and cause blindness in humans. One 
specific disease called Retinitis Pigmentosa can be caused by a defect in a molecule 
called RP2. It is not understood why defects in RP2 cause death of photoreceptors, 
therefore research into the function of RP2 is essential for the development of 
treatments for patients. Previous research has suggested that RP2 controls the 
localisation of other molecules in the photoreceptors by working with another 
molecule called ARL3. RP2 acts as a switch to inactivate ARL3 in cells, therefore 
defects in RP2 are thought to lead to photoreceptors which have too much active 
ARL3. It is thought that this active ARL3 disrupts photoreceptor function eventually 
leading to cell death. In order to determine if high levels of active ARL3 is the only 
issue in photoreceptors with defective RP2 I used mouse models that had been 
designed to have no RP2, defective RP2 or only active ARL3. If having high levels of 
active ARL3 is the only issue in photoreceptors with defective RP2 all of these mice 
should become progressively blind at the same rate. Analysis of visual function and 
photoreceptor health in these animals revealed that they do not all become blind at 
the same time and that the issues in the photoreceptors leading to blindness are not 
identical, suggesting RP2 may have other roles in photoreceptors, which when 
missing also contribute to photoreceptor cell death.  
The mechanisms which control RP2 in photoreceptors are not understood, therefore 
an experiment which identifies new molecules which regulate RP2 was performed. 
This revealed a new molecule, which controls where RP2 is located in cells and 
provides new insights into the ways the localisation of molecules in photoreceptors 
are controlled. Overall, the research described in this thesis provides new knowledge 
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Chapter 1: Introduction 
 
1.1 General Structure and Function of the Retina and Photoreceptor Cells 
 
The mammalian eye facilitates vision by focusing light that passes through the lens 
and cornea to the retina. The retina is a layer of neural tissue at the back of the eye 
which captures light and sends signals to the brain to facilitate vison. Shortly after 
gastrulation, the eye field is specified in the medial anterior neural plate and contains 
all the progenitors required for the development of the neural retina (Heavner and 
Pevny 2012). Cells in the eye field express a set of eye field specific transcription 
factors that constitute a gene regulatory network required for the development of the 
eye. In mammals, these transcription factors include paired box protein 6 (Pax6), 
retina and anterior neural fold homeobox (Rax), six homeobox 3 (Six3) and LIM 
homeobox 2 (Lhx2) (Heavner and Pevny 2012). Both eyes develop from this single 
eye field which is split into two separate hemispheres, a process which is regulated 
by sonic hedgehog (Shh) and Six3 (Chiang et al. 1996; Oliver et al. 1995). In mouse 
at E8.5-9, optic vesicles form from evagination of the embryonic tissue which is 
densely packed with retinal stem cells, which go on to form the neural retina (Heavner 
and Pevny 2012). At E9.5 the optic vesicle is reorganised into 3 tissue types: the 
retinal pigment epithelium (RPE), neural retina and the ventral optic stock which 
eventually becomes the optic nerve (Heavner and Pevny 2012). At E10.5 the optic 
vesicles invaginate centrally and create two optic cups from which the eye develops 
(Adler and Canto-Soler 2007). During development of the optic cup a wave of 
neurogenesis occurs from the retinal stem cells which gives rise to the cell types 
present in the adult retina. The first cell type produced is the retinal ganglion cells 
followed by horizontal cells, amacrine cells and cone photoreceptors. Post-natal 
retinal precursors give rise to rod photoreceptors, bipolar cells and Muller glial cells 
(Heavner and Pevny 2012). The precursor cells which give rise to the neural retina 
cell types migrate to their future destination prior to completing differentiation giving 
rise to the characteristic conserved laminal structure of the retina (Hoon et al. 2014; 
Heavner and Pevny 2012).  
The retina is supported by the choroid that provides blood supply and nutrients 
required for cell function and survival (Figure 1.1 A). The retina has a highly conserved 
laminated structure and is oriented so that the photoreceptors, the light detecting cells, 
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are at the back of the eye (Thoreson W.B, 2017) (Figure 1.1 B). The photoreceptors 
are supported by a single layer of pigmented cells, the retinal pigment epithelium 
(RPE), which are essential for photoreceptor survival (Raymond and Jackson 1995). 
The RPE physically contact the photoreceptor outer segments and phagocytose the 
shed photoreceptor outer segment discs (Hall and Abrams 1987). They also contain 
photoprotective pigment granules, release neurotrophic factors, recycle 11-cis retinal, 
regulate the flow of ions and nutrients from the retinal blood supply to the outer retina 
and form the retinal blood-brain barrier (Strauss et.al 2005; Ming et al., 2009). The 
photoreceptor layer consists of the outer segments (OS), inner segments (IS) and 
outer nuclear layer (ONL). The ONL contains the photoreceptor cell bodies and nuclei 
of rod and cone photoreceptors, the IS the region of the photoreceptor where proteins 
required for vision are synthesised and the OS is made up of OS disc membranes 
where light detection and phototransduction occurs. Below the ONL is the outer 
plexiform layer (OPL) which contains the synapses between photoreceptors and 
horizontal and bipolar cells. Photoreceptors use glutamate as a neurotransmitter and 
form synapses with the bipolar cells which respond to the neurotransmitter signals 
(Hoon et al. 2014). Synaptic transmission of this signal is controlled by horizontal cells 
(Hoon et al. 2014).  
Bipolar cells exist in two functional classes the rod bipolar cells and cone bipolar cells 
where rod bipolar cells preferentially synapse with rod photoreceptors and cone 
bipolar cells with cones (Hoon et al. 2014). Two further subtypes of bipolar cell exist, 
ON bipolar cells and OFF bipolar cells. ON bipolar cells depolarise in response to light 
and all rod bipolar cells are ON bipolar cells. OFF bipolar cells hyperpolarise in 
response to light, cone bipolar cells can be either the ON or OFF subtypes (Hoon et 
al. 2014). The inner nuclear layer (INL) consists of the nuclei and cell bodies of the 
horizontal, bipolar and amacrine cells. The inner plexiform layer (IPL) contains the 
synaptic junctions between the bipolar, horizontal, amacrine and ganglion cells. The 
ganglion cell layer (GCL) contains the cell bodies of the ganglion cells. Ganglion cells 
are the output cells of the retina and their projections form nerve fibres which converge 
to form the optic nerve (ON) that carries signals from the retina to the brain where 
visual processing occurs (Thoreson W.B, 2017) (Figure 1.1 B). Excitation of ganglion 
cells is controlled by amacrine cells and two fast neurotransmitters, γ- aminobutyric 
acid and glycine. Either Amacrine cells form synapses which directly interact with 
ganglion cell dendrites, which enables a pathway of signal transduction called 
feedforward inhibition, or form synapses with axons of bipolar cells, which results in 
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(A) Schematic of Mammalian Eye.  
(B) Cross section of primate retina showing different layers. 
(C) Schematic of rod and cone photoreceptor cells. Rods are the predominant cell 
type in the retina with the ratio of rods to cones about 20:1 in the humans. 
Rods and Cones differ in the organisation of OS discs. Both cell types contain 
many mitochondria in the IS directly below the OS. IS also contains the 
machinery required for protein synthesis.  
 
RPE Retinal Pigment Epithelium OS Outer Segment IS Inner Segment ONL 
Outer Nuclear Layer OPL Outer Plexiform Layer INL Inner Nuclear Layer IPL 
Inner Plexiform Layer GCL Ganglion Cell Layer 
Taken from (A and B) Thoreson W.B, 2017 (C) Rick, 2006 
feedback inhibition, which is responsible for the transmission of scotopic signals from 
rod cells. The two inhibition mechanisms result in regulation of ganglion cell activation 

















1.1.1 Photoreceptor OS Morphogenesis 
 
Photoreceptors are the most abundant cells in the retina and function to detect light 
and initiate the phototransduction cascade (Kendal et.al 2013). Photoreceptors fall 
into two distinct cell types, rods and cones. Rods through the photopigment rhodopsin 
facilitate long wave light detection and night vision whilst cones contain M/L or S opsin 
photopigments and facilitate daytime and colour vision (Ferrari et al. 2011). 
C 




Photoreceptors are polarised neurons composed of two distinct compartments the 
OS, a modified sensory cilium, and the IS connected via a connecting cilium (CC) 
(Ferrari et.al 2011) (Figure 1.1 C). The IS is rich in factors involved in protein 
synthesis, energy generation and transport, whereas the OS contains proteins 
involved in phototransduction (Liu et.al, 2007). The proper regulation of protein 
trafficking from the IS to the OS via the CC is essential for photoreceptor function and 
survival (Besharse et al. 2003).  
Rods and cones differ in the morphology of their OS. In rods, stacks of disc 
membranes are sealed and separated from the plasma membrane by cytosol and in 
cones the plasma membrane invaginates to form a tightly packed lamellae structure 
which is open and physically continuous with the plasma membrane (Kawamura and 
Tachibanaki 2008; Molday 1998) (Figure 1.1 C). In rods it was thought that OS discs 
develop by evagination of the plasma membrane at the OS base (Ding, Salinas, and 
Arshavsky 2015) however it was recently discovered that OS discs form as a result of 
inhibition of ciliary ectosome release (Salinas et al. 2017). Cilia contain the ability to 
produce ectosomes which are proposed to function to facilitate disposal of proteins 
from the cell or to transfer materials and genetic information between cells (Wood et 
al. 2013; Nager et al. 2017; Wood and Rosenbaum 2015). It was demonstrated that 
in peripherin knockout mice (retinal degeneration slow, rds-/-), which do not develop 
OS’s, ciliary ectosomes accumulate at the tip of the connecting cilia during 
development of the first OS discs (Salinas et al. 2017). In WT retinas peripherin 
functions to inhibit the release of ciliary ectosomes and membrane structures trapped 
at the ciliary tip form OS discs through elongation and flattening (Salinas et al. 2017).  
In cones, OS’s develop from incomplete rim development of the connecting cilia. 
Evagination of the plasma membrane from the rim of the connecting cilia occurs at 
the OS base followed by multiple membrane invaginations to form the lamellae 
structure (Mustafi, Engel, and Palczewski 2009; Farjo et al. 2006). It was shown that 
although peripherin is essential for the development of the rod outer segments (ROS), 
absence of peripherin does not prevent cone outer segment (COS) development 
(Farjo et al. 2006). In order to specifically investigate the development of the COS a 
Nrl-/-rds-/- knockout mouse was generated (Farjo et al. 2006). Nrl (neural retina lucine 
zipper) is required for the development of Rods, thus the Nrl-/- mice develop a retina 
which contains only cones (Mears et al. 2001). This double knockout mouse revealed 
that in the absence of peripherin, COS’s develop and are capable of 
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phototransduction but are morphologically disrupted suggesting peripherin is not 
required for the initial membrane evagination but is required for the subsequent 
membrane invaginations which lead to the lamellae structure of cone OS discs (Farjo 
et al. 2006).  
1.1.2 OS Disc Shedding 
 
Daily renewal of OS’s is required for normal retina function (Kevany and Palczewski 
2010). Throughout the day photoreceptors add new discs at the base of the OS 
whereas at the tip older discs are removed and phagocytosed by the adjacent RPE 
cells (Jonnal et al. 2010). This continual process is thought to counterbalance the light 
toxicity and metabolic demands endured by the photoreceptors (Organisciak and 
Winkler 1994; Daemen 1973). RPE cells are thought to recognise the OS by a 
receptor based mechanism (Kevany and Palczewski 2010). It has been shown that 
integrin avβ5 and its proposed ligand milk fat globule–EF (MGF-EF) and cluster of 
differentiation 36 (CD36) are important for OS binding, as mice deficient in these 
genes or treated with CD36 inhibitors develop retinal degeneration due to inefficient 
phagocytosis of OS discs (Silvia C Finnemann et al. 1997; S C Finnemann and 
Silverstein 2001; Nandrot et al. 2007).  
Recognition of the OS is thought to trigger a phosphorylation cascade involving MER 
proto-oncogene tyrosine kinase (MERTK), focal adhesion kinase (FAK) and src 
kinases. This surge in protein phosphorylation activates signalling that leads to actin 
cytoskeleton reorganisation, which is required for engulfment of the OS by RPE cells 
(D’Cruz et al. 2000; Feng et al. 2002; Silvia C Finnemann 2003; Law et al. 2010; 
Kevany and Palczewski 2010). Internalisation of OS’s by the RPE has been shown to 
require the actin regulator annexin 2 (A2) as knockdown of this gene results in 
reduced OS internalisation (Law et al. 2010). Formation of the pseudopod that is 
essential for phagocytosis  requires myosin, and in RPE cells myosin II is known to 
interact with MERTK upon OS stimulation (Strick, Feng, and Vollrath 2009). After 
internalisation the OS are degraded in phagosomes containing cathepsin D (Deguchi 




1.1.3 Photoreceptor Connecting Cilia 
 
The photoreceptor connecting cilium separates the IS from the OS of photoreceptors 
and is analogous to the transition zone in cilia (Besharse & Horst 1999). The 
connecting cilia contains nine microtubule doublets that originate from the basal body 
which resides in the IS (Greiner et al. 1981). Y shaped linkers connect the 
microtubules to the integral membrane forming the ciliary necklace which can be 
visualised by electron microscopy (Besharse and Horst 1990; Insinna and Besharse 
2008). The connecting cilia is only 0.25μm in diameter forming a narrow passageway 
through which all outer segments proteins pass (Insinna and Besharse 2008). 
Proteins involved in phototransduction such as rhodopsin and the cyclic nucleotide 
gated (CNG) membrane channels are localised exclusively in the OS (Keady, Le, and 
Pazour 2011; Moritz et al. 2001; Deretic et al. 2005; Hüttl et al. 2005) and are not 
found in the IS suggesting the CC acts as a gatekeeper regulating protein entry to the 
OS. This was confirmed in a study using frogs in which rods that were isolated from 
the retina by mechanical dissociation were analysed for rhodopsin localisation. 
Mechanical dissociation causes fusion of the IS and OS and in these rods rhodopsin 
localised throughout the IS and OS demonstrating that with lack of the connecting 
cilia, proteins can freely diffuse between segments (Spencer, Detwiler, and Bunt-
Milam 1988).  
The regulation of protein trafficking in the connecting cilia is thought to occur through 
multiple mechanisms including intraflagellar transport (IFT) and other forms of 
regulated membrane trafficking (see 1.5.1 and 1.5.2) which is essential for the 
function and survival of photoreceptors. Many genes which are associated with 
human diseases which cause blindness encode for proteins which localise to the 
connecting cilia, for example Retinitis Pigmentosa GTPase Regulator (RPGR) and 
Retinitis Pigmentosa 2 (RP2) which cause X-linked Retinitis Pigmentosa  (Hardcastle 
et al. 1999; Meindl et al. 1996) Nephrocystin 1 (NPHP1) which causes 
Nephronophthisis, a kidney disorder often associated with Retinitis Pigmentosa 
(Fliegauf 2006) and Usher Syndrome Type 1 (USH1)  and Usher Syndrome Type 2 
(USH2), the genes which cause Usher Syndrome which manifests as deafness and 






1.1.4.1 Phototransduction in Rods 
Phototransduction involves absorption of a photon by rhodopsin resulting in rhodopsin 
becoming catalytically active (R*). R* catalyses the activation of the G protein 
transducin (G), generating Gα-GTP (G*). G* then activates phosphodiesterase 6 
(PDE6) generating PDE6* which hydrolyses cGMP to GMP. Decreased levels of 
cGMP causes hyperpolarisation in the cell as cGMP gated channels close due to 
reduced levels of cytoplasmic free cGMP (Yingbin Fu and Yau 2007). Closure of 
channels leads to decrease in cytoplasmic Ca2+ concentration which generates an 
action potential which stimulates downstream bipolar cells (Shiells and Falk 1990) 
(Figure 1.2).  
Rhodopsin contains the chromophore 11-cis-retinal which binds K296 on mammalian 
rhodopsin (Yingbin Fu and Yau 2007). In darkness 11-cis-retinal locks rhodopsin in 
the inactive state however upon absorption of a photon a cis-trans transformation 
occurs which activates rhodopsin. Rhodopsin activation occurs within milliseconds of 
photon absorption and generates a series of intermediates which can be identified by 
their absorption spectra. Meta I describes the bathorhodopsin, lumirhodopsin and 
metarhodopsin I states this is followed by the metarhodopsin II state (Meta II), which 
is active rhodopsin also known as R* (Yingbin Fu and Yau 2007).  
RPE cells also play an important role in the vision cycle. This was first discovered in 
Rpe65 -/- mice which have progressive retinal degeneration and no photoreceptor 
response despite expression of rhodopsin (Redmond et al. 1998). Rpe65 is a gene 
expressed exclusively in the RPE. An accumulation of all-trans retinal was detected 
in the RPE cells of these mice suggesting RPE65 is required for the generation of 11-
cis retinal from all trans retinyl esters (Redmond et al. 1998). As expected RPE65 has 
isomerhydrolase activity and is required for the conversion of all trans retinal to 11 
cis-retinal in vivo (Moiseyev et al. 2005).  
Transducin activation is the first amplification step in phototransduction, as around 20 
transducin molecules are activated by a single R* (Yingbin Fu and Yau 2007; Claudia 
M. Krispel et al. 2006). In rods the Gαt1Gβ1γ1 isoform of transducin is expressed (Lerea 
et al. 1986; Fung, Lieberman, and Lee 1992; Y. W. Peng et al. 1992). The Gαt1 null 
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mouse (gnat-/-) has no detectable rod photoreceptor response, confirming transducin 
is essential for the propagation of signal from R* to PDE6 (Calvert et al. 2000).  
PDE6 is a tetrameric protein made up of two catalytically active domains, α and β, 
and two γ subunits (Hurley and Stryer 1982). In dark conditions, the two γ subunits 
are bound to the two catalytic subunits ensuring they remain inactive. However in the 
light Gα-GTP displaces the γ subunits and frees the catalytic subunits to allow 
hydrolysis of cGMP (Yingbin Fu and Yau 2007). A mouse with specifically the PDE6γ 
subunit knocked out demonstrated that the γ subunit is not only required to supress α 
and β catalytic activity but is also essential for their stability, which in turn is essential 
for photoreceptor survival as Pde6γ -/- mice display rapid retinal degeneration (Tsang 
et al. 1996). In addition, the retinal degeneration 1 (rd1) mouse, a commonly used 
naturally occurring model of retinal degeneration that carries a nonsense mutation in 
the β subunit has a rapid severe retinal degeneration demonstrating the β subunit is 
also required for cell survival (Bowes et al. 1990; B. Chang et al. 2002).   
Closure of CNG channels is the final amplification phase of phototransduction. cGMP-
gated channels are plasma membrane localised non-cation specific channels that 
belong to the family of CNG channels present in most cell types (Yingbin Fu and Yau 
2007). The rod CNG channel has a 3 CNGA1: 1 CNGB1 subunit ratio (Weitz et al. 
2002; Zheng, Trudeau, and Zagotta 2002; Zhong et al. 2002). The baseline 
concentration of cGMP in the dark ensures channels stay open. However upon light 
absorption, reduction in cGMP stimulates rapid closure of the channels with sub-
millisecond efficiency (Yau 1994; Karpen et al. 1988). Cngb1 knockout mice revealed 
that CNGB1 is required to localise CNGA1 to the plasma membrane to form a 
functional channel, consequently only minimal levels of CNGA are present in these 
mice and photoreceptors do not respond to light (Hüttl et al. 2005). In humans 
mutation of CNGA1 causes Retinitis Pigmentosa (Dryja et al. 1995) (Table 1.1).  
1.1.4.2 Termination of Phototransduction in Rods 
 
In order to respond to changes in illumination a rapid inactivation of each activated 
component is required so that photoreceptors can recover and respond to subsequent 
photons (Yingbin Fu and Yau 2007). R* is first phosphorylated at several sites by G- 
protein coupled receptor kinase 1 (GRK1), which lowers its activity, and then bound 
by arrestin which reduces any residual activity (Wilden, Hall, and Kuhn 1986; Kühn 
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and Wilden 1987). Six serine/threonine residues on rhodopsin’s C-terminus are 
phosphorylated by GRK1 in mouse with 7 such residues identified in humans (Ohguro 
et al. 1995). Studies using transgenic mouse models with rhodopsin phosphorylation 
site mutations demonstrated that at least three sites are required for efficient 
deactivation of R*, however it was also shown that multiple phosphorylation sites may 
be required for reproducibility of the single photon response (Doan et al. 2006; Ana 
Mendez et al. 2000; Hamer et al. 2003; Rieke and Baylor 1998). In mice with multiple 
phosphorylation site deletions, the reproducibility of the single photon response is 
reduced with each phosphorylation site that is mutated and this does not depend on 
site identity (Ana Mendez et al. 2000; Doan et al. 2006). GRK1 mediated 
phosphorylation and deactivation of rhodopsin is very rapid occurring about ~100ms 
after the light exposure (Yingbin Fu and Yau 2007).  
Recoverin is a calcium binding protein which is N-terminally myristoylated. This 
myristoylation facilitates interaction with the photoreceptor membrane when calcium 
levels in the cell are high (Calvert, Klenchin, and Bownds 1995). Recoverin-Ca2+ binds 
GRK1 and inhibits its ability to phosphorylate rhodopsin, this binding was shown to 
occur in a calcium dependant manner and does not require recoverin myristoylation 
(C. L. Makino et al. 2004; Calvert, Klenchin, and Bownds 1995). Upon light absorption 
intracellular calcium levels decrease and calcium free recoverin is unable to bind 
GRK1, leaving GRK1 free to phosphorylate rhodopsin and induce photoreceptor 
recovery after phototransduction (C. L. Makino et al. 2004). The phenotype of the 
recoverin knockout mice (Rec-/-) supports this mechanism as Rec -/- mice have a 
faster flash recovery time than WT mice indicating a reduced ability to deactivate R* 
(C. L. Makino et al. 2004) 
Arrestin knockout mice (Arr -/-) have ERG responses similar to WT except in the 
recovery phase where responses only recover to half the baseline value,  
demonstrating that GRK1 phosphorylation can reduce R* activity but is not sufficient 
to return responses to baseline values (Xu et al. 1997). Two isoforms of arrestin are 
expressed in rods, full length p48 and a C-terminal truncated p44 version (Smith et 
al. 1994). P44 has faster on site binding than P48 and is more efficient than P48 at 
deactivation of R* in vitro and P44 is not transported from the OS during dark 
adaptation (Palczewski 1994; Philp, Chang, and Long 1987). P48 is expressed 10 
times more abundantly than P44 but is translocated from the OS during dark 
adaptation (see 1.1.3.4) therefore is not present in the OS of active photoreceptors 
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(Whelan and McGinnis 1988; Philp, Chang, and Long 1987). Rescue experiments in 
Arr-/- mice with specific arrestin isoforms demonstrated that both p44 and p48 could 
rapidly bind phosphorylated R* however only p48 could inactivate unphosphorylated 
R* (M. E. Burns 2006).   
G* is inactivated by hydrolysis of its bound GTP to GDP. As with many G proteins 
transducin has intrinsic GTPase activity which is amplified by a GTPase activating 
protein (GAP) complex (Yingbin Fu and Yau 2007). The GAP for transducin is a 
complex of regulator of G protein signalling proteins 9-1 (RGS9-1), the long form of 
Gβ5 subunit (Gβ5-L) and membrane anchor protein, RGS9-anchoring protein 
(R9AP). RGS9-1 has a G protein γ- like domain that interacts with Gβ5-L. Gβ5-L 
interacts with R9AP through its Dishevelled/Eg110/Pleckstrin (DEP) domain (W. He, 
Cowan, and Wensel 1998; E. R. Makino et al. 1999; G. Hu and Wensel 2002). Gα-
GDP then dissociates from PDE6γ, allowing PDE6γ to again interact with PDE6α and 
PDE6β to inhibit their catalytic activity (Yingbin Fu and Yau 2007). 
Transgenic mice lacking either RGS9-1, Gβ5-L or R9AP all show a similar phenotype 
of delayed recovery of the flash response with no effect on A-wave amplitude 
demonstrating all 3 members of the complex are obligatory for GTPase activity 
(Keresztes et al. 2004; C M Krispel et al. 2003; Ching Kang Chen et al. 2000). 
Disruption of any one component leads to reduction in the levels of other components 
through a post translational mechanism (C.-K. Chen et al. 2003; Ching Kang Chen et 
al. 2000; Keresztes et al. 2004). The GAP activity of transducin is also increased by 
PDE6γ thereby ensuring that termination of phototransduction cannot occur until after 
PDE6α and β have hydrolysed cGMP (Angleson and Wensel 1994; Skiba, Hopp, and 
Arshavsky 2000). 
Guanyl cyclase (GC) enzymes synthesis cGMP and are essential for restoring dark 
levels of cGMP during recovery of phototransduction. GC activity is regulated by Ca2+ 
and guanyl cyclase activating proteins (GCAP) (Yau 1994). In mouse two gaunyl 
cyclase enzymes exist, GC1 and GC2. GC1 is expressed in both rods and cones and 
GC2 is expressed in only rods (Xinran Liu et al. 1994; Lowe et al. 1995). A Gc1 -/- 
mouse revealed that GC1 is required for cone survival as these mice exhibit cone 
degeneration (R. B. Yang et al. 1999). In the dark the high concentration of Ca2+ in 
the cell facilitates the formation of GCAP-Ca2+ which inhibits GCs however in the light 
the low level of Ca2+ results in Ca2+ free GCAP and GCs are free to generate more 
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cGMP (Yingbin Fu and Yau 2007). In mice there are two GCAPs, GCAP1 and 
GCAP2, both of which are expressed in rods (Cuenca et al. 1998; Howes et al. 1998). 
A double knockout mouse revealed GCAP deficient photoreceptors have an 
increased A-wave amplitude and decreased recovery rate after phototransduction in 
line with a decreased rate of cGMP restoration (A. Mendez et al. 2001). These mice 
were also used to determine that activation of GCs occurs 40ms after the flash much 
faster than phosphorylation of rhodopsin which occurs 80-100ms after flash (Marie E. 
Burns et al. 2002). 
1.1.4.3 Phototransduction in Cones 
 
Human cone photoreceptors express either M/L or S opsin photopigments which bind 
11-cis retinal to facilitate colour vision. M/L opsin and S opsin have peak absorption 
spectra a 508nm and 360nm respectively and the Meta II state of cone opsins 
degrades 50 times faster than rhodopsin (Yingbin Fu and Yau 2007; Imai et al. 1997). 
After activation of opsin by light absorption, the downstream signalling process in 
cones is similar to that in rods however some differences in specific protein isoforms 
do exist (Yingbin Fu and Yau 2007). In cones signal amplification from a single photon 
is 250 times less efficient than in rods and 30 times less efficient at activating 
transducin (Kawamura and Tachibanaki 2008). In cones the Gαt2Gβ3γ8 isoform of 
transducin is expressed and the CNG channel in cones has a 2 CNGA3: 2 CNGB3 
stoichiometry (Lee et al. 1992; C. Peng, Rich, and Varnum 2004; Fung, Lieberman, 
and Lee 1992). As expected CNGA3 deficient mice show no cone photoreceptor 
responses and are commonly used in studies as a method of blocking cone 
photoreceptor responses (Biel et al. 1999; Y. Fu et al. 2005). In humans, mutations in 
CNGA3 and CNGB3 cause achromatopsia, a condition in which patients have no 
colour vision (S Kohl et al. 1998; Susanne Kohl et al. 2000). Rod PDE6 consists of 
the PDE6α and PDE6β catalytic subunits and two identical PDE6γ inhibitory subunits 
however in cones the catalytic core of PDE6 contains two identical PDE6α subunits 
and cone PDE6 also contains two cone specific PDE6γ subunits. AAV delivery of 
cone PDE6α in the rd10 mouse, which carries a point mutation in Pde6β (B. Chang 
et al. 2002), demonstrated that cone PDE6α can form a functional complex with rod 
PDE6γ which restores rod photoreceptor responses. Rods expressing cone PDE6α 
were two times more sensitive to light that WT rods demonstrating that cone PDE6α 
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has distinct physiological properties which contribute to the functional differences 
between rods and cones (Deng et al. 2013).  
To terminate phototransduction in cones, cone opsin pigments are phosphorylated on 
more residues than rhodopsin, on human M/L opsin 10 phosphorylation sites have 
been identified (Yingbin Fu and Yau 2007). In all species studied except mice and 
rats, two GRKs are expressed, GRK1 in rods and GRK7 in cones, mice and rats 
express only GRK1 in both rods and cones (Lyubarsky et al. 2000; C K Chen et al. 
1999; Yingbin Fu and Yau 2007). GRK7 is present at a much higher concentration in 
cones than GRK1 is in rods and the specific activity of GRK7 has been shown to be 
higher than that of GRK1 (Weiss et al. 2001; Tachibanaki et al. 2005; Wada et al. 
2006). Phosphorylation of opsin occurs 50 times faster in carp cones compared to 
rods and the presence of more phosphorylation sites and expression of GRK7 rather 
than GRK1 is thought explain this difference (Kawamura and Tachibanaki 2008).  
Cone photoreceptors also express their own arrestin known as cone arrestin or X-
arrestin, however in mice both rod and cone arrestin are expressed in cones (Cheryl 
M. Craft and Whitmore 1995; Zhu et al. 2005). A cone arrestin knockout mouse 
demonstrated that cone arrestin is essential for recovery of cone response and even 
though rod arrestin is expressed in cones it does not compensate for cone arrestin (C 
M Craft et al. 2006). In rods overexpression of the RGS9-1 R9AP Gβ5-L GAP complex 
established that termination of G*-PDE6* is the rate limiting step in recovery of the 
photoresponse as no effect on rate of recovery was detected with GRK1 
overexpression but increased recovery was observed with overexpression of the GAP 
complex (Claudia M. Krispel et al. 2006). It is thought that this is also the rate limiting 
step in cones however  the concentration of RGS9-1 R9AP Gβ5-L is much higher in 
cones than in rods indicating that this may not necessarily be the rate limiting step in 























1.1.4.4 Light and Dark Adaptation 
 
After exposure to bright light photopigment bleaching occurs resulting in reduced 
photoreceptor sensitivity. This process occurs due to delay in the renewal of 
photopigment and the presence of a steady decreased cytoplasmic Ca2+ 
concentration (Fain, Matthews, and Cornwall 1996). Under steady background light 
rods become gradually desensitised, this is known as background or light adaptation. 
After photobleaching, the slow recovery of the dark current is known as dark 
adaptation (Fain, Matthews, and Cornwall 1996). Some proteins undergo light 
induced translocation from the OS to the IS after exposure to bright light (Whelan and 
McGinnis 1988). The most well studied example of this phenomenon is transducin. In 
rods the Gαt1 and the Gβ1γ1 subunits of transducin translocate to the IS upon light 
Schematic of the steps of phototransduction in rods. Rhodopsin is activated by 
absorption of a photon becoming R*. R* then hydrolyses the Gα subunit of 
transducin generating G*. G* then displaces PDE6γ freeing catalytically active 
PDE6α and PDE6β to hydrolyse cGMP. The resulting decrease in cGMP levels 
lead to closure of the CNG channels which decreases cytoplasmic Ca2+ levels. The 
decrease in cytoplasmic Ca2+ levels stimulates the production of cGMP from GC 
which in turn leads to re-opening of the CNG channels and restoration of 
intracellular Ca2+ levels.  
Taken from Fain et.al 1996 
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stimulation (Brann and Cohen 1987; Sokolov et al. 2002). This process is thought to 
prevent rod photoreceptor activation under bright light and to protect against light 
induced toxicity (Elias et al. 2004; Sokolov et al. 2002). Gαt2 does not translocate from 
the cone OS under light stimulation, thus cone phototransduction can occur under 
bright light conditions (Kennedy, Dunn, and Hurley 2004). Transducin is lipid modified 
at both the N and C terminus, the N Terminal Gα subunit is acylated and the C terminal 
Gγ subunit is farnesylated (Y. Fukada et al. 1990; Kokame et al. 1992; Neubert et al. 
1992). These post translational lipid modifications regulate its ability to translocate 
under light adaption as Kassai et.al demonstrated in mice where the farnesylated 
group on Gγ1 was replaced with a geranylgeranyl group the ability of Gγ1 to 
translocate under light adaption was reduced and consequently these mice were 
unable to facilitate proper light adaptation (Kassai et al. 2005). In electroretinography 
(ERG) studies,  to analyse rod responses, subjects are firstly dark adapted so that 
maximum sensitivity can be detected however when cone function is to be studied 
rod responses are shut off through photobleaching by exposure to a bright 
background light. 
1.1.5 Comparison of Human and Mouse Retina 
 
The mouse retina is rod dominated, as only 3% of photoreceptors are cones (Carter-
Dawson and LaVail 1979). One of the most pertinent differences between the human 
and the mouse retina is the absence of the macula or fovea in the mouse (Carter-
Dawson and LaVail 1979). The macula is a region in the central retina of humans and 
many other non-primates that facilitates the sharp central vision which is required for 
reading, driving and seeing fine details. The centre of the macula contains the fovea 
centrialis where cone photoreceptors are most densely packed and no rod 
photoreceptors are found (Curcio et al. 1990; Hendrickson 2005). Although the mouse 
retina does not have a fovea it does have a region of high cone cell density present 
near the central retina (Volland et al. 2015). The mouse has large RPE cells which 
facilitate 3 times the phagocytic load of human RPE cells (Volland et al. 2015). Given 
that OS phagocytosis is essential for survival of photoreceptors, this may be an 
important feature to consider when analysing disease progression in the mouse. 
Mouse cone photoreceptors differ from human cones in that humans have three 
subtypes of cones, one which expresses L opsin, one which expresses M opsin and 
one which expresses S opsin (Hunt et.al 2005), however in the mouse only one type 
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of cone cell exists that expresses both M/L and S opsin (Applebury et al. 2000). In 
this study, it was demonstrated that all mouse cones express M/L and S opsins but 
the level of expression of each per cone cell varies from the peripheral to the central 
retina. In extremely peripheral regions S opsin expression was stochastic and some 
cones expressed only M/L opsin (Applebury et al. 2000). Mice are the most commonly 
used model of human retinal degenerations therefore, it is important to consider these 
differences in the retina when comparing findings to human patients. 
1.2 Inherited Retinal Degeneration 
 
Retinal degeneration can be associated with either syndromic or non-syndromic 
ciliopathies, with non-syndromic inherited retinal degeneration displaying a huge 
amount of genetic and clinical heterogeneity. Mutations in approximately 250 genes 
are associated with inherited retinal degenerations meaning a specific diagnosis is 
often not possible based on clinical phenotype alone (Hafler 2017). The shear amount 
of genetic heterogeneity that exists in diseases of  inherited retinal degeneration 
suggests photoreceptor cell death may be a common outcome resulting from the 
disruption of multiple biochemical processes (Sullivan and Daiger 1996). Non- 
syndromic inherited retinal degenerations include Retinitis Pigmentosa (RP), Macular 
Degeneration (MD), Startgardt’s Disease, Leber Congenital Amaurosis (LCA) and 
Cone-Rod Dystrophies (Daiger, Sullivan, and Bowne 2013; de Jong 2006; den 
Hollander et al. 2008; C. P. Hamel 2007) which differ by rate of disease progression 
and age of onset. Syndromic forms of retinal degeneration include the ciliopathies 
Joubert syndrome and Bardet Bidel syndrome which involve retinal degeneration in 
combination with kidney, lung and brain phenotypes. Another well known syndromic 
form of RP is Usher syndrome which  manifests as retinal degeneration in combination 
with hearing impairment in childhood (Saraiva and Baraitser, n.d.; Forsythe and 
Beales 2013; Boughman, Vernon, and Shaver 1983). Table 1.1 lists various non-
syndromic forms of inherited retinal degenerations, examples of genes which when 





Table 1. 1 Non-Syndromic and Syndromic Inherited Retinal Degenerations 
Disease Genes Mutated Patient Phenotype 
Retinitis Pigmentosa Examples of some 
causative genes:  
Autosomal Dominant: 
CRX, PRPF3, BEST1, 
CA4, ARL3 
Autosomal Recessive: 
CNGA1, CNGB1, CRB1, 
IDH3B 
X-linked: RPGR, RP2  
Over 100 genes known to 
cause the disease (Strom 
et al. 2016; Daiger, 
Sullivan, and Bowne 
2013; Galan et al. 2011) 
Loss of night vision 
followed by progressive 
loss of peripheral and 
central vision (Daiger, 
Sullivan, and Bowne 
2013) 
Macular Degeneration CFH, APOE, ABCA4 
Environmental risk factor 
is smoking. (de Jong 
2006) 
Late onset loss of central 
vision occurs in 
adulthood.  
Wet form caused by 
haemorrhage in the eye 
which causes detachment 
of the RPE. Occurs 
rapidly and vison loss 
occurs after a few weeks.  
Dry form progresses 
slowly over time. (de Jong 
2006) 
 
Stargardt’s Disease  ABCA4 (Kong et al. 2008) Occurs in second decade 
of life leads to progressive 
loss of central vision and 
development of macular 




List of non-syndromic forms of Inherited Retinal Degenerations. Inherited Retinal 
Degenerations are highly heterogenous as mutations in many genes have been 
identified as causative. Phenotypes vary between conditions but consistently 




CRB1, RPE65 (den 
Hollander et al. 2008) 
Autosomal recessive 
blindness from birth or 
before 1 year of age. No 
ability to follow light and 
flat line ERG response. In 
childhood retinal 
degeneration occurs and 
is observed by 
appearance of pigmented 
deposits in the retina. 
(den Hollander et al. 
2008)  
Cone-Rod Dystrophy ABCA4, CRX, GUCY2D, 
RPGR (C. P. Hamel 2007) 
Loss of central vison, 
photosensitivity followed 
by later onset of night 





1.2.1 X-Linked Retinitis Pigmentosa 
 
Retinitis Pigmentosa (RP) is a leading cause of inherited blindness worldwide 
affecting around 1:3000-1:7000 people (C. Hamel 2006). RP firstly presents as night 
blindness in childhood, adolescence or adulthood caused by the degeneration of rod 
photoreceptors followed by secondary cone cell death which leads to loss of central 
vision (Daiger, Sullivan, and Bowne 2013). Retinitis Pigmentosa is genetically 
heterogeneous, as over 100 genes have been identified as being causative for the 
condition (Galan et al. 2011) (see Table 1.1 for examples). A huge amount of clinical 
heterogeneity exists in RP with age of onset and rate of disease progression varying 
even between patients from the same families, which harbour the same pathogenic 
mutation (Sullivan and Daiger 1996; Daiger, Sullivan, and Bowne 2013). RP has three 
sub-types attributed to the mode of inheritance autosomal dominant (ADRP), 
autosomal recessive (ARRP) and X-linked (XLRP). Autosomal recessive and X-linked 
have the most severe clinical phenotype in terms of age of onset and disease 
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progression (Daiger, Sullivan, and Bowne 2013). Most cases of X-linked RP (70-90%) 
are caused by mutations in Retinitis Pigmentosa GTPase Regulator (RPGR), 
mutations in Retinitis Pigmentosa 2 (RP2) account for the remaining 7-18% (see 1.3 
for detailed discussion of RP2 function) however an intronic mutation in Oral Facial 
Digital syndrome 1 (OFD1)  has also been reported to cause X-linked RP in one family 
(Sahel, Marazova, and Audo 2015; Webb et al. 2012).  
1.2.2 RPGR Function in the Photoreceptor 
 
Initial isolation of RPGR identified a transcript containing 19 exons that is expressed 
in multiple tissues (Meindl et al. 1996; Yan et al. 1998). Identification of a second 
splice isoform originating from a splice site within intron 15 lead to the identification of 
RPGRORF15 (Vervoort et al. 2000). Further studies have shown that the RPGRORF15 
isoform is specifically expressed in the retina and is a mutational hotspot in patients 
with XLRP (Kirschner et al. 1999). RPGRORF15 contains a highly GC rich sequence 
and Glu-Gly rich repetitive C-terminal domain which is glutamylated prior to anchoring 
to the membrane of the CC in vivo (Sergouniotis et al. 2014; Hong et al. 2000, 2003). 
The Rpgr knockout mouse displayed mislocalisation of opsins generating the 
hypothesis that RPGR has a role in trafficking opsins from the IS to the OS via the 
CC (Hong et al. 2000). This was also observed in autopsy samples from human XLRP 
patients (Adamian et al. 2006). The N-terminal region of RPGR has guanine 
nucleotide exchange factor (GEF) activity for the small GTPase Rab8 (Murga-
Zamalloa et al. 2010). Rab8 is involved in trafficking rhodopsin to the OS implying 
RPGR may regulate rhodopsin trafficking through this mechanism (Moritz et al. 2001).  
RPGR has also been shown to interact with PDE6δ (Linari, Hanzal-Bayer, and Becker 
1999), a highly conserved chaperone protein that functions to traffic prenylated 
proteins to the OS (H Zhang et al. 2007).  RPGR also interacts with RPGRIP1 (RPGR 
Interacting Protein 1) at the CC of photoreceptors (Boylan and Wright 2000; Roepman 
et al. 2000) and RPGRIP1 also interacts with PDE6δ (Wätzlich et al. 2013). The 
binding sites on RPGR for PDE6δ and RPGRIP1 overlap (Remans et al. 2014) 
indicating that PDE6δ may be involved in trafficking RPGR to the CC where RPGRIP1 
stimulates release of RPGR from PDE6δ. However this also alludes to the possibility 
that RPGR may have a role in regulating trafficking of prenylated OS proteins, a 
phenomenon that when disrupted causes photoreceptor cell death (Houbin Zhang et 
al. 2015; Z. C. Wright et al. 2016; H Zhang et al. 2007).  
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The ORF15 domain interacts with the scaffolding protein Whirlin which has been 
shown to regulate actin dynamics in the ear through its interaction with epsin (R. N. 
Wright, Hong, and Perkins 2012; J. Yang et al. 2010). Rhodopsin trafficking is 
controlled by the actin based motor protein myosin VIIa (Wolfrum and Schmitt 2000) 
implying RPGR could regulate rhodopsin trafficking through regulation of actin 
dynamics. It has recently been demonstrated that a human XLRP mutation in RPGR 
disrupts the interaction of RPGR with the actin cleavage protein gelsolin. Rpgr 
knockout mice and retinal cultures derived from human RPGR mutation carrying 
patient induced pluripotent stem cells (iPSC) displayed increased actin polymerisation 
in the CC and mislocalisation of rhodopsin. Furthermore, this phenotype is also 
present in the gelsolin (Gsn-/-) knockout mouse demonstrating that RPGR is required 
for regulation of gelsolin, which regulates actin polymerisation in the CC, thus 
regulating rhodopsin trafficking which is essential for photoreceptor maintenance 
(Megaw et al., 2017).  
1.2.3 Mechanisms of Cell Death in RP 
 
The mechanism of photoreceptor cell death in humans is not well understood however 
studies of  cell death mechanism in multiple animal models has revealed that 
photoreceptors commonly die by apoptosis (Travis 1998). This finding has been 
observed in studies focussing on the rd1 mouse, which carries a nonsense mutation 
in Pde6β, the rds mouse, which carries a mutation in peripherin, and engineered mice 
containing human rhodopsin mutations associated with ADRP (G. Q. Chang, Hao, 
and Wong 1993; Portera-Cailliau et al. 1994). However in retinal degeneration 10 
(rd10) mice, which carry a point mutation in exon 13 of Pde6β and have a slower, 
later onset degeneration than the rd1 mouse (B. Chang et al. 2002), ablation of 
necrosis factor receptor interacting protein kinase 3 (RIP3) protected against cone 
cell death. Further analysis of the morphology of cone cells during retinal 
degeneration in rd10 retinas revealed the presence of both apoptotic nuclei and 
necrotic cells (Murakami et al. 2012). In human patients the method of cell death as 
well as the mechanisms which drive cell death are unclear, in order to preserve vision 
in patients with inherited retinal degenerations it is essential that the mechanisms 





1.2.3.1 Phototransduction Defects 
 
In rd1 -/- mice the levels of cGMP are 10 fold higher than WT leading to a huge influx 
of Ca2+ from the cGMP-gated channels. The large increase in Ca2+ levels is thought 
to directly activate apoptosis (Farber and Lolley 1977; Bowes et al. 1990). Continuous 
exposure to light causes photoreceptor cell death and blindness (Travis 1998) and 
many mutations associated with retinal degeneration constitutively activate the 
phototransduction cascade. Homozygous mutations in cGMP gated channels (Dryja 
et al. 1995) and human rhodopsin mutations G90, T94, A292, are all thought to lead 
to constitutive activation of transducin (Mendes et al. 2005). The hyper- activation of 
phototransduction is thought to cause oxidative stress in the photoreceptor however 
the exact mechanism which triggers apoptosis is not completely understood (Travis 
1998). In salamander rods it was shown that mislocalised rhodopsin is still able to 
activate the phototransduction cascade and this initiates apoptosis through a 
caspase-3 mechanism (Alfinito and Townes-Anderson 2002). Many human 
pathogenic mutations in rhodopsin lead to rhodopsin mislocalisation (Mendes et al. 
2005) and therefore it is possible that these mislocalised rhodopsin molecules can 
aberrantly activate phototransduction (Alfinito and Townes-Anderson 2002) and 
stimulate apoptosis.  
1.2.3.2 ER Stress 
  
The ER performs essential functions in protein synthesis, regulation of protein post 
translational modifications and protein sorting (Bravo et al. 2013). An accumulation of 
misfolded or misprocessed proteins can activate the unfolded protein response (UPR) 
which exists to protect against ER stress. UPR involves multiple mechanisms which 
are activated to restore ER homeostasis including upregulation of factors to assist 
protein folding, inhibition of protein translation and increased degradation of  
misfolded proteins (Bravo et al. 2013). If the insult to the ER cannot be contained by 
the UPR ER stress ensues and this can trigger apoptosis through caspase 12 
(Szegezdi et al. 2006). Multiple human rhodopsin mutations, which cause RP,  have 
been shown to result in rhodopsin retention in the ER (Mendes et al. 2005). It has 
been demonstrated in the rd1 mouse that degenerating photoreceptors have 
increased expression of the ER stress factors glucose regulated protein 78kDa/ 
binding immunoglobulin protein (GRP78/BiP), eukaryotic translation initiation factor 
30 
 
2A  (EIF2a) and protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) 
furthermore caspase 12 can translocate from the IS to the nuclei of degenerating 
photoreceptors (L. P. Yang et al. 2007; Sanges and Marigo 2006).  
1.2.3.3 Oxidative Stress 
 
Generation of reactive oxidative species (ROS) and oxidative stress is the natural 
biproduct of mitochondrial ATP generation, consequently cells contain multiple 
mechanisms to protect against oxidative damage known as the antioxidant network 
(Sancho-Pelluz et al. 2008). Increased oxidative stress can result from increases in 
the ATP demand in cells, defects in oxidative phosphorylation or deficiencies in 
defence mechanisms (Halliwell 2006). In other forms of neurodegeneration oxidative 
stress is prompted by loss of apoptosis inducing factor (AIF) localisation to 
mitochondria. AIF has high redox activity therefore depletion of AIF results in an 
increase in ROS (Yamashima 2004). Downregulation of the oxidative stress 
protective proteins glutathione-S-transferase and glutathione peroxidase has been 
reported to contribute to retinal degeneration in the rd1 mouse (Ahuja-Jensen et al. 
2007; Ahuja et al. 2005). The major biproduct in DNA resulting from ROS’s is 
oxidation of guanine to generate 8-oxoguanasine (8-oxoG) (Kasai and Nishimura 
1984). 8-oxoG is able to base pair with either adenine or cytosine so is highly 
mutagenic (Maki 2002), the accumulation of multiple mis-matched bases if not 
repaired can lead to apoptosis (Hickman and Samson 1999). Interestingly, samples 
of visceral fluid from eyes of human RP patients demonstrated increased oxidative 
stress as measured by increased levels of carbonyl adducts on proteins which 
occurs as a result of oxidative stress (Campochiaro et al. 2015). Furthermore 
antioxidant treatment increased photoreceptor survival in rd1 mice (Sanz et al. 
2007) together suggesting oxidative stress induced apoptosis may be an attractive 
therapeutic target in patients.  
1.2.3.4 DNA Damage and Transcription 
 
DNA damage induces the expression of multiple repair enzymes such as poly ADP-
ribose polymerase (PARP) and oxyguanine glycosylase (OGG) (Shakibaei et al. 
2007; Schreiber et al. 2006). OGG is required to repair mis-match lesions which 
result from ROS induced 8-oxoG generation (Hill, Hu, and Evans 2008). As PARP 
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functions to promote DNA repair (Schreiber et al. 2006) it is natural to assume that 
its activity is protective to the cell, however overexpression of PARP causes 
increased ATP consumption and oxidative stress (Du et al. 2003). In the rd1 mouse 
excessive activity of PARP has been reported and may promote retinal degeneration 
(François Paquet-Durand et al. 2007). The increased survival of photoreceptors in 
antioxidant treated rd1 retinas was partially attributed to a reduction in oxidative 
stress induced DNA damage (Sanz et al. 2007).  
Onset of retinal degeneration is accompanied by huge changes in the transcriptome 
of the retina (Loscher et al. 2008). Changes in the transcription of transcription 
factors can influence a myriad of downstream signalling and can influence cell 
survival pathways. For example ablation of c-fos, a subunit of transcription factor 
complex activator protein- 1 (AP-1), completely prevented cell death in a light 
induced model of retinal degeneration (Eferl and Wagner 2003; Wenzel et al. 2000). 
cAMP response element binding protein (CREB) is a master transcription factor 
which controls the transcription of multiple genes involved the survival of neurons 
(CREB target gene database: http://natural.salk.edu/CREB). CREB regulates the 
transcription of OGG and the anti-apoptotic protein B-cell lymphoma 2 (BCL2) (X. 
Zhang et al. 2005; Lonze and Ginty 2002). Reduced CREB expression was detected 
in the rd1 mouse (Francois Paquet-Durand et al. 2006) and furthermore in a study 
in rats with retinal degeneration, the protective effect of antioxidant pituitary 
adenylate cyclase-activating polypeptide (PACAP) was attributed to increased CREB 
expression and signalling (Rácz et al. 2006).  
1.2.3.5 Secondary Cone Cell Death 
 
A hallmark of RP is loss of rod photoreceptors followed by secondary cone cell 
death. Currently four models exist which may explain why cone cells die after rod 
degeneration; 1. Death of rod cells releases toxic factors which kills cones (Ripps 
2002), 2. As rod cells die microglial activation occurs and microglial cells migrate to 
the photoreceptor layer and secrete substances which kill cones (Gupta, Brown, and 
Milam 2003), 3. Rods secrete a factor that is required for cones for survival 
(Léveillard et al. 2004)  4. Death of rods causes increased oxidative stress in cones 
(Shen et al. 2005). The major flaw of the first three hypotheses is that in patients 
cones can survive for years after all rods have been lost (Shen et al. 2005) therefore 
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rod cell death resulting in  increased oxidative stress in cones is currently the 
prevailing hypothesis.  
As rods degenerate oxygen levels in the retina increase (D.-Y. Yu et al. 2000). This 
is because the retinal vasculature does not enter the outer retina instead, the outer 
retina is provided with oxygen by diffusion from choroidal vessels located behind the 
RPE (Figure 1.3). In the inner retina if oxygen levels are high vessels constrict, 
reducing blood flow however as the choroidal vessels do not enter the outer retina 
they do not adapt to changes in oxygen concentration (Campochiaro and Mir 2018) 
(Figure 1.3). This results in extremely elevated oxygen levels as rod cells die as the 
volume of oxygen supplied remains steady despite loss of the prevailing cell type. 
This effect was observed  in a cat model of RP where photoreceptor oxygen 
consumption was reduced as retinal degeneration progressed causing high levels 
of oxygen throughout the outer retina that spread to the inner retina causing 
increased restriction of vessels (Padnick-Silver et al. 2006). Increased oxygen levels 
lead to oxidative stress which manifests via the mechanism described above (see 
1.2.3.3). Further evidence supporting this hypothesis comes from multiple studies 
which have demonstrated decreasing oxidative stress protects against cone cell 





























1.2.3.6 Loss of OS Targeting and OS Shortening 
 
A common feature in mouse models of RP is mislocalisation of OS proteins within 
the photoreceptor (F. Liu et al. 2015; Houbin Zhang et al. 2015; Z. C. Wright et al. 
2016; Hong et al. 2000). This phenotype is observed in mouse models harbouring 
mutations in Rpgr and Rp2h and precedes photoreceptor cell death (Houbin Zhang 
et al. 2015; L. Li et al. 2013; Hong et al. 2000). Many human pathogenic mutations 
in rhodopsin result in rhodopsin mislocalisation (Mendes et al. 2005). Furthermore 
in mice where the  photoreceptor chaperone proteins PDE6δ and Uncoordinated 
119 (UNC119), which function to traffic proteins to the OS, have been knocked out 
mislocalisation of various proteins is observed accompanied by progressive retinal 
degeneration (H Zhang et al. 2007; Ishiba et al. 2007). It is hypothesised that these 
mistargeted proteins may trigger apoptosis as; they overwhelm the normal 
Schematic of Retinal Vasculature. The Retina has two blood supplies. The retinal 
vasculature supplies the inner retina with oxygen. The choroidal vasculature 
provides the outer retina with oxygen via diffusion through the RPE and inner and 
outer segments. 
Adapted from Campochario et.al 2018 
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trafficking machinery and interrupt with the trafficking of normal cargos, the large 
amount of mistargeted proteins in the wrong cellular compartments may interfere 
with normal cellular processes or a metabolic burden may be put on photoreceptors 
due to continuous degradation of mutant proteins (Mendes et al. 2005).  
Another common feature of mouse models of retinal degeneration is shortening of 
the OS prior to cell death (Travis 1998). Loss of the OS is accompanied by loss of 
the cGMP-gated channels leading to a decrease in cation influx. This then unloads 
the mitochondrial Na+K+ ATPase channels resulting in reduced oxygen consumption 
and reduced ATP generation by the IS mitochondria. With loss of the OS the IS and 
ONL are closer to the oxygen rich choroid capillaries (Figure 1.3) and may be 
exposed to higher oxygen concentrations which may in itself trigger oxidative stress 
and cell death (Mendes et al. 2005). Interestingly a double knockout of peripherin 
and β subunit of PDE6 (rds -/-, rd1 -/-) has a slower rate of cell death than the rd1 -
/- mutant alone demonstrating that loss of OS reduces cation influx which produces 
a protective effect against loss of PDE6β (Sanyal and Jansen 1989) as a dramatic 
increase in intracellular Ca2+ levels is avoided.  
Mislocalisation of OS proteins is a common outcome of mutations in many genes 
which cause retinal degenerations. Mislocalised OS proteins and shortening of the 
OS likely stimulate apoptosis through various mechanisms as discussed above e.g. 
mistrafficked proteins may stimulate ER stress, shortening of the OS and 
mistargeting of proteins involved in phototransduction would likely cause 
phototransduction defects and loss of Ca2+ regulation, which in turn can affect 
mitochondrial function leading to oxidative stress and DNA damage. Therefore, in 
order to develop effective therapies for RP it is paramount that the functional defects 
caused by pathogenic mutations are understood as treatments that reduce oxidative 
stress may only be effective temporarily as ultimately apoptosis may be activated 
through alternative mechanisms. However, a treatment that directly prevents 
mislocalisation of proteins would be expected to be effective long term. It is 
important to note that mislocalisation of proteins may not be the only pathogenic 
mechanism which stimulates apoptosis in RP as mutations in genes which encode 
for splicing factors, which would be expected to affect RNA transcripts, not protein 
localisation, are causative of ADRP (Chakarova et al. 2002; McKie et al. 2001; 
Vithana et al. 2001).  
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1.3 RP2 and ARL3 Protein Structure and Function 
 
1.3.1 The RP2 Protein  
The RP2 gene encodes the 350aa protein RP2 which is ubiquitously expressed at a 
low level in all tissues (Schwahn et al. 1998). The crystal structure of the RP2 protein 
revealed an amino-terminal β sheet domain which is homologous to the tubulin 
specific chaperone co-factor C (Kühnel et al. 2006). Co- factor C in conjunction with 
co factor D stimulates GTP hydrolysis during tubulin folding. In vitro assays by 
Bartolini et.al demonstrated RP2 also has GAP activity by establishing that RP2 is 
capable of stimulating the GTP hydrolysis of tubulin in conjunction with co factor D 
(Bartolini et al. 2002). A second C terminal domain of unknown function shows 
homology to nucleoside diphosphate kinase (NDK) (Kühnel et al. 2006). In renal 
epithelial cells, RP2 localised to the basal body and axoneme of primary cilia (Hurd, 
Fan and Margolis, 2011). In the mouse retina RP2 localises to the basal body of the 
photoreceptor connecting cilia, the periciliary ridge and Golgi (Evans et al. 2010). 
Localisation of RP2 is regulated by post translational modifications, palmitoylation at 
Cysteine 3 (C3) and myristolation at Glycine (G2)(Chapple et al., 2000, 2002).  
RP2 interacts with the small GTPase ARF Like Protein 3 (ARL3) (Figure 1.4). 
Biochemical studies demonstrated RP2 co-crystallises with ARL3-GTP and is capable 
of increasing ARL3 GTPase activity by about 90,000 times in vitro (Veltel, Gasper, et 
al. 2008). ARL3 is localised to microtubule structures throughout the human retina 
and is highly enriched at the CC (Grayson et al. 2002). Therefore similar to the 
function of ARF proteins in intracellular transport it is hypothesised that ARL3 and 
RP2 play an important role in the trafficking of cargo within the retina from the IS to 
the OS with disruptions in this process known to cause retinal degeneration (Kühnel 
et al. 2006). Ismail et.al demonstrated that ARL3 is capable of trafficking prenylated 
proteins in cells. Upon activation by its guanine nucleotide exchange factor (GEF) 
ARL13B (Gotthardt et al. 2015), ARL3 is converted from the inactive ARL3-GDP to 
the active conformation, ARL3-GTP. ARL3-GTP is able to bind to the chaperone 
phosphodiesterase 6 δ (PDE6δ), which forms a soluble complex with prenylated 
proteins, and uncoordinated 119 (UNC119) which solubilises myristolated proteins 
(Fansa et al. 2016; Ismail et al. 2011). Upon stimulation of GTP hydrolysis by RP2, 
ARL3-GTP is converted to ARL3-GDP resulting in a conformational change in either 
PDE6δ or UNC119 and the release of their cargo (Ismail et al. 2011; Wätzlich et al. 
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2013). RP2 and ARL3 also regulate the trafficking of transducin β1 (Gβ1) in ARPE19 
cells. RP2 is required for membrane localisation of Gβ1 and expression of ARL3-
Q71L, constitutively active ARL3, locked in the GTP bound form, disrupted this 
membrane localisation. RP2 is required for the incorporation of Gβ1 into Rab11 
vesicles suggesting RP2 and ARL3 may regulate the trafficking of Gβ1 to the OS 
through this mechanism (Schwarz et al. 2012). Rab11 has been implicated in the 
trafficking of rhodopsin in drosophila photoreceptors and is essential for ciliogenesis 
in mammalian cells (Satoh 2005; Knodler et al. 2010). Rab11 mediates trafficking 
through the trans-Golgi network from early endosomes and stimulates the GEF 
activity of Rabin 8 for Rab8 (Wilcke et al. 2000; Knodler et al. 2010). As Rabin 8 and 
Rab8 mediate membrane trafficking during ciliogenesis and as rhodopsin is trafficked 
to the OS in Rab8 associated vesicles in mammalian photoreceptors (Nachury et al. 
2007; Moritz et al. 2001), this suggests that RP2 and ARL3 could regulate the 
trafficking of other G proteins through this mechanism in vivo.  
The ciliary localisation of RP2 is regulated by binding of importin β2 through the M9-
core like sequence on RP2’s N terminus (T. W. Hurd, Fan, and Margolis 2011). 
Importin β2 directly binds cargo and releases them upon binding of Ran-GTP (Pollard 
et al. 1996; Bonifaci et al. 1997; Siomi et al. 1997). As Importins classically regulate 
the trafficking of nuclear proteins (Stewart 2007) this demonstrated a new role for 
importins in the trafficking of cilia proteins. As mutations in the importin β2 M9-core 
like binding sequence are found in patients with XLRP, this suggests this interaction 
is required for the function of RP2 in vivo (D. Sharon et al. 2000; T. W. Hurd, Fan, and 
Margolis 2011). RP2 also interacts with N-ethylmaleimide-sensitive factor (NSF), a 
protein which facilitates membrane/vesicle fusion by promoting disassembly of the 
soluble NSF attachment protein receptor (SNARE) complex in an ATP-dependant 
manner (Holopainen et al. 2010). This interaction suggests that RP2 could play a role 
in regulating vesicular trafficking as disassembly of the SNARE complex is required 
for recycling of the complex to enable the next round of vesicle- membrane fusion 
(Littleton et al. 2001). In MDCK cells RP2 regulates the ciliary localisation of polycystin 
2 and when either rp2 or polycystin 2 (pkd2)  is knocked down in zebrafish with 
morpholinos a similar phenotype of left-right asymmetry defects occurs and injection 
of morpholinos for both rp2 and pkd2 enhanced this phenotype suggesting both 
proteins function in the same pathway to regulate cilia function during zebrafish 
development (T. Hurd et al. 2010). Another study using rp2 morpholinos to knockdown 
Rp2 expression in zebrafish demonstrated rp2 is a maternal effect gene and 
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maternally derived rp2 mRNA is required for normal embryo development (Desvignes 
et al. 2015). However this finding has not been replicated in zebrafish with rp2 
knocked out using transcription activator-like effector nucleases (TALENs) (F. Liu et 
al. 2015) or in mammals as no fertility defects have been reported in mouse models 
where Rp2h expression is knocked out (Li et al. 2013; Zhang et al. 2015).  
1.3.2 RP2 Pathogenic Mutations 
 
Many identified pathogenic mutations in RP2 are predicted to result in no protein 
expression, however multiple missense mutations have been reported which are not 
destabilising therefore must disrupt RP2 function (Dror Sharon et al. 2003; F. Liu et 
al. 2017). The RP2 E135G and R118H mutations are predicted to disrupt the RP2-
ARL3 interaction (Veltel, Gasper, et al. 2008). Mutations at C3 and G2 disrupt the 
residues which are post-translationally modified in vivo leading to mislocalised RP2 
(Chapple et al. 2000, 2002). Expression of these mutants in cells has shown that 
mutations of C3 prevents palmitoylation and results in accumulation of RP2 at 
intracellular membranes, whereas mutation at G2 results in nuclear accumulation 
(Chapple et al. 2000). Mutation at G2 prevents myristoylation and palmitoylation of 
RP2 therefore nuclear accumulation is thought to occur as a result of the nuclear 
localisation sequence-like (NLS-like) sequence downstream from G2 (Chapple et al. 
2000; T. W. Hurd, Fan, and Margolis 2011). The R211L mutation is not destabilising 
and does not disrupt the RP2-ARL3 interaction as this residue is not close to this 
interaction interface. R211L does disrupt the interaction of RP2 with osteoclast 
stimulating factor 1 (OSTF1) although whether loss of this interaction directly leads to 
retinal degeneration still needs to be determined (Lyraki et al. 2018).  
1.3.3 RP2 vs RPGR Patient Phenotype 
 
In a review of the clinical phenotype of patients with XLRP attributed to RP2 mutation 
it was shown that early macular involvement was common in RP2 disease and 
therefore may be a hallmark of RP2 disease (Jayasundera et al. 2010). RP2 patients 
have earlier loss of central vision compared to RPGR patients despite the similarity in 
disease progression as measured by ERG response (Dror Sharon et al. 2003). Rod 
photoreceptors do not appear to be more severely affected in RP2 patients than in 
RPGR patients as onset of night blindness is similar (Flaxel et al. 1999). Early effects 
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on cone photoreceptors have also been recapitulated in mouse models where RP2 is 
knocked out (Li et al. 2013).  
1.3.4 The ARL3 protein 
 
Small GTPases act as the molecular switches of the cell by binding and hydrolysing 
GTP and therefore converting from the active to the inactive state. ARF-like GTPases 
facilitate GDP-GTP exchange via interacting GEFs and GAPs. GEFs bind the inactive 
GDP bound ARLs and stimulate conversion to the active state, followed by GAPs 
which stimulate the hydrolysis of GTP reverting the ARLs back to the inactive GDP 
bound form (Figure 1.5).   
The ARL family of small GTPases contains over 20 members which are conserved 
across eukaryotes (Yawei Li et al. 2004). A 3D conformation of ARL3 predicted it to 
have a similar structure to Ras GTPases with a six stranded β sheet surrounded by 5 
α helices (Hillig et al. 2000). Human CAGE data reveals ARL3 is most highly 
expressed in eye, heart and pineal gland, the pineal gland is one of the most ancient 
features of the vertebrate brain suggesting that ARL3 may have an ancient functional 
role conserved across species.  A comparative genomics study demonstrated that 
ARL3 and ARL6 are only found in ciliated organisms (Avidor-Reiss et al. 2004). ARL3 
is a microtubule associated protein which localised to the CC and microtubules in the 
human retina (Grayson et al. 2002). In cell culture systems ARL3 localises to the 
centrosome, mitotic spindle, Golgi membranes, nucleus and is enriched in primary 
cilia (Enjalbert et al. 2006; Avidor-Reiss et al. 2004). Early functional studies in C. 
elegans demonstrated that ARL3 is a negative regulator of ciliogenesis as Arl3-/- 
worms form normal cilia however overexpression of constitutively active ARL3 
(ARL3Q70L) causes ciliogenesis defects (Yujie Li et al. 2010). SiRNA knockdown of 
ARL3 in mammalian cells caused a range of phenotypes including defects in ciliary 
trafficking (Lai et al. 2011), Golgi fragmentation and defective cytokinesis (Enjalbert 
et al. 2006) suggesting ARL3 may have other roles not related to cilia function.  
A knockout of Arl3 in mice has a severe ciliopathy like phenotype with abnormal renal, 
hepatic and pancreatic epithelial tube structures, defects in photoreceptor 
development and severe cystic kidney disease resulting in death by 3 weeks of age 
(Schrick et al. 2006).  
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Figure 1.  4 Crystal Structure of RP2 and ARL3-GTP Interaction 
















Small GTPases are activated through interaction with GEFs (Guanine Nucleotide 
Exchange Factors) which facilitate GTP to GDP exchange. Active GTPases can 
then interact with their effector proteins. GTPases are inactivated by GAPs 
(GTPase Activating Proteins) which stimulate the hydrolysis of GTP to revert the 
GTPase back to the inactive state.  
Crystal Structure of ARL3-GTP complexed with RP2. Ribbon diagram of the ARL3-
GTP-RP2 complex (ARL3 Q71L): β-strands (red), α-helices (blue for ARL3 and 
green for RP2), and loops (purple) are shown with GTP bound to ARL3 (GTP, 
black). Figure was drawn with PyMOL (www.pymol.org, in the public domain). 
Taken from Baehr 2014 
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1.4 Roles of RP2 and ARL3 in Ciliary Trafficking 
 
1.4.1 General Principles of Cilia 
Cilia are small hair like microtubule-based organelles which protrude from the surface 
of almost every mammalian cell type and exist in two forms motile and non-motile or 
primary. Primary cilia are the cells antenna to the extracellular environment with 
studies over the last two decades demonstrating their role as the signalling hub for 
sonic hedgehog, wnt and other G- protein coupled receptor (GPCR) signalling 
pathways (Singla and Reiter 2006). Motile cilia protrude from specialised cell types 
and use dynein motors to generate beating motions essential for facilitating fluid flow 
across the cell surface (Ibañez-Tallon, Heintz, and Omran 2003). Many genes related 
to cilia function have been identified as causative of human ciliopathies, a 
heterogeneous group of syndromic and non-syndromic conditions which manifest with 
phenotypes including retinal degeneration, cystic kidneys, obesity and mental 
retardation. Cilia do not contain ribosomes so require a specialised trafficking system 
to supply the protein load required for their formation and function. This process is 
known as intraflagellar transport (IFT) and involves the co-operation of IFT complex 
A and dynein motors and IFT complex B and kinesins which control retrograde and 
anterograde transport of cargo, respectively (Rosenbaum and Witman 2002). A role 
for small GTPases in the regulation of cilia formation and function including members 
from the ARF, ARF-like, Ran and Rab super families has been established (Yujie Li 
and Hu 2011). ARF-like GTPases are thought to have a particularly significant role 
with regards to cilia function demonstrated by the identification of human pathogenic 
mutations in these proteins, ARL13B in Joubert syndrome (Cantagrel et al. 2008), 
ARL6 in Bardet-beidl syndrome (Khan et al. 2013) and most recently a point mutation 
in ARL3 being linked to dominantly inherited Retinitis Pigmentosa (Strom et al. 2016).  
1.4.2 Intraflagellar Transport  
During IFT non-membrane, bound particles are moved across the axonemal doublet 
microtubules from the base to the tip of the cilia. Cargos moving in this anterograde 
direction carry cargo required for the maintenance of the axonemes and cilia 
membranes. In the retrograde direction particles travel from the tip to the basal body, 
movement of cargo in this direction is required for recycling of  IFT particles and 
motors (Rosenbaum and Witman 2002) (Figure 1.6). Kinesin II is a heterotrimeric 
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complex of three subunits, two motor subunits kinesin family member 3A (Kif3a) and 
kinesin family member 3B (Kif3b) and the non-motor subunit kinesin associated 
protein (KAP) (Scholey 1996). Dynein’s use ATP hydrolysis to produce force required 
to move cargo within cells (Roberts et al. 2013) (Figure 1.6). Ciliated organisms have 
15 different dynein heavy chains however in mammals the dynein heavy chain 
required for IFT is dynein heavy chain 2 (DHC2H1) which exists in a complex with the 
cytoplasmic light intermediate chain 1 (DYNC2L11) (Pazour, Dickert, and Witman 
1999). The kinesins and dynein’s required for IFT associate with two large multiprotein 
intraflagellar transport complexes, IFTA and IFTB (Goetz and Anderson 2010). IFTB 
and kinesin II are required for anterograde trafficking and disruption of either one 
prevents cilia formation in vivo. IFTA and dynein’s regulate retrograde trafficking and 
disruption of retrograde transport results in small bulged cilia (Goetz and Anderson 
2010).  
RP2 and ARL3 has also been shown to function in ciliary trafficking as demonstrated 
by the mislocalisation of ciliary polycystins in Arl3 -/- worms and the requirement of 
RP2 for polycystin 2 cilia localisation in MDCK cells (Q. Zhang, Hu, and Ling 2013; T. 
Hurd et al. 2010). In cultured RPE cells it has been demonstrated that siRNA 
knockdown of RP2 does not affect ciliogenesis but causes Golgi fragmentation and 
consequently mislocalisation of intraflagellar transport protein 20 (IFT20) (Evans et 
al. 2010) and in MDCK cells RP2 knockdown again does not affect ciliogenesis but 
results in malformed cilia (T. Hurd et al. 2010). Golgi fragmentation was also observed 
with expression of constitutively active ARL3, ARL3 Q71L, and knockdown of Kif3a 
demonstrating RP2’s GAP activity on ARL3 is required for Golgi cohesion which has 
















1.4.3 Lipid Modified Protein Trafficking  
 
Cilia contain a large amount of lipid modified proteins and many studies have 
demonstrated the necessity of various posttranslational acylations for cilia membrane 
targeting (Mick et al. 2015; Roy et al. 2017; Kokame et al. 1992; Chapple et al. 2000). 
The prenyl binding protein PDE6δ and the myristol binding protein UNC119 interact 
with the RP2-ARL3 complex (S. a Ismail et al. 2011; S. A. Ismail et al. 2012). Both 
ARL2 and ARL3 are able to interact with PDE6δ and induce the release of prenylated 
cargo (S. a Ismail et al. 2011). Recently a study by Fansa et.al sought to investigate 
the mechanism by which PDE6δ can selectively target some cargo to the cilia and 
some to the cell body. Using inositol polyphosphate 5-phosphatase E (INPP5E) as an 
example of a protein trafficked exclusively to the cilia and Ras homolog enriched in 
brain (Rheb) a protein localised to endomembranes by PDE6δ, they showed that 
INPP5E has a 100x higher affinity for PDE6δ than Rheb. Using in vitro kinetic assays 
they demonstrated that ARL2 and ARL3 were both able to release Rheb from PDE6δ, 
however only ARL3 could release INPP5E. This has been confirmed in RPE-1 cells  
where it has been shown that only ARL3 and not ARL2 can release INPP5E from 
PDE6δ (S. Thomas et al. 2014). Furthermore siRNA knockdown of ARL3 caused 
INPP5E to be partially mislocalised to the cell body (Fansa et.al 2016). Together this 
The kinesin II motor protein and IFTB particles travel in the anterograde 
direction carrying cargo essential for building and maintenance of cilia. IFTA 
particles and the dynein motor complex travel in the retrograde direction 
carrying particles out of cilia so that IFT particles and motors can be recycled.  
Adapted from Rosenbaum and Witman 2003 
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Figure 1.  7 The Role of RP2-ARL3-PDE6δ in Cilia Trafficking 
evidence suggests a model of ciliary trafficking such that prenylated cargos are 
solubilised by PDE6δ, complexes binding with high affinity are trafficked to the cilia. 
ARL3 is activated by it’s GEF ARL13b, cargo is then released by ARL3-GTP in the 
cilia and low affinity complexes are released in the cytosol by ARL2-GTP (Fansa et 
al. 2016)(Figure 1.7). Only ARL3-GTP can efficiently release cargo from UNC119 (S. 
A. Ismail et al. 2012; K. J. Wright et al. 2011) and this is required for ciliary localisation 
of nephrocystin 3 (NPHP3) (K. J. Wright et al. 2011). The exact mechanism of cargo 
release differs slightly between PDE6δ and UNC119 such that when ARL3-GTP binds 
UNC119 it induces opening of the hydrophobic binding pocket resulting in release of 
cargo, whereas for PDE6δ ARL3-GTP binding induces closure of the hydrophobic 













Schematic of RP2-ARL3-PDE6δ trafficking in Cilia. High affinity cargo such as 
proteins destined for cilia e.g. INP55E bind tightly to PDE6δ so are trafficked to 
the cilia. At the cilia, ARL3-GDP is activated to ARL3-GTP by ARL13B. ARL3-GTP 
then interacts with PDE6δ and causes closure of the hydrophobic pocket and 
release of INP55E in the cilia. ARL3-GTP is converted back to ARL3-GDP by RP2. 
Low affinity binding cargo e.g. Rheb is released by ARL2-GTP outside the cilia. 




1.5 The Role of RP2 and ARL3 in Photoreceptor Protein Trafficking  
 
1.5.1 Intraflagellar Transport in Photoreceptors 
Intraflagellar transport occurs in photoreceptors and has important roles in the 
morphogenesis and maintenance of the OS (Marszalek et al. 2000; Pazour et al. 
2002) (Figure 1.8). IFT proteins, IFT20, IFT88, kinesin II and dynein’s have been 
detected at the ciliary axoneme of the connecting cilia in photoreceptors (Baker et al. 
2003; Insinna et al. 2008; Mikami 2002; Pazour et al. 2002). IFT complexes have 
been identified in photoreceptors containing kinesin II, dynein’s, rhodopsin and GC1 
suggesting IFT is required for the trafficking of these proteins to the photoreceptor OS 
(Bhowmick et al. 2009). Transgenic mice where Kif3a, Ift20 or Ift88 were knocked out 
in photoreceptors confirmed IFT is required for rhodopsin and GC1 trafficking in vivo, 
as all of these mice display defects in OS development, mislocalised rhodopsin and 
rapid retinal degeneration (Keady, Le, and Pazour 2011; Marszalek et al. 2000; 
Pazour et al. 2002).  
Evidence for a role of RP2 and ARL3 in IFT mediated trafficking in photoreceptors 
comes from a mouse in which Rp2h was knocked out (L. Li et al. 2013) and resulted 
in mislocalisation of M/L opsin prior to onset of retinal degeneration (L. Li et al. 2013). 
M/L opsin is thought to be trafficked to the OS by an IFT mediated mechanism 
involving Kif3a and the homomeric kinesin kinase like protein 17 (Kif17) (Avasthi et 
al. 2009; Insinna et al. 2008). It has since been demonstrated that RP2 and ARL3 
interact with Kif17 and regulate its localisation at ciliary tips in vitro (Schwarz et al. 
2017) suggesting a mechanism by which RP2 and ARL3 may regulate the localisation 
of Kif17 and thus regulate M/L opsin trafficking in vivo. In a rp2 knockout zebrafish 
mislocalisation of rhodopsin and M/L opsin was not observed casting doubt on the 
importance of RP2 and ARL3 in IFT mediated trafficking in vivo. In another Rp2h 
knockout mouse model no mislocalisation of rhodopsin or M/L opsin was observed 
even at late stages of retinal degeneration casting further doubt on the role RP2 and 
ARL3 play in IFT in vivo (Houbin Zhang et al. 2015). Rp2h knockout mouse 





















(A) Electron micrograph showing the photoreceptor connecting cilia (CC) between 
the Inner Segment (IS) and Outer Segment (OS) in a rod photoreceptor.  
(B) Schematic of IFT in photoreceptors. Cargo is sorted into vesicles destined for 
the OS and transported to the base of the connecting cilia via cytoplasmic 
Dynein 1 on microtubules. Once at the base of the CC IFT particles associate 
with vesicles and vesicles fuse with the ciliary or plasma membrane. IFT 
particles and their attached cargo are transported through the CC by kinesin II. 
At the tip of the CC IFT particles disassociate from their cargo and are taken 
back to the IS by cytoplasmic dynein 2.  


















1.5.2 Trafficking of OS Proteins in Photoreceptors 
The function of RP2 and ARL3 in photoreceptors has been studied in depth using 
mouse models. Retina (RetARL3-/- ) and rod specific Arl3 knockout (RodARL3-/-) mice 
were generated using cre-lox system in order to investigate the roles of ARL3 pre and 
post ciliogenesis in the mouse retina (Hanke-Gogokhia et al. 2016). Mice were 
generated by crossing into two different transgenic lines, iCre75 which expresses Cre 
in rods (S. Li et al. 2005) and six3Cre which expresses Cre in retinal progenitors 
(Furuta et.al 2002). RodARL3-/- retinas developed normally with normal connecting cilia. 
These mice showed normal photopic and scotopic ERG responses at p15, 
demonstrating normal function of photoreceptors, however ERG responses were 
reduced at 1 month of age and by 2 months of age both rods and cones were severely 
degenerated. Global mislocalisation of lipid modified proteins was reported in these 
mice with lipid modified outer segment proteins; GRK1, PDE6  and Transducin α,β 
and γ, detected in the IS and ONL (Hanke-Gogokhia et al. 2016). It has been 
previously reported that PDE6δ interacts strongly with GRK1 (Houbin Zhang et al., 
2004) and that this is required for its localisation in photoreceptors (H Zhang et al. 
2007). UNC119 interacts with transducin α and may function in dissociating Gα from 
membranes to facilitate its diffusion back to the OS during dark adaption (Zhang et al. 
2011). Therefore, this supports the hypothesis that the RP2-ARL3 complex controls 
the localisation of lipid-modified proteins in the photoreceptors through the GDI 
effector activity of ARL3-GTP for PDE6δ and UNC119 (Figure 1.9 A). 
 Pde6δ knock out mice are viable however they are 20-30% smaller than their WT 
littermates and display a slow progressive rod/cone dystrophy with shortening of the 
OS evident from 4 weeks and thinning of the ONL evident from 5 months of age (H 
Zhang et al. 2007). Pde6δ -/- retina’s show loss of GRK1 in the OS and have PDE6 
mislocalised to the inner segments (H Zhang et al. 2007). Similarly Unc119 -/- mice 
have progressive retinal degeneration evident from 5 months of age and almost 
complete at 20 months (Ishiba et al. 2007). The mechanism of degeneration is unclear 
in Unc119 -/- mice therefore a Pde6δ, Unc119 double knockout was generated 
(Houbin Zhang, Frederick, and Baehr 2014). In these mice expression of GRK1 is 
undetectable in rods however appears to be increased in cones, compared to Pde6δ 
single knockout.  This increase in GRK1 was enough to partially rescue cone scotopic 
ERG responses compared to Pde6δ-/- but was not enough to restore WT responses. 
The authors speculate that the increase in GRK1 expression in Pde6-/- Unc119 -/- 
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cones compared to Pde6δ-/- cones may be attributed to an increase in the levels 
ARL3-GTP as it is free from binding UNC119. This would then allow ARL3-GTP to 
transport GRK1 via an alternative mechanism independent of PDE6δ (Houbin Zhang, 
Frederick, and Baehr 2014). A possible mechanism for this has yet to be elucidated 
and it is currently unknown how GRK1 can traffic to the cone OS in the absence of 
PDE6δ.  
A retinal specific knockout of ARL3, RetARL3-/-,  mice have severe retinal degeneration 
evident from P15 and almost complete by 2 months of age shown by severely reduced 
ERG responses and significant thinning of the retina (Hanke-Gogokhia et al. 2016). 
These mice fail to develop photoreceptor OSs and do not form connecting cilia 
suggesting a role for ARL3 in ciliogenesis in photoreceptors (Hanke-Gogokhia et al. 
2016). As a result of lack of OS formation, mislocalisation of OS pigments rhodopsin 
and M/L opsin, as well as the progressive accumulation of GRK1, PDE6 and rod 
transducin α (Gα) in the inner segments and ONL was observed (Hanke-Gogokhia et 
al. 2016). This is similar to the phenotype of Arl3 -/- mice which also fail to develop 
proper photoreceptor OS, form only rudimentary CC and have mislocalised rhodopsin 
(Schrick et al. 2006). This phenotype suggests defects in both IFT and membrane 
protein trafficking implying ARL3 may play essential roles in both pathways.  
The role of RP2 in photoreceptors has also been studied using animal models. As 
previously discussed two Rp2h knockout mice have been generated which show 
contradictory phenotypes. The first Rp2h knockout mouse, Rp2hnull, generated by 
gene trap cassette displayed progressive retinal degeneration attributed to early 
mislocalisation of M/L opsin. No mislocalisation of lipid modified OS proteins was 
observed suggesting a pathogenic mechanism which is not be attributed to RP2’s 
regulation of ARL3-GTP and subsequent regulation of PDE6δ (L. Li et al. 2013). The 
second Rp2h knockout mouse, Rp2h -/-, generated by the cre lox system displayed 
progressive retinal degeneration attributed to mislocalisation of GRK1, transducin α 
and other lipid modified proteins (Houbin Zhang et al. 2015).  No mislocalisation of 
rhodopsin or M/L opsin was observed suggesting retinal degeneration is driven by 
increased ARL3-GTP levels and aberrant release of PDE6δ cargo (Houbin Zhang et 
al. 2015) (Figure 1.9 B) (Rp2h knockout mice phenotypes discussed in detail in 3.1).  
The hypothesis that mutation of RP2 results in increased levels of ARL3-GTP and 
aberrant trafficking of lipid modified OS proteins is also supported by the phenotype 
of a transgenic mouse with expression of ARL3-GTP driven by the rhodopsin 
48 
 
promoter, RodARL3Q71L. This mouse demonstrated severe, rapid retinal degeneration 
attributed to mislocalisation of lipid modified OS proteins. Rhodopsin or GC1 were not 
mislocalised in this model demonstrating increased levels of ARL3-GTP specifically 
caused mislocalisation of lipid modified OS proteins (Z. C. Wright et al. 2016) 
(Phenotype of Rod ARL3Q71L mouse discussed in detail in 4.1).  
The mechanism by which mutation in RP2 causes retinal degeneration in patients 
with XLRP remains unclear however increased levels of ARL3-GTP and subsequent 
mistrafficking of lipid modified OS protein is the prevailing hypothesis (Figure 1.9). 
The two opposing phenotypes of the Rp2h knockout mice mean the function of RP2 
in the retina remains unclear. Some  proteins reported to be mislocalised in Rp2h -/- 
mice and RodARL3Q71L mice overlap however these models do not phenocopy each 
other as would be expected if increased levels of ARL3-GTP was the pathogenic 
mechanism in both cases. The RodARL3Q71L mouse is a transgenic model which 
expresses ARL3 Q71L under the rhodopsin promoter thus it is only expressed in rods 
and overexpressed compared to the endogenous locus. Therefore, to study the 
contribution of levels of ARL3-GTP to retinal degeneration this mouse may not be an 
ideal model as it is not clear whether the phenotypes present occur because of 
increased ARL3-GTP levels or because ARL3 Q71L is overexpressed compared to 
the endogenous locus. Therefore, the question remains as to whether retinal 




























(A) Schematic of GRK1 trafficking in WT photoreceptors. After translation and post-
translational prenylation, GRK1 anchors at the ER membrane. PDE6δ extracts 
GRK1 from the ER membrane and forms a soluble complex. PDE6δ-GRK1 
traffic to the destination membrane which is the CC or OS membrane. PDE6δ-
GRK1 may dock to the destination membrane via its interaction with RPGR. 
After docking PDE6δ-GRK1 form a tertiary complex with ARL3-GTP which 
stimulates a conformational change in PDE6δ converting its hydrophobic pocket 
from the open conformation to the closest conformation resulting in release of 
GRK1. ARL3-GTP then interacts with RP2 which stimulates ARL3’s intrinsic 
GTPase activity converting ARL3-GTP to ARL3-GDP. ARL3-GDP is converted 
to ARL3-GTP via its GEF which has recently been identified as ARL13b. 
(B) Absence of RP2 prevents hydrolysis of ARL3 so ARL3 remains in the GTP 
bound state as ARL3-GDP continues to be activated to ARL3-GTP by the GEF. 
PDE6δ can still extract prenylated GRK1 from the ER membrane but ARL3-GTP 
is able to stimulate release of GRK1 before PDE6δ-GRK1 reach the destination 
membrane leading to GRK1 mislocalisation.  
 
Taken from Baehr et.al 2014 
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1.6 Aims:  
In order to determine whether the pathogenesis of XLRP in cases of RP2 mutation is 
attributed to dysregulation of ARL3 new mouse models of RP were generated using 
CRISPR genome editing. A new Rp2h knockout model was generated (Rp2h 
DEL26/Y), a mouse lacking RP2 GAP activity (Rp2h E135G/Y) and mice expressing 
constitutively active ARL3 (Arl3 Q71L/+ and Arl3 Q71L/Q71L). 
The first aim of this study was to characterise the phenotype of the Rp2h DEL26/Y, 
Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L mice. By characterising, the 
phenotype of these mice and analysing genotype to phenotype correlations insights 
into the contribution of ARL3 mis-regulation to Retinitis Pigmentosa could be made. 
The mice were analysed continually until 12 months of age to fully observe the 
process of retinal degeneration over time using both invasive and non-invasive 
techniques. Analysis also facilitated the comparison of Rp2h DEL26/Y and Rp2h 
E135G/Y to the previously published Rp2h knockout mice providing information about 
the function of RP2 in the retina. 
As Rp2h and Arl3 mutant mice were generated using the same CRISPR technique 
on the same background strain they could be directly compared to each other in order 
to assess whether increased levels of ARL3-GTP phenocopy Rp2h knockout and loss 
of RP2 GAP activity. This allowed the question of whether the pathogenesis of XLRP 
in patients with RP2 mutations is solely due to dysregulation of ARL3 to be directly 
addressed.  
The function of RP2 was further analysed via a study of the interactions RP2 is 
involved in retinal pigment epithelium cells (RPE-1). To analyse RP2 interactions in 
vitro the proximity based biotinylation (BIO-ID) method was used. This identified 
ZDHHC5 as a novel RP2 interactor and the functional consequence of this interaction 
was investigated with the aim of providing further insights into the mechanisms that 
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Chapter 2: Materials and Methods 
 
2.1 Mouse Studies Methods 
 
2.1.1 Animal Husbandry 
 
Mice used in this study were housed in the University of Edinburgh Transgenic Unit 
(TGU) mouse facility. Mice used for ERG studies were transferred through to the 
University of Edinburgh Biomedical Research Facility (BRF) facility. Where required, 
all procedures were performed under a Personal and Project Home Office Licence. 
PIL: SAB/SCT-E/145/15, PPL: 60-4424, P1914806F 
2.1.2 Generation of Rp2h and Arl3 mutant mouse lines 
 
Constructs used to generate the Rp2h and Arl3 mutant lines were designed and 
synthesised by Dr Hurd before I joined the lab. CRISPR gRNA guides were designed 
to target Rp2h and Arl3. To generate Rp2h mice, paired guides were used in 
conjunction with Cas9n mRNA (Sigma Aldrich). To generate Arl3 mice, a single guide 
with conventional Cas9 mRNA (Sigma Aldrich) was used. Repair templates (ssDNA) 
were provided to allow the introduction of Rp2h E135G and Arl3 Q71L point mutations 
(ssDNA repair template sequences provided in Table 2.1). CRISPR guides, 
Cas9/Cas9n mRNA and rescue ssDNA (25ng/ul per Guide; 50ng/ul ssDNA; 150ng/ul 
ssDNA) were injected into the cytosol of single cell C57BL6/J embryos by staff  in the 
University of Edinburgh Transgenic (TGU) mouse facility. Founder (F0) pups 
generated from these injections were genotyped and those carrying appropriate 
mutations were outbred to C57BL6/J control mice in order to establish the F1 animals 
to establish lines. 
2.1.3 Genotyping of Rp2h and Arl3 mouse lines 
 
Genomic DNA generated from mouse ear clips was used for genotyping. Genomic 
DNA was prepared using DNA-Releasy (Anachem) and a thermocycler. DNAreleasy 
was diluted 1:5 with DNAse/RNAse free H2O. 30μl of diluted DNA-Releasy was 
added to each ear clip. Samples were then placed in a BIO-RAD Tetrad 2 Peltier 
Thermo cycler as follows: 
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65⁰C for 15 min 
96⁰C for 2 min 
65⁰C for 4 min 
96⁰C for 1 min 
65⁰C for 1 min 
96⁰C for 30 sec 
4⁰C forever 
Samples were then centrifuged at 13,000 rpm for 1 minute. Genomic DNA was 
amplified using Polymerase Chain Reaction (PCR) using the Phusion High Fidelity 
PCR Master Mix (New England Biolabs). The reaction mix contained Phusion High 
Fidelity PCR master mix, 0.5μM primers (Listed in Table 2.1) and 2μl DNA template 
in a 25μl reaction. PCR reactions were carried out in a BIO-RAD Tetrad 2 Peltier 
Thermo Cycler. 
RP2 Genotyping PCR Programme: 
Initial Denature 98⁰C for 2 min 
Denature 98⁰C for 10 sec 
Extension and Annealing 72⁰C for 10 sec 
Final Extension 72⁰C for 10 min 
4⁰C forever 
ARL3 Genotyping Programme: 
Initial Denature 98⁰C for 2 min 
Denature 98⁰C for 10 sec 
Annealing 66⁰C for 30 sec 
Extension 72⁰C for 15 sec 






PCR samples were then analysed by Sanger sequencing. Sanger sequencing was 
performed by the Institute of Genetic and Molecular Medicine (IGMM) core technical 
services using a 3730 genetic analyser (Applied Biosystems). The same primers were 
used for PCR amplification and sequencing of PCR products for genotyping (Listed 
in Table 2.1).  
 
Table 2.  1 List of Primers and Their Applications 
 
Primer 











mARL3 F CCGTCTCTTTCAGGGATTAAC ARL3 genotyping 
and sequencing 
IDT 




































































Generation of WT 
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Generation of WT 
RP2, E135G RP2, 
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Generation of G2A 
RP2 PCR 
products with Not1 
and Pac1 
restriction sites 
used with RP2 






Generation of C3S 
RP2 PCR 
products with Not1 
and Pac1 
restriction sites 
used with RP2 
Pac 1 R 
IDT 
 
2.1.4 Histology Methods 
 
After euthanasia by cervical dislocation eyes were removed from mice with forceps 
and washed in PBS before being immersed in Davidson’s Fixative (22% v/v 10% 
neutral formalin in phosphate buffer (40% PFA, 900 ml/L distilled water, 18.6 g/l 
NaH2PO4, 42.2g/l NaOH), 33% v/v 95% ethanol, 11% v/v acetic acid in distilled 




2.1.4.2 Paraffin Sectioning 
 
After fixation, eyes were stored in 70% ethanol. Dehydration of the tissues and 
embedding in paraffin took place in the Tissue Tek Tissue VIP5 Jr. embedding 
console system (Sakura). The procedure included the following steps, each one 
lasting for 45 minutes: 
1. 70% ethanol 
2. 70% ethanol 
3. 85% ethanol 
4. 95% ethanol 
5. 100% ethanol 
6. 100% ethanol 









After embedding in molten paraffin, the eyes were transferred into casts where they 
were orientated according to the plane of sectioning required. Paraffin was then 
allowed to set completely around the specimen and form a block. A Leica RM2235 
microtome was used to obtain 7μm-thick sections of the eyes. Sections were obtained 
orthogonally to the vertical meridian of the eye. Sections were spread out in a water 
bath at 47⁰C and then collected on the (+) side of Superfrost microscopy slides 
(Menzer-Gläser, Thermo Fisher Scientific). They were subsequently air-dried for a 











After fixation eyes were washed in PBS and cryoprotected by immersion in sucrose 




20% sucrose/PBS (4⁰C overnight) 
Eyes were then incubated in OCT (VWR International) in vinyl moulds on dry ice. 
Once the OCT had completely frozen samples were stored at -80⁰C. Eyes were 
sectioned using a Leica 3M3050 S Cryostat. Eyes were allowed to adjust to the 
chamber temperature (-20⁰C) before 10μm sections were cut and collected on 
Superfrost Plus microscope slides. Sections were then air dried for 1 hour at room 
temperature then stored at -80⁰C. 
2.1.4.4 Haematoxylin and eosin (H&E) staining 
 
To prepare for staining, eye sections were first de-waxed by three 5-minute 
incubations in xylene. Next, they underwent stepwise rehydration; passing through a 
reverse series of graded ethanol washes (100%, 90%, 70%, 50% and 30%) for two 
minutes each. Sections were subsequently dipped in haematoxylin for 4 minutes, 
washed in running tap water, differentiated in 1% HCl in 70% alcohol and washed well 
in running tap water. Next, the sections were dipped in saturated lithium carbonate 
solution for a few seconds, washed well in tap water, stained in eosin for 4 minutes, 
rinsed in water and finally rinsed in 100% ethanol. After staining, the sections were 
dehydrated again through three 5-minute incubations in 100% ethanol. After passing 
through three xylene incubations for 5 minutes each, the sections were mounted with 
22x 50mm coverslips (VWR International Ltd) and DPX medium (Cell Path). Mounted 





2.1.4.5 Imaging and analysis 
 
Brightfield microscopy was carried out using the Hamamatsu Nanozoomer XR 
microscope and the NdpVeiw.2 software used to measure the thickness of each of 
the retinal layers. This data was then exported to Microsoft Excel for analysis.  
2.1.5 Electroretinography in Mice 
 
Mutant and WT control mice were dark adapted overnight prior to electroretinography 
(ERG) through housing in dark cages. All ERG readings were recorded on a 
Ocuscience HMsERG Model 2000 Full Field Flash Electroretinography Machine 
inside a Faraday Cage (Ocuscience).  All ERG procedures were carried out in the 
dark with red safety lights. Immediately prior to the procedure one drop of 1% 
tropicamide was placed in each eye of the animals in order to dilate the pupils. 
Anaesthesia was induced with 3% isoflurane in an isoflurane chamber, and after 
induction of anaesthesia animals were transferred to the ERG apparatus and 
anaesthesia was maintained at 1.5%-2% isoflurane using a nose cone. The body 
temperature of the mice was monitored using a rectal probe (Ocuscience, 
ERGACC5). Reference electrodes were placed sub-dermally in each cheek and a 
grounding electrode placed sub-dermally at the base of the tail. One drop of 
methylcellulose was placed on each eye and the eye electrodes placed across the 
apex of the cornea and secured with a contact lens (Ocuscience). The faraday cage 
was closed and an earthing cable attached to the cage and the mains electrics supply. 
An impedance test was run on the electrodes prior to each reading and the experiment 
only proceeded when the impedance value was below 10,000Ohm. For my studies, 
the ISCEV (International Society for Clinical Electrophysiology of Vision) protocol was 
used to investigate the function of both rod and cone photoreceptors (Table 2.2). After 
recordings, the sub-dermal electrodes were removed and cleaned with 100% ethanol; 
contact lenses were removed and placed into water to remove any excess 
methylcellulose. Isoflurane was turned off and animals transferred to a heated 






























Table taken from HMsERGLab Manual. Dark Adaptation for my studies was carried 
out overnight as stated above.  
Table 2.  2 ISCEV Protocol for ERG 
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2.1.6 Immunofluorescence Analysis of Retinal Cryosections 
 
Retinal cryosections were post-fixed by immersion in ice cold 100% acetone for 10 
minutes at room temperature. After air-drying for 10 minutes and washing 3 times 5 
minutes in TBST (0.2% Tx100) or PBS (depending on antibody specifications) 
sections were blocked in 10% heat inactivated goat serum/TBS (AMS Biotechnology) 
for 1 hour at room temperature. Primary antibodies were diluted in 1% Goat 
serum/TBS to the appropriate dilutions (Antibodies listed on Table 2.3) and incubated 
on sections overnight at 4⁰C in a humidified chamber. Slides were washed 3 times for 
5 minutes in appropriate wash buffer. Secondary antibodies were diluted in 1% Goat 
Serum/TBS (Listed Table 2.2) with Dapi (Sigma Aldrich) diluted to 1:10,000 and 
incubated on sections for 1 hour at room temperature. Slides were then washed 3 
times for 5 minutes and mounted with Prolong Gold (Molecular Probes).  
2.1.6.1 Imaging and Analysis 
  
Fluorescent images were taken using a Leica SP5 inverted confocal microscope and 
viewed using LAS AF Lite software where appropriate scale bars were applied. 
Images were subsequently edited for generation of figures using Adobe Photoshop. 
2.1.7 Protein Extraction from Whole Eyes 
 
2.1.7.1 Tissue Lysis 
 
Mice were culled by cervical dislocation and the eyes removed, immediately placed 
on dry ice then stored at -80⁰C. Two eyes per mouse were lysed in either CO-IP lysis 
buffer or RIPA buffer (supplied by Santa Cruz, sc-24948) (See Table 2.4 for lysis 
Buffer compositions) supplemented with 1mM PMSF, protease and phosphatase 
inhibitor cocktails (Sigma- Aldrich) immediately prior to use. Tissues were 
homogenised using an electric dounce homogeniser. Lysates were then cleared by 
centrifugation for 20 minutes at 13,000 rpm in a refrigerated centrifuge. Lysates were 





2.1.7.2 Quantification of Protein Concentration 
 
Protein concentration of lysates made with RIPA buffer was determined using the 
Biorad DC assay, as per manufacturers’ instructions. After mixing well and incubating 
for 5 minutes at room temperature, colorimetric readings were recorded by measuring 
absorbance at 750 nm using the BioMate 3 Spectrophotometer (ThermoFisher 
Scientific). Lysates made using CO-IP lysis buffer or General Triton Lysis buffer were 
measured using Bradford Reagent (Sigma). 1μl of lysate was added to 1ml of 
Bradford Reagent, and after mixing and incubating for 15 minutes at room 
temperature colorimetric readings were recorded by measuring absorbance at 
595nm.  A BSA (bovine serum albumin) (Sigma) reference curve was used to estimate 
protein concentration based on the colorimetric readings. 
2.1.8 ARL3-GTP Pulldown Assays from Whole Eyes 
 
WT, Rp2h and Arl3 mutant eye lysates, previously lysed in CO-IP lysis buffer and 
normalised to the same concentration were used for this assay (lysis and protein 
concentration measurement protocol described above). Ten percent of these lysates 
were removed for input samples and the remaining lysates were  incubated with 15μl 
glutathione beads +/- 5μl of 1ug/ul GST-RP2 recombinant protein and incubated for 
1 hour at 4⁰C under continuous rotation. Beads were then washed 3 times by spinning 
for 2 minutes at 4000rpm and resuspending in lysis buffer. Beads and appropriate 
volumes of input lysate were then mixed with appropriate volume of sample buffer (1x 
LDS Sample Buffer (Thermo), 50mM DTT and dH2O) and incubated at 70⁰C for 10 
minutes to elute proteins from the beads and to denature proteins in preparation for 
gel electrophoresis and Western blot analysis. (See 2.3.2 and 2.3.3 for gel 
electrophoresis and western blot methods). 
2.2 Tissue Culture Methods 
 
2.2.1 Cell Culture Techniques 
 
RPE1 cells were cultured with DMEM-F12 medium (Hyclone, Thermo Fisher 
Scientific) with the addition of 10% v/v foetal calf serum, penicillin/streptomycin 
cocktail at 1 mg/ml final concentration and hygromycin (10μg/ml final concentration 
(Gibco)). HEK293T, HEK293-ET and Hela cells were cultured with Dulbecco’s 
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modified Eagle medium (DMEM) with 4.5g/l L/D glucose and pyruvate (Gibco, Life 
Technologies), with the addition of 10% v/v foetal calf serum and 
penicillin/streptomycin cocktail at 1 mg/ml final concentration. Cells were regularly 
split using the TrypLE trypsin substitute (ThermoFisher Scientific). RP2 BIRA and 
BIRA RP2 null RPE1 cells were cultured in DMEM-F12 medium (Hyclone, Thermo 
Fisher Scientific) with the addition of 10% v/v foetal calf serum, penicillin/streptomycin 
cocktail at 1 mg/ml final concentration, hygromycin (10μg/ml final concentration 
(Gibco) and 500ng/ml G418 (Sigma)). 
2.2.2 Transient Transfection and siRNA knockdown 
 
Cells were transiently transfected with 1μg purified plasmid DNA containing the 
relevant constructs (per 0.2x106 cells) using the nonliposomal reagent Fugene HD 
(Promega). 1μg of DNA was incubated with the appropriate volume of Opti-Mem 
serum free media (Thermo Fisher), appropriate volume of Fugene was added (always 
keeping ratio of 3μl Fugene to 1μg DNA). Reactions were mixed and incubated for 
15-20 mins at room temperature. Cells to be transfected were incubated in fresh 







Media (ml)  




6 well 100 2 1 3 
10cm dish 500 10 1-3 9-18 
  
For knockdown experiments, HEK293T or Hela cells were seeded on a six well plate 
and transfected with 25pmol siRNA per well using Lipofectamine RNAi Max Reagent 
(Life Technologies). Cells were transfected once they were around 60%-70% 
confluent. SiRNA (5μm) was added to 75μl of Opti-Mem Reduced Serum Media 
(Thermo Fisher). 6μl of RNAi Max Reagent (Life Technologies) was added to 75μl of 
Opti-Mem Reduced Serum Media in a separate tube. The solutions were then mixed 
and after a 5-minute incubation, 150μl of this mix was added to cells. After 24 hours, 
this media was removed and replaced with fresh media (as described 2.2.1). 
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ZDHHC5 siRNA: AGGGATTAGAGTGTGCTCCTA, ACCACCATTGCCAGACTACAA 
(Qiagen) 
CTRL siRNA: SCRAMBLED siRNA (Qiagen) 
2.2.3 Generation of RP2 BIRA Cell Lines 
 
2.2.3.1 Generation of RP2 BIRA and BIRA Retroviral Constructs 
 
To generate a BIRA retroviral construct for BIOID assays BIRA (R118G) (BIRA*) was 
cloned into PQCXIN retroviral plasmid. To insert BIRA* into PQCXIN plasmid a PCR 
strategy was used to generate a PCR product containing BIRA* and BamHI and 
EcoR1 restriction sites (Primers listed in Table 2.1). pCDNA3.1 MCS-BirA (R118G)-
HA was used as a template for the PCR reaction. A 50μl PCR reaction was set up 
containing 25μl Phusion High Fidelity PCR Mastermix, 0.5μM F primer, 0.5μM R 
primer, 19μl dH2O and 10ng of plasmid template. PCR reactions were carried out on 
a BIO-RAD Tetrad 2 Peltier Thermo Cycler as before.  
BIRA (R118G) BamHI, EcoR1 PCR Programme:  
Denature 98⁰C 2 min 
Denature 98⁰C 2 min 
Extension and Annealing 72⁰C for 20 sec 
Final Extension 72⁰C for 10 min 
The resulting PCR product was purified using Qiagen PCR purification (Qiagen, 
28104) kit as per manufacturer’s protocol. 
After purification the PCR product was analysed by agarose gel electrophoresis to 
confirm it was of the expected size (~1kb) (1% agarose gel: 1.5g agarose (Hi pure 
Low EEO Agarose (Biogene) was added to 150ml 1XTBE and heated in the 
microwave until agarose had completely dissolved. Agarose was then poured into gel 
tray and left to set for 30mins before electrophoresis. 5μl of PCR product + 1μl 6X 
DNA loading dye (New England Biolabs) were loaded onto the gel in lanes adjacent 




gel tanks containing 1xTBE at 120V for 40 minutes to allow separation of DNA 
fragments. 
After conformation that the PCR product (BIRA BamHI, EcoR1) was of the correct 
size, this product and the PQCXIN retroviral plasmid underwent restriction digest with 
EcoR1 (EcoR1 HF, NEB, R3101S) and BamHI (BamH1 HF, NEB, R3136S)  restriction 
enzymes. 20μl restriction digest was used to digest PQCXIN plasmid. 20μl Restriction 
digest reaction mix: 3ng plasmid DNA, 2μl 10x cutsmart buffer (NEB, B7204S), 0.5μL 
BamHI, 0.5μl EcoR1, 12μl dH2O. 100μl restriction digest reaction was used to digest 
BIRA, BamHI, EcoR1 PCR product. Restriction digest reaction mix: 50μl purified PCR 
product, 10μl 10x cutsmart buffer,0.5μl BamHI, 0.5μl EcoR1, 39μl dH20. Restriction 
digests were heated at 37⁰C for one hour in a tabletop heat block. After restriction 
digest the reactions were purified using Qiagen PCR purification kit (as before) and 
the resulting digested PQCXIN and BIRA PCR product were eluted in 30μl elution 
buffer (provided in Qiagen PCR purification kit). Digested PQCXIN and digested BIRA 
PCR products were ligated (as described 2.2.3.1.2) and transformed into competent 
bacteria (as described 2.2.3.1.3) to generate the PQCXIN-BIRA-Myc plasmid. After 
transformation and generation of starter cultures and miniprep of plasmid DNA a 
EcoR1 and BamHI restriction digest (20μl restriction digest as described above) 
followed by gel electrophoresis (as described above) was used to assess that the 
PQCXIN plasmid contained the BIRA insert.  
In order to generate PQCXIN-BIRA vectors containing RP2 point mutations RP2 
pentry plasmids (WT RP2, E135G RP2, R21LL BIRA, G2A BIRA C3S BIRA) were 
used as templates to generate RP2 PCR products that were cloned into  the PQCXIN-
BIRA plasmid. To facilitate cloning a PCR strategy was designed to generate RP2 
PCR products that contained Not1 and Pac1 restriction sites which are also present 
on the PQCXIN-BIRA plasmid. Primers used are listed in Table 2.1. 50μl PCR 
reactions containing (25μl Phusion High Fidelity PCR Mastermix, 0.5μM F primer, 
0.5Μm R primer, 10ng plasmid DNA, up to 50μl dH20). PCR reactions were carried 






RP2 Not1,Pac1 PCR programme:  
Denature 98⁰C 2 min 
Denature 98⁰C 2 min 
Extension and Annealing 72⁰C for 60 sec 
Final Extension 72⁰C for 10 min 
PCR products were then purified using Qiagen PCR purification kit (as described). 
PCR products and PQCXIN-BIRA (vector) then underwent restriction digest with Not1 
(Not1 HF,NEB, R3189S) and Pac1 (Pac1, NEB, R0547S) restriction enzymes. 
PQCXIN-BIRA 20μl restriction digest reaction mix (3ng plasmid DNA, 0.5μl Not1,0.5 
μl Pac1, 10x cutsmart buffer, up to 20μl dH2O), RP2 PCR product 100μl restriction 
digest reaction mix (50μl purified PCR product, 10x cutsmart buffer, 1μl Not1, 1μl 
Pac1, up to 100μl dH2O). After digestion and purification RP2 PCR products were 
ligated together (as described 2.2.3.1.2) followed by transformation into competent 
bacteria (2.2.3.1.4). Miniprepped DNA  followed by restriction digest and gel 
electrophoresis was used to confirm correct incorporation of inserts (as described 
above) and plasmids from cultures which contained the correct insert were 
subcultured for midipreps as described (2.2.3.1.3) to extract high purity,  high 
concentration DNA for retroviral transfection.  
2.2.3.1.2 Ligation Reactions 
 
All ligation reactions were set up at a 1:3 vector to insert ratio using the NEB quick 
ligation protocol. 20μl ligation reaction was set up on ice: 50ng vector DNA, 37.5ng 
insert DNA (~1kb), 10μl 2x Quick Ligase Reaction Buffer (provided in NEB Quick 
Ligation Kit, M2200S), 1μl Quick Ligase (provided in NEB Quick Ligation Kit, 
M2200S), dH2O up to 20μl. Ligation reactions were mixed and incubated at room 
temperature for 5 mins. Ligation reactions were then immediately used for 
transformation of competent bacteria or stored at -20⁰C.  
2.2.3.1.3 Transformation of Competent Bacteria 
 
Ligation reactions were transformed into DH5α competent bacteria (NEB, C2987I). 
Vials of competent cells were thawed on ice and 25μl of competent cells were mixed 




mins then heat shocked by incubation in a 42⁰C water bath for 30 seconds 
immediately followed by incubation in ice for 2 minutes. 375μl SOC media 
(ThermoFisher) was then added to each reaction and reactions were then shaken in 
a 37⁰C incubator for 1 hour. 100μl of this transformation mix was plated onto ampicillin 
agar plates (provided by HGU technical services), as PQCXIN carries an ampicillin 
resistance gene, and incubated in a 37⁰C incubator overnight. Single colonies 
produced were then picked using sterile pipette tips and placed immediately into 
15mls of L-Broth containing 100μg/ml Carbenicillin (ampicillin analogue) (L-Broth 
provided by HGU technical services, Carbenicillin, Sigma) and shaken at 37⁰C 
overnight. DNA from starter cultures was extracted using Qiaprep miniprep kit 
(Qiagen, 27104) per manufacturer’s protocol. In order to extract and purify higher 
concentrations of plasmid DNA for transfections 500μl of starter cultures were added 
to 50ml L-Broth containing 100μg/ml Carbenicillin and shaken overnight at 37⁰C. 50ml 
cultures were then midiprepped using Qiagen plasmid midi kit (Qiagen, 12143) as per 
manufactures protocol.  
2.2.3.1.4 Retroviral Transfection of RP2 null RPE1 cells 
 
HEK293 ET cells were used to generate viral particles containing the RP2 BIRA or 
BIRA only constructs. HEK293-ET cells were seeded on 6-well plates at a density so 
they were 70% confluent the next day. These cells were transfected with 1μg of PVSV, 
1μg GAG/POL vectors and 1μg each PQXCIN RP2-BIRA vector using Fugene HF 
reagent (see 2.2.2 for detailed protocol). Cells were then moved to the designated 
retroviral incubator at 37⁰C overnight. RP2 null RPE1 cells were seeded so they were 
60% confluent the next day. Polybrene (Sigma) was added to 15ml of DMEM-F12 
G418 containing media and media from HEK293-ET cells (containing the newly 
synthesised retrovirus) was filtered through a 0.2μm filter in a 5ml syringe into the 
polybrene and G418 media mix. RP2 null RPE cells were then incubated in this media 
and placed in the retroviral incubator overnight at 37⁰C. Infected RP2 null RPE cells 
were incubated in fresh media every day for 2 days and then transferred by trypsin 
detachment, spinning and resuspension in fresh media into a T.75 flask. RP2 null RP2 
BIRA RPE cell lines were not transferred to normal incubator until 4 more media 




2.2.4 Immunofluorescence of Cultured Cells 
 
Cells were grown on sterile coverslips previously treated with HCl to create a rough 
surface for the adherent cells (12 hours at 55⁰C). Cells were fixed in 4% 
paraformaldehyde (PFA) in PBS for 10 minutes at room temperature, washed 2 times 
for 10 minutes in PBS to remove PFA and then permeabilised in 0.2% Triton X100 in 
PBS for 10 minutes. Cells were blocked in 10% Goat Serum in PBS for one hour at 
room temperature. Primary antibodies were diluted in 1% Goat serum in PBS to 
appropriate concentrations (See Table 2.3) and incubated on cells for one hour at 
room temperature. Cells were then washed 3 times in PBS and incubated with 
secondary antibodies (Listed in Table 2.3) diluted in 1% Goat Serum in PBS for one 
hour at room temperature. After three further washes in PBS cells were then mounted 
with Prolong Gold (Molecular Probes). 
2.3 Protein and Proteomics Methods 
 
2.3.1 Protein Extraction from Cells 
 
Cells were plated on either 10cm dishes or 6 well plates and allowed to become fully 
confluent before lysis. Cells were incubated on ice and washed twice with ice cold 
PBS, then lysed in appropriate volumes of lysis buffers (Listed Table 2.4) 
supplemented with 1mM PMSF, protease and phosphatase inhibitor cocktails (Sigma) 
for 20 minutes on ice. Lysates were then cleared by centrifugation for 10 minutes at 
13,00rpm at 4⁰C. Lysates were then transferred to a fresh tube and used immediately 
or stored at -80⁰C. Protein concentration of lysates were calculated as described 
2.1.7.2 Quantification of Protein Concentration.  
2.3.2 Protein Separation by Gel Electrophoresis  
 
Proteins were separated by their molecular weight by SDS-polyacrylamide gel 
electrophoresis (PAGE) on 4-12% Bis-tris gels (NuPage, Life Technologies), which 
were inserted in an XCell SureLock electrophoresis chamber (Life Technologies). 
Before loading on the gel, protein samples were reduced and denatured by the 
addition of sample buffer (4x LDS Sample buffer, NuPage, 1M DTT and dH2O), and 
subsequent heating at 70⁰C for 10 minutes. As a molecular weight marker, 5μl of 
Broad Range Colour Protein Standard (New England Biolabs) was loaded alongside 
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the protein samples. After sample loading, gels were run in MOPS running buffer with 
500μl of antioxidant (Life Technologies) added to the middle chamber immediately 
before electrophoresis. Gels were run at 180V for one hour until proteins were fully 
separated.  
 
2.3.3 Western Blotting 
 
Proteins separated by SDS-PAGE were then transferred onto polyvinylidene fluoride 
(PVDF) or nitrocellulose membranes (0.45 μm pores, Amersham GE Healthcare) by 
semi-dry transfer. Transfer was carried out in Towbin transfer buffer (0.25 M Tris base, 
1.92 M glycine, 20% methanol, pH was fixed to 8.1-8.5). For semi-dry transfer, the gel 
containing the resolved proteins was “sandwiched” with the activated and equilibrated 
wet membrane between two stacks of three pieces of wet paper and inserted into the 
BioRad Trans-Blot Turbo Transfer system. Transfers were run at 25V for 30 minutes. 
After transfer, transfer membranes were checked by staining the membrane with 
Ponceau S (Sigma-Aldrich). Ponceau S was removed by TBS washes, and 
membranes were blocked for either one hour at room temperature or overnight at 4⁰C. 
Membranes were blocked in either 5% Milk in TBS-0.05% Tween (TBST) or 5% BSA 
(Sigma) in TBST. After blocking Membranes were incubated with primary antibodies 
for either one-hour at room temperature or overnight at 4⁰C. Primary antibodies were 
diluted to the appropriate dilution in blocking buffer (Listed Table 2.3). After incubation 
with primary antibodies membranes were washed in TBST 3 times for 5 minutes and 
incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies 
(Table 2.3) for one hour at room temperature. Membranes were then washed in TBST 
3 times for 5 minutes and protein band detection was achieved by incubating the 
membrane in Chemiluminescence reagent for Horseradish Peroxidase (Serva) 
supplemented with hydrogen peroxide solution (Sigma) at a 1:1000 dilution or Clarity 
Western ECL substrate (BIO-RAD) for low abundance signals. The membrane was 
then inserted in a darkroom cassette and exposed onto a photographic film 
(Amersham Hyper film ECL by GE Healthcare) which was then developed in a 






2.3.4 Membrane Stripping 
 
In order to re-probe membranes for a loading control (β-actin), primary and secondary 
antibodies were removed by incubating the membrane in a mild stripping buffer (0.2Μ 
glycine, 0.1% SDS, 0.1% Tween20, pH adjusted to 2.2), twice for 5 minutes. The 
membrane was then washed twice with PBS (5 minutes each) and twice with TBST 
(5 minutes each) before proceeding to the blocking stage. 
 


















Millipore 05-724 2919011 1:1000  
Mouse anti Actin  Sigma A5441 014M4759 1:10000  
Rabbit anti 
ZDHHC5 
Abcam Ab200572  1:1000  
Mouse anti HA-
Probe F7 
Santa Cruz Sc-7392 L1115 1:2000 1:1000 
Mouse anti V5 Invitrogen 46-0705 1805125 1:5000  
Rabbit anti Myc Cell 
Signalling 
2272S 6  1:1000 
Streptavidin- 




S11227 1587669  1:10000 











  1:400 
Mouse anti 
Rhodopsin 
Santa Cruz Sc-57432 E1316  1:500 
Rabbit anti M/L 
Opsin 
Millipore AB5405 3011830  1:500 
Goat anti S opsin Insight sc-14363   1:500 
Rabbit anti GFAP DAKO Z0034   1:500 


























Anti mouse IGg 
HRP linked  
Cell 
Signalling 
706S 32 1:2000  
Anti Rabbit IGg 
HRP linked  
Cell 
Signalling 
704S 36 1:2000  
Goat Anti Rabbit- 
Alexa Flour 488 
Life 
Technologies 
R37116 1884984  1 
drop/ml 
Goat anti Mouse -
Alexa Flour 594 
Life 
Technologies 




Goat Anti Mouse -
Alexa Flour 680 
Invitrogen A21058 982289  1:1000 
Goat Anti Rabbit – 
Alexa Flour 594 
Life 
Technologies 
R37117 1780825  1 
drop/ml 
Goat Anti Mouse- 
Alexa Flour 488 





















































Lysis of eyes for 
western blot 
 
Lysis of cells for 
western blot 
 
Lysis of RPE1 
RP2BIRA and 




Lysis of cells for 
Click Chemistry IP 
assays 




MgCl2, 1% Triton 
X-100, 10% 
Glycerol 





Triton Lysis Buffer 50mM Tris-HCl pH 
7.5, 150 mM 
NaCl, 1% Triton 
x100 
Lysis of cells for 
V5-IP assays 
Table 2.  4 List of Buffers used for Protein Extraction 
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2.3.5 BIO-ID Assay  
 
RPE1 RP2 Null RP2-BIRA and RPE1 RP2 Null BIRA cells were seeded on 10 cm 
dishes and once confluent incubated in DMEM-F12 medium (as above) 
supplemented with or without 50μm biotin for 24 hours. After two washes with ice cold 
PBS, cells were lysed in 500μl RIPA lysis buffer (Santa Cruz, sc24928) and PMSF, 
protease and phosphatase inhibitor cocktails (Sigma) as described above. 
Streptavidin pulldowns were performed on Kingfisher duo automated IP machine 
using magnetic streptavidin Dynabeads (Thermo). Plates for processing in Kingfisher 
duo were set up as follows: 
 




2M urea + 100 mM tris + 1 mM 
DTT + 5ug/mL trypsin 
100 uL 
B TBS 50 mM tris, 150 mM NaCl, pH 
7.4 
300 uL 
C TBS 50 mM tris, 150 mM NaCl, pH 
7.4 
300 uL 
D TBS 50 mM tris, 150 mM NaCl, pH 
7.4 
300 uL 
E RIPA Santa Cruz (sc-24948) 300 uL 
F RIPA Santa Cruz (sc-24948) 300 uL 
G Lysate RP2-BIRA/ BIRA only Lysate 500 uL 
H Beads MyOneStreptavidin 





Samples were processed on the 1hr-IP-Digest protocol which performs an 1hr IP 
followed by an overnight trypsin digestion at 37⁰C to elute and digest proteins from 





2.3.6 Mass Spectrometry Analysis 
 
2.3.6.1 Peptide Clean-up 
 
Prior to mass spectrometry analysis samples were loaded onto tips containing C18 
material (Sigma), proteins were stored at -20⁰C on the C18 material in the tips before 
loading onto the mass spectrometry machine. Firstly, samples were acidified by 
addition of 0.5% TFA and the pH checked by pH paper. After C18 material was loaded 
onto tips 20μl of MS-grade Methanol was added to each tip to activate the C18 
material and pushed through using a syringe. Tips were then equilibrated by addition 
of 0.1%TFA and the sample then loaded onto the tips. The tips were then washed by 
a final addition of 0.1%TFA and stored at -20⁰C. 
2.3.6.2 Mass Spectrometry 
 
Samples were processed on a Thermo Scientific 3000 RSLC Nano liquid 
Chromatography system coupled to QExactive Plus mass spectrometer by Dr Jimi 
Wills and Dr Alex von Kreigheim at the IGMM Mass Spectrometry Facility. Samples 
were analysed in three technical repeats. Results were searched, filtered and 
statistically analysed, any hits that were enriched in experimental samples 5 fold more 
than in control were considered valid hits and these proteins were then organised by 
statistical significance.  
2.3.7 Streptavidin Pulldown Assay 
 
RP2 BIRA and BIRA cells were plated on 10cm dishes and once confluent 
supplemented with or without 50μm biotin for 6 hours. Cells were lysed in RIPA lysis 
buffer (Santa Cruz) with PMSF, protease and phosphatase inhibitor cocktails (Sigma) 
(As described 2.3.1). Ten percent of the lysates were removed for inputs and the 
remaining lysate was incubated with 25μl dynobeads (MyOne Streptavidin C1, 
Invitrogen) for 1 hour at 4⁰C with continuous rotation. Beads were then washed 3 
times with PBS and biotin labelled proteins eluted off the beads by adding Sample 





2.3.8 Click Chemistry Immunoprecipitation Assay 
 
HEK293T cells were seeded on six well plates and transiently transfected with RP2-
V5 and ZDHHC5-HA. For knockdown experiments, cells were transfected with 
ZDHHC5 siRNA and CTRL siRNA 48hrs prior to transient transfection with RP2-V5 
and ZDHHC5-HA (see 2.2.2). Twenty-four hours after transfection, cells were serum 
starved in DMEM supplemented with 1% fatty acid free BSA (Sigma) for 30 minutes. 
After washing in PBS cells were incubated with DMEM/1% fatty acid free BSA 
supplemented with 100μM ODYA (Caymen Chemicals) overnight to facilitate labelling 
of palmitolyated proteins. Cells were lysed in Triton lysis buffer (50mM Tris pH7.5, 
150mM NaCl, 1% Triton x100) with 1x PMSF, protease and phosphatase Inhibitors 
(Sigma) (as described 2.3.1). Ten percent of the lysate was removed for input sample. 
Lysates were incubated with 10μl V5 beads (mouse anti V5 Agarose Affinity gel 
antibody, Sigma) for 1 hour at 4⁰C to immunopercipitate RP2-V5. After 3 washes in 
triton lysis buffer click chemistry reaction mix (IRdye 800CW,Licor, CuSO4 40mM, 
TBTA 100mM, Sigma and dH20) was added to each lysate followed by 40mM 
Ascorbic Acid (Sigma). Reactions were mixed in a table top Thermomixer C 
(Eppendorf) at 1300rpm 1 hour at room temperature. Samples were then prepared 
for electrophoresis and Western blot by addition of sample buffer as described above. 
After electrophoresis and transfer, (see 2.3.3) membranes were blocked in 50% 
Odyssey Blocking Buffer/PBS (Licor) for 1 hour at room temperature. V5 primary and 
Alexa- Flour 680 goat anti mouse secondary (Invitrogen) were diluted in the same 
buffer and incubated on membranes for 1 hour at room temperature. Membranes 
were imaged on Odyssey FC imaging system (LICOR). Remaining input samples 
















 Phenotype Analysis of Rp2h 








In order to gain a better understanding of the role of RP2 in the retina and to therefore 
better understand the mechanism causing photoreceptor death in patients with RP2 
mutations, two Rp2h knock out mouse models have previously been generated (L. Li 
et al. 2013; Houbin Zhang et al. 2015). A gene trap cassette targeting the first intron 
of the Rp2h gene was used to generate Rp2h -/- mice (Houbin Zhang et al. 2015). 
These mice presented with a progressive rod-cone dystrophy with vision loss evident 
from one month of age. The retinal pathology of these mice was studied up to two 
years of age with little difference in the thickness of the outer nuclear layer (ONL) 
detected even at late stages of the disease. However, mislocalisation of the 
prenylated proteins rod and cone Phosphodiesterase 6 (PDE6) and G- coupled 
receptor  kinase 1 (GRK1) were detected in these mice (Houbin Zhang et al. 2015). 
This is similar to the findings in zebrafish in which the absence of RP2 results in 
mislocalisation of PDE6, GRK1 and transducin α (F. Liu et al. 2015). These findings 
collectively provide strong evidence in support of a mechanism of disease progression 
caused by mistrafficking of prenylated proteins attributed to excessive levels of ARL3-
GTP due to the absence of RP2. However, transducin α appeared to be localised 
normally in Rp2h -/- mice despite it being a known RP2-ARL3 target, highlighting the 
possibility that in vivo, compensatory mechanisms exist.  
A second Rp2h knockout mouse, Rp2null, was generated by flanking exon 2 of the 
Rp2h gene with lox p sites and crossing into a cre line (L. Li et al. 2013). The cre line 
used expressed the cre transgene under control of the cytomegalovirus immediate 
early enhancer chicken β-actin hybrid (CAG) promoter. Cre expression in this line is 
activated before the two cell stage of embryonic development which facilitates 
deletion of genes from the very early stages of development (Sakai and Miyazaki 
1997). Rp2null mice presented with a progressive rod-cone dystrophy with 
deterioration of photoreceptor function detected as early as one month of age. This 
model showed no significant decrease in ONL thickness at 1 month however, a 
significant decrease in ONL thickness was detected at both 5 months and 9 months 
of age. Immunofluorescence analysis of the retinas revealed normal localisation of 
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transducin β subunit 1 (Gβ1) and nephrocystin 3 (NPHP3) even in older mice where 
retinal degeneration was severe. These mice however, did present with early M/L 
opsin mislocalisation evident from one month of age, which occurred prior to 
photoreceptor cell death (L. Li et al. 2013). This model demonstrated that in the 
absence of RP2, prenylated proteins can still be trafficked correctly within the retina 
and therefore a dysfunction of ARL3 may not be the major factor causing retinal 
degeneration in this case. This model suggests a novel function for RP2 in cone opsin 
trafficking, a mechanism which appears to be independent of ARL3 activity. 
 A review of the clinical symptoms of Retinitis Pigmentosa patients revealed patients 
with RP2 mutations tend to have early cone deterioration prior to rod deterioration 
(Jayasundera et.al, 2010) therefore this model may better recapitulate the human 
phenotype. This is further supported by a study in which RP2 was ablated specifically 
in rods or cones revealing Rp2h knock out in cones leads to an elongated cone OS 
and phenocopy of the Rp2null mouse, a finding which is not replicated when Rp2h is 
knocked out in rods only (Li et.al, 2015).  If RP2 mutations do cause a cone 
autonomous effect, which leads to secondary rod cell death it is difficult to explain this 
defect through a disease mechanism based primarily on ARL3 dysfunction as ARL3 
is expressed in the connecting cilia of both rod and cone photoreceptors, 
consequently a cell autonomous effect would not be expected. Therefore, this 
suggests RP2 in cones has other functions independent of its GAP activity on ARL3, 
which when perturbed contribute to retinal degeneration. The differential findings 
presented in the two Rp2h knock out mouse models demonstrate the necessity of 
establishing whether the major driver of retinal degeneration in cases with RP2 
mutations is attributed solely to defects in ARL3 regulation. Therefore, to address this 
question, I generated new Rp2h knockout and Rp2h E135G mouse models using 
CRISPR genome editing. The mouse E135G mutation is equivalent to the E138G 
human pathogenic mutation that is predicted to result in a stable RP2 protein, which 
is unable to interact with ARL3 (Kühnel et.al 2006).This enables the comparison of 
loss of RP2 GAP activity to complete RP2 knockout, allowing the contribution of ARL3 





3.2 Rp2h DEL26/Y and Rp2h E135G/Y Mice have Progressive Retinal 
Degeneration 
 
3.2.1 Validation of Rp2h DEL26/Y and Rp2h E135G/Y Mice 
 
To generate mice carrying the Rp2h E135G mutation paired guide RNAs, cas9 
nickase mRNA and a repair template designed to introduce the E135G mutation were 
injected by cytosolic injection into C57BL6/J single cell embryos (see 2.1.2 for detailed 
methods and sequences of guide RNAs and the repair template). From this round of 
injections, a 26bp deletion allele was also introduced which was predicted to result in 
no protein expression. F0 founder animals carrying both E135G and DEL26 mutations 
were outbred with C57BL6/J animals to generate F1 mice which were used to 
establish the line. The line was maintained by crossing Rp2h DEL26/+ and Rp2h 
E135G/+ female mice to C57BL6/J control male animals. F2 Rp2h DEL26/Y and Rp2h 
E135G/Y were used as experimental animals and Rp2h DEL26/+ and Rp2h E135G/+ 
females were continually outbred to C57BL6/J control male animals to generate 
further generations of experimental male animals and to maintain the line.   
In order to confirm that the E135G mutation and the DEL26 mutation introduced by 
CRISPR genome editing (Figure 3.1 A) generated a stable protein and a null allele 
respectively, a western blot for RP2 was performed. RP2 expression was detected in 
WT and Rp2h E135G/Y lysates but was absent in Rp2h DEL26/Y kidney lysates 
(Figure 3.1 B). RP2 expression was also detected in WT, Rp2h E135G/Y, Arl3 
Q71L/+, Arl3 Q71L/Q71L eye lysates but not in Rp2h DEL26/Y eye lysates (Figure 
3.1 C) (Arl3 Q71L+ and Arl3 Q71L/Q71L mice discussed in chapter 4). The levels of 
RP2 E135G were comparable to WT in both kidney and eye lysates demonstrating 








(A) Schematic of the generation of RP2 E135G and RP2 DEL26 mutations by 
CRISPR genome editing. 
(B) Western blot of RP2 expression in Rp2h DEL26/Y, Rp2h E135G/Y and WT 
kidney lysates. Rp2h DEL26/Y lysates had no RP2 expression. Rp2h 
E135G/Y and WT lysates had RP2 expression.  
(C) Western blot of RP2 expression in WT, Rp2h DEL26/Y, Rp2h E135G/Y, 
Arl3 Q71L/+ and Arl3 Q71L/Q71L whole eye lysates. Rp2h DEL26/Y eyes 
had no RP2 expression. RP2 expression was detected in WT and Rp2h 
E135G/Y eyes.  
Arl3 Q71L/+ and Arl3 Q71L/Q71L discussed in chapter 4 




3.2.2 Histological Analysis of Rp2h DEL26/Y and Rp2h E135G/Y Retinas 
 
In order to determine whether Rp2h DEL26/Y and Rp2h E135G/Y retinas exhibit 
retinal degeneration, which models the human XLRP phenotype of progressive 
photoreceptor cell loss, paraffin sections of retinas were stained with haematoxylin 
and eosin and the histology analysed. Eyes were fixed in Davidson’s Fix for 24 hours 
and processed for wax sectioning (as described 2.1.4), 7µm thick sections were cut 
from paraffin embedded eyes (as described 2.1.4) and sections which contained the 
optic nerve (ON) were used for histological analysis. Retina sections were taken from 
mice aged 1 month, 3 months, 6 months, 9 months and 12 months and the thickness 
of the ONL measured at specific distance from the ON. The ONL was measured as it 
contains the nuclei of the photoreceptors therefore thinning of the ONL reflects loss 
of photoreceptors. To confirm that retinal degeneration was attributed to loss of 
photoreceptors and not loss of other cells in the retina the inner nuclear layer (INL) 
thickness was measured as a control as it contains the nuclei of bipolar, horizontal 
and amacrine cells. Rp2h DEL26/Y retinas displayed no difference in ONL thickness 
at 1 month of age (Figure 3.2 A, Figure 3.3 A (i)). At 3 months of age Rp2h DEL26/Y 
retinas had a significantly thinner ONL at peripheral regions demonstrating loss of 
photoreceptors (Figure 3.2 B, Figure 3.3 A (ii)). At 6 months of age Rp2h DEL26/Y 
retinas displayed retinal thinning compared to WT and significant reduction in ONL 
thickness in multiple regions (Figure 3.2 C, Figure 3.3 A (iii)). At 9 months and 12 
months of age extensive retinal thinning was observed compared to WT and ONL 
thickness was significantly reduced at most regions (Figure 3.2 D, E, Figure 3.3 A (iv), 
(v)). The INL was not significantly thinner than WT at any age (Figure 3.3 C) 
suggesting that the retinal degeneration was specifically due to loss of 
photoreceptors.  
Rp2h E135G/Y retinas had no significant difference in ONL thickness at 1 month or 3 
months of age (Figure 3.2 A, Figure 3.3 A (i), Figure 3.2 B, Figure 3.3 B (ii)). At 6 
months of age no retinal thinning was observed in Rp2h E135G/Y retinas compared 
to WT, however ONL thickness was reduced significantly in some regions (Figure 3.2 
C, Figure 3.2 A (iii)). At 9 months and 12 months of age, thinning of the retina 
compared to WT was observed and the ONL was significantly thinner than WT in most 
regions (Figure 3.2 D, E, Figure 3.3 A (iv), (v)). The INL thickness was not significantly 
reduced compared to WT at any age demonstrating the retinal degeneration observed 
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was attributed to loss of photoreceptors (Figure 3.3 B). Rp2h E135G/Y retinas were 
not thin as Rp2h DEL26/Y retinas at 9 months or 12 months of age and the ONL 
thickness of Rp2h DEL26/Y retinas was thinner than Rp2h E135G/Y from age 3 
months demonstrating Rp2h knockout results in more severe retinal degeneration 























H&E staining of paraffin sections of Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y 
Retinas. Aged 1 month (A), 3 months (B), 6 months (C), 9 months (D) and 12 months 
(E). Retinal degeneration can be observed from 6 months of age in both Rp2h DEL26/Y 














































































(A) ONL thickness measurements at central, medial and peripheral regions from 
ON in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas aged 1 month (i), 
3 months (ii), 6 months (iii), 9 months (iv) and 12 months (v). Significant 
reductions in ONL thickness was present in Rp2h DEL26/Y retinas from 3 
months. Significant reduction in ONL thickness was present in Rp2h E135G/Y 
retinas from 6 months of age. 
(B) INL thickness measurements at central, medial and peripheral regions from the 
ON in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas ages 1 month (i), 
3 months (ii), 6 months (iii), 9 months (iv) and 12 months (v). INL thickness is 
not significantly different from WT for Rp2h DEL26/Y and Rp2h E135G/Y retinas 
at any ages examined.  


































3.2.3 ERG Analysis of Rp2h DEL26/Y and Rp2h E135G/Y Retinas 
 
The electroretinogram (ERG) is a test that measures the electrical activity generated 
by neural and non-neuronal cells in the retina in response to a light stimulus. The 
electrical response is a result of a retinal potential generated by light-induced changes 
in the flux of ions during phototransduction (Bach et al. 2013). To perform ERGs on 
mice, mice were firstly dark adapted to analyse the function of rod photoreceptors and 
then light adapted to analyse the function of cone photoreceptors. Mice were 
anaesthetised by inhalation of 1% isoflurane and electrodes were placed over the 
front of the cornea and secured with a contact lens (see 2.1.5 for detailed methods). 
ERGs recordings produce wave forms which reflect the activity of photoreceptors. The 
negative A-wave amplitude reflects the activation of photoreceptors and is used as a 
read out of photoreceptor function. The positive B-wave amplitude represents 
activation of the downstream signalling cells such as Muller cells and bipolar cells 
(Bach et al. 2013). 
To examine photoreceptor function in Rp2h DEL26/Y and Rp2h E135G/Y mice ERG 
recordings using 3cd flash and 10cd flash were analysed. Firstly, a dark-adapted ERG 
was recorded using a 3cd flash which can stimulate both rod and cone photoreceptors 
however, the A-wave amplitude recorded is rod dominated. To examine the function 
of cone photoreceptors a light adapted ERG was recorded using a 10cd flash. Rp2h 
DEL26/Y mice had no significant difference in 3cd ERG response compared to WT 
mice aged 3 months (Figure 3.4 A (i), B). From age 6 months a significant reduction 
in A-wave response was recorded which decreased as the mice aged demonstrating 
a progressive reduction in photoreceptor function (Figure 3.4 A, B). Similarly, 
recordings from the 10cd light adapted test demonstrated no significant difference in 
responses in Rp2h DEL26/Y mice aged 3 months but a reduction in A-wave response 
was detected from age 6 months to12 months (Figure 3.5 A, B). These ERG 
recordings demonstrate Rp2h DEL26/Y mice have progressive reduction in both rod 
and cone function from age 6 months. Rp2h E135G/Y mice had no statistically 
significant difference in A-wave amplitude detected in the 3cd test, demonstrating no 
significant reduction in photoreceptor function (Figure 3.4 A, C). Recordings from the 
10cd Test revealed a significantly reduced A-wave amplitude in Rp2h E135G/Y mice 
compared to WT at age 9 and 12 months (Figure 3.5 A (iv), (v), C). This demonstrates 
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Rp2h E135G/Y mice have a reduction in cone photoreceptor function from age 9 

















































(A) Representative traces from 3cd flash dark adapted ERGs for Rp2h 
DEL26/Y compared to WT and Rp2h E135G/Y compared to WT aged 3 
months (i), 6 months (ii), 9 months (iii) and 12 months (iv). 
(B) Quantification of average A-wave amplitude in Rp2h DEL26/Y and WT 
aged 3, 6, 9 and 12 months. Significant reduction in A-wave amplitude in 
Rp2h DEL26/Y mice detected from age 6 months.  
(C) Quantification of average A-wave amplitude in Rp2h E135G/Y and WT 
mice aged 3,6,9 and 12 months. No significant reduction in A-wave 
amplitude detected at any age.  
N=5 for each genotype at each age, statistics calculated by students 
T.Test. Rp2h DEL26/Y and Rp2h E135G/Y mice compared to WT CTRL 

























(A) Representative traces from light adapted 10cd Test ERGs for Rp2h 
DEL26/Y compared to WT and Rp2h E135G/Y compared to WT aged 3 
months (i), 6 months (ii), 9 months (iii) and 12 months (iv). 
(B) Quantification of average A-wave amplitude in Rp2h DEL26/Y and WT 
aged 3, 6, 9 and 12 months. Significant reduction in A-wave amplitude in 
Rp2h DEL26/Y mice detected from age 6 months.  
(C) Quantification of average A-wave amplitude in Rp2h E135G/Y and WT 
mice aged 3,6,9 and 12 months. Significant reduction in A-wave amplitude 
detected at 9 and 12 months of age.  
N=5 for each genotype at each age, statistics calculated by students 
T.Test. Rp2h DEL26/Y and Rp2h E135G/Y mice compared to WT CTRL 






3.3 Rp2h DEL26/Y and Rp2h E135G/Y Retinas exhibit Retinal Stress at 1 month 
 
Given that Rp2h DEL26/Y and Rp2h E135G/Y mice have a retinal degeneration 
phenotype apparent from 6 months and 9 months of age respectively by ERG 
responses, I assessed whether there were any signs of retinal stress prior to 
photoreceptor loss. Glial fibrillary acidic protein (GFAP) is expressed in astrocytes 
and Muller cells, however upon retinal stress, these microglial cells become activated 
forming fibres which spread into other layers of the retina and GFAP expression is 
increased. Retina sections from Rp2h DEL26/Y and Rp2h E135G/Y mice aged 1 
month were analysed for GFAP expression (Figure 3.6). In WT retinas GFAP staining 
was confined to the GCL in both central and peripheral regions (Figure 3.6 A, D). In 
RP2h DEL26/Y and Rp2h E135G/Y retinas GFAP expression was confined to the 
GCL in central regions (Figure 3.6 B,C) but was observed in the upper layers of the 
retina (throughout the ONL, INL, IPL) in peripheral regions (Figure 3.6 E,F). The Rp2h 
DEL26/Y retinas had more gliosis than in Rp2h E135G/Y retinas indicating more 
retinal stress in these mice. As observed at the periphery of the retina, this suggested 
that peripheral photoreceptors may be more sensitive to Rp2h mutation. 
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(A) GFAP (green) staining in WT central retina aged 1 month demonstrating 
GFAP is expressed in ganglion cell layer. 
(B) GFAP staining in Rp2h DEL26/Y central retina aged 1 month. GFAP 
staining was present in the ganglion cell layer. 
(C) GFAP staining in Rp2h E135G/Y central retina aged 1 month. GFAP 
staining was present in ganglion cell layer.  
(D) GFAP staining in WT peripheral retina. GFAP staining was localised to the 
ganglion cell layer.  
(E) GFAP staining in Rp2h DEL26/Y peripheral retina. GFAP staining was 
present within the GCL, INL, OPL and ONL.  
(F) GFAP staining in Rp2h E135G/Y peripheral retina. Some GFAP staining 
was present in the IPL and INL.  
Figure 3. 6 GFAP Expression in Rp2h DEL26/Y and Rp2h E135G/Y Retinas 
Aged 1 Month 
  
A B C 























3.4 M/L Opsin is mislocalised in Rp2h DEL26/Y and Rp2h E135G/Y Retinas after 
Onset of Photoreceptor Cell Death 
 
As it has been previously reported that M/L opsin is mislocalised in Rp2null mice from 
one month of age, prior to photoreceptor cell death (L. Li et al. 2013), I analysed M/L 
opsin localisation in the Rp2h DEL26/Y and Rp2h E135G/Y mice. Rp2h DEL26/Y 
mice displayed normal M/L opsin localisation to the OS and IS of cone photoreceptors 
identical to the localisation in WT retinas at ages 1 month and 3 months (Figure 3.7 
A). At 6 months of age M/L opsin staining was observed in the IS, ONL and IPL of 
cone photoreceptors (Figure 3.7 C). At 9 months and 12 months of age a reduction in 
M/L opsin staining was observed suggesting loss of cone photoreceptors as retinal 
degeneration progressed. At 6 months of age a reduction in the ERG response of 
cone photoreceptors and a reduction in ONL thickness (Figure 3.4, Figure 3.2, 3.3) 
was also observed suggesting that mislocalisation of M/L opsin likely contributes to 
dysfunction of cones and may cause cone photoreceptor cell death. Significant 
thinning of the ONL is detected at 3 months of age in peripheral regions when M/L 
opsin is not mislocalised suggesting that another factor may be driving retinal 
degeneration at early stages and M/L opsin mislocalisation may be a secondary effect 
causing dysfunction of cones. 
Rp2h E135G/Y retinas had normal M/L opsin localisation in the IS and OS of cone 
photoreceptors at 1 month, 3 months and 6 months of age (Figure 3.7 A, B, C). At 9 
months of age M/L opsin expression was detected in the IS of the cone 
photoreceptors and not the OS. At 12 months of age the Rp2h E135G/Y retinas had 
reduced M/L opsin immunostaining possibly reflecting loss of cone photoreceptors 
(Figure 3.7 E). In Rp2h E135G/Y mice at 9 months and 12 months of age a significant 
reduction in cone photoreceptor function was detected by ERG and as M/L opsin 
mislocalisation was also observed at these ages, this suggests that mislocalisation of 
M/L opsin contributed to cone dysfunction and cone cell death. Thinning of the ONL 
in Rp2h E135G/Y retinas was first detected at 6 months of age suggesting another 
factor was driving retinal degeneration and secondary effects on M/L opsin followed 
this at 9 and 12 months.  
A reduction in M/L opsin staining was observed earlier in Rp2h DEL26/Y retinas than 
in Rp2h E135G/Y retinas suggesting earlier cone loss in DEL26/Y mutants (Figure 
3.7 D). M/L opsin mislocalisation was also detected in Rp2h DEL26/Y retinas at earlier 
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stages than Rp2h E135G/Y retinas demonstrating that RP2 E135G expression can 
facilitate M/L opsin trafficking for some time despite loss of ARL3 GAP activity 
suggesting that RP2 may interact with other factors along with ARL3 to regulate 
trafficking of M/L opsin or M/L opsin may be mislocalised as a secondary effect due 
























































(A) M/L Opsin (green) staining in Rp2h WT, Rp2h DEL26/Y and Rp2h 
E135G/Y aged 1 month. M/L opsin staining was present in the OS of cone 
photoreceptors.  
(B) M/L opsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y aged 
3 months. M/L opsin staining was present in OS of cone photoreceptors in 
WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas.  
(C) M/L opsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y aged 
6 months. M/L opsin staining was present in the OS of cone photoreceptors 
in WT retinas. In Rp2h DEL26/Y retinas M/L opsin staining was present in 
the OS, IS, ONL and OPL of cone photoreceptors. In Rp2h E135G/Y 
retinas M/L opsin staining was detected in the OS of cone photoreceptors 
similar to WT retinas.  
(D) M/L opsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 9 months. In WT retinas M/L opsin staining was present in the OS of 
cone photoreceptors. In Rp2h DEL26/Y retinas M/L opsin staining was 
reduced compared to WT. In Rp2h E135G/Y retinas M/L opsin staining 
was present in the IS, ONL and OPL of cones. 
(E) M/L opsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 12 months. In WT retinas M/L opsin staining was present in the OS 
of cone photoreceptors. In Rp2h DEL26/Y and Rp2h E135G/Y retinas M/L 
opsin staining was reduced compared to WT retinas.  
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3.5 Rhodopsin is mislocalised in Rp2h DEL26/Y and Rp2h E135G/Y Retinas 
  
As M/L opsin was mislocalised in older Rp2h DEL26/Y and Rp2h E135G/Y mice I 
investigated whether the localisation of rhodopsin was affected in these mice. Rp2h 
DEL26/Y mice had normal rhodopsin localisation to the OS of rod photoreceptors 
identical to WT retinas, at 1 month of age (Figure 3.8 A). At 3 months of age rhodopsin 
was observed to be mislocalised to the IS of photoreceptors (Figure 3.8 B). At 6 
months of age rhodopsin was detected in the OS, IS and OPL. At 9 and 12 months of 
age rhodopsin was detected throughout the OS, IS, ONL and OPL. In Rp2h DEL26/Y 
retinas significant changes in ONL thickness was observed at 3 months of age in 
peripheral regions with more widespread changes observed at 6 months of age 
(Figure 3.3 A (iii)) however, reduction in ERG response was not detected until 6 
months of age (Figure 3.4 B).  As thinning of the ONL was first detected at the same 
stage as rhodopsin mislocalisation it is possible that mislocalisation of rhodopsin may 
be a mechanism driving retinal degeneration in Rp2h DEL26/Y mice. 
Rp2h E135G/Y mice displayed normal rhodopsin localisation to the OS of rods at 1 
month, 3 months and 6 months of age (Figure 3.8 A, B, C). At 9 months of age 
rhodopsin was detected throughout the photoreceptor layer with signal present in the 
OS, IS, ONL and OPL (Figure 3.8 C, D). At 12 months of age rhodopsin was again 
detected in the OS, IS, ONL and OPL (Figure 3.8 E,D). Significant reduction in ONL 
thickness and ERG response was detected from 6 months however; no significant 
reduction in rod photoreceptor response was detected even at 12 months of age 
(Figure 3.3, Figure 3.4 B). As thinning of the ONL was detected prior to rhodopsin 
mislocalisation it suggests another factor may be driving retinal degeneration in Rp2h 
E135G/Y retinas.  
These results demonstrate that mislocalisation of rhodopsin can occur without a 
significant effect on rod function as no significant difference in rod ERG response was 
detected in Rp2h DEL26/Y mice aged 3 months or in Rp2h E135G/Y mice aged 9 
months, the ages at which rhodopsin mislocalisation was detected. Rhodopsin 
mislocalisation was detected at 3 months prior to onset of major photoreceptor cell 
loss in Rp2h DEL26/Y mice suggesting rhodopsin mislocalisation may be a 
mechanism which drives retinal degeneration in these retinas. In Rp2h E135G/Y mice 
rhodopsin mislocalisation was not observed until age 9 months whereas reduction in 
ONL thickness was present from age 6 months. This suggests that another 
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mechanism may drive retinal degeneration in Rp2h E135G/Y mice and lead to 
secondary rhodopsin mislocalisation. This demonstrates that RP2 expression even 
without GAP activity for ARL3 can partially facilitate proper rhodopsin trafficking but 
is not sufficient to completely maintain trafficking suggesting that interactors other 
than ARL3, which can still interact with RP2 E135G may be involved in rhodopsin 
trafficking. This emphasises that multiple mechanisms may contribute to retinal 
degeneration in Rp2h DEL26/Y mice and may help to explain why they have a more 











































(A) Rhodopsin (red) staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y 
retinas aged 1 month. In WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
rhodopsin staining was detected in the OS of rod photoreceptors.  
(B) Rhodopsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y 
retinas aged 3 months. In WT and Rp2h E135G/Y retinas rhodopsin was 
present in the OS of rod photoreceptors. In Rp2h DEL26/Y retinas 
rhodopsin was detected in the OS and IS of rods. 
(C) Rhodopsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y aged 
6 months. In WT and Rp2h E135G/Y retinas rhodopsin was detected in the 
OS of rod photoreceptors. In Rp2h DEL26/Y retinas rhodopsin was 
detected in the OS, IS and OPL.  
(D) Rhodopsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y aged 
9 months. Rhodopsin was detected in the OS of WT photoreceptors. In 
Rp2h DEL26/Y and Rp2h E135G/Y rhodopsin was observed in the OS, IS, 
ONL and OPL of the photoreceptors.  
(E) Rhodopsin staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y aged 
12 months. In WT retinas rhodopsin was present in the OS of rod 
photoreceptors. Rp2h DEL26/Y and Rp2h E135G/Y retinas had rhodopsin 
localised throughout the OS, IS, ONL and OPL.  
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3.6 GRK1 is Mislocalised in Rp2h DEL26/Y and Rp2h E135G/Y mice  
 
GRK1 is a G- coupled protein receptor essential for recycling rhodopsin during the 
visual cascade. Following light activation GRK1 phosphorylates activated rhodopsin 
at multiple sites reducing its activity and facilitating the binding of arrestin which 
reduces activated rhodopsin’s catalytic activity, generating inactive rhodopsin 
(Yingbin Fu and Yau 2007). Several studies have reported mislocalisation or loss of 
GRK1 expression  when RP2 is mutated (Houbin Zhang et al. 2015; F. Liu et al. 2015). 
In the Rp2h -/- mouse, cone GRK1 was absent from outer segments at 1 month 
however normal protein levels were detected by western blot (Houbin Zhang et al. 
2015). Rp2 null zebrafish displayed mislocalisation of GRK1 to the OPL at 5.5 months 
old with the protein levels reduced to about ~50% of that in WT (F. Liu et al. 2015). 
Given these results and that GRK1 has been shown to require RP2, ARL3 and the 
ARL3 adaptor chaperone PDE6δ for proper trafficking (H Zhang et al. 2007), I 
investigated GRK1 localisation in Rp2h DEL26/Y and Rp2h E135G/Y retinas (F. Liu 
et al. 2015; Houbin Zhang et al. 2015). Rp2h DEL26/Y had normal GRK1 localisation 
in the OS of rod photoreceptors at 1 month of age (Figure 3.9 A). From 3 months of 
age Rp2h DEL26/Y mice had reduced GRK1 immunostaining (Figure 3.9 B, C, D, E) 
suggesting loss of GRK1 expression. Western blot analysis of whole eye lysates 
demonstrated that GRK1 was expressed in Rp2h DEL26/Y eyes even at 9 months of 
age (Figure 3.9 G). This suggests that lack of GRK1 immunostaining in the 
photoreceptor OS was the result of GRK1 mislocalisation, resulting in a diffuse weaker 
signal. 
Rp2h E135G/Y retinas also displayed normal GRK1 localisation aged 1 month (Figure 
3.9 A). At 3 months of age mislocalisation of GRK1 to the ONL was observed (Figure 
3.9 B). From 6 months of age GRK1 immunostaining was reduced in Rp2h E135G/Y 
retinas (Figure 3.9 C,D,E). Similarly, to the Rp2h DEL26/Y mice, western blot analysis 
of GRK1 expression in whole eye lysates demonstrated GRK1 was still expressed in 
Rp2h E135G/Y mice aged up to 9 months (Figure 3.9 G). 
This is similar to the findings in the Rp2h -/- mouse in which loss of GRK1 
immunostaining from the OS was observed but no reduction in protein levels was 
detected (Houbin Zhang et al. 2015).  In Rp2h E135G/Y mice disruptions in GRK1 
localisation occurred prior to any defect in photoreceptor function by ERG or change 
in histology. This suggests that in this mutant mislocalisation of GRK1 and likely other 
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lipid modified proteins could be a driver mechanism for retinal degeneration. However, 
in Rp2h DEL26/Y mice, loss of GRK1 localisation to the OS occurred age three 
months, the same stage mislocalisation of rhodopsin and thinning of the ONL was 
detected. Therefore, it is not possible to conclude which is a driver mechanism in this 
case and it is likely multiple mechanisms may drive retinal degeneration in Rp2h 


















































(A) GRK1 (red) staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y 
retinas aged 1 month. GRK1 staining was present in the OS of 
photoreceptors in WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas.  
(B) GRK1 staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 3 months. GRK1 staining was present in the OS of photoreceptors in 
WT retinas. Rp2h DEL26/Y retinas had reduced GRK1 staining compared 
to WT. Rp2h E135G/Y retinas had GRK1 staining present throughout the 
OS, IS, ONL, OPL of photoreceptors.  
(C) GRK1 staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 6 months. In WT retinas, GRK1 was present in the OS of 
photoreceptors. Rp2h DEL26/Y and Rp2h E135G/Y retinas had reduced 
GRK1 staining compared to WT.  
(D) GRK1 staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 9 months. Rp2h WT mice had GRK1 staining in the OS of 
photoreceptors. Rp2h DEL26/Y and Rp2h E135G/Y had reduced GRK1 
staining compared to WT. 
(E) GRK1 staining in Rp2h WT, Rp2h DEL26/Y and Rp2h E135G/Y retinas 
aged 12 months. Rp2h WT retinas had GRK1 staining in the OS of 
photoreceptors. Rp2h DEL26/Y and Rp2h E135G/Y retinas had reduced 
GRK1 staining compared to WT.  
(F) Secondary antibody only control demonstrating that all samples with 
reduced GRK1 immunostaining had higher levels than the background 
staining. 
(G) Western blot analysis of GRK1 expression in WT, Rp2h DEL26/Y, Rp2h 
E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L aged 1-9 months. GRK1 
expression was detected in all lysates aged one month. WT, Rp2h 
DEL26/Y and Rp2h E135G/Y lysates had GRK1 expression at all ages and 
the levels appeared unchanged compared to WT. Actin blots used as 
loading control. 





3.7.1 Rp2h DEL26/Y and Rp2h E135G/Y mice have Progressive Retinal 
Degeneration 
 
Analysis of histology of Rp2h DEL26/Y retinas and Rp2h E135G/Y retinas 
demonstrated differences observed from 3 months and 6 months of age respectively. 
The thinning of the ONL was not significant in every region measured even at late 
stages of retinal degeneration. In Rp2h DEL26/Y retinas thinning of the retina was 
firstly observed in peripheral regions in line with increased gliosis observed in 
peripheral regions at age one month. Rod photoreceptor cell density increases from 
the periphery of the retina to the centre of the retina however the ratio of photoreceptor 
to RPE cells is 2 fold higher in the central retina of the mouse than in the periphery 
(Volland et al. 2015) suggesting that peripheral photoreceptors may be more sensitive 
as there are less RPE cells present to support their survival. Alternatively, RP2 
mutation may affect the function of the RPE cells and therefore effect the 
photoreceptors they support and peripheral photoreceptors supported by fewer RPE 
cells would be expected to be the most sensitive. Expression of RP2 was shown not 
to be photoreceptor specific, as in the aryl hydrocarbon receptor interacting protein 
like 1 knockout (Aipl1-/-) mouse which has no photoreceptors, expression of RP2 was 
not significantly reduced compared to WT retinas demonstrating RP2 is expressed in 
other retinal cell types and is not highly enriched in photoreceptors (Murphy et al. 
2016). RP2 is also endogenously expressed in cultured human RPE cell lines (Wright 
et al. 2011). The regions where thinning of the ONL is not significant even at late 
stages may represent sectioning artefacts and to counteract this the number of nuclei 
present in the ONL could be calculated at specific distances from the ON and 
compared between Rp2h mutants and WT.  
Analysis of ERG responses did not detect significant differences in photoreceptor 
response in Rp2h DEL26/Y mice until 6 months of age. However, differences in 
histology were detected at 3 months of age. Similarly, no difference in ERG response 
was detected in Rp2h E135G/Y mice aged 6 months despite subtle differences in 
ONL thickness detected at this age. The ERG responses recorded in mice were quite 
variable which may have reduced the sensitivity of the assay. The ISCEV 
(International Society for Clinical Electrophysiology of Vision) protocol runs several 
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tests to detect changes in rod and cone function however only the 3cd dark adapted 
ERG test and the 10cd light adapted ERG test gave consistent results in WT mice 
therefore other tests were not analysed. In order to reduce variability in the ERG 
response mutants were compared to WT ERGs recorded on the same day however 
to reduce this variation further and to allow the detection of smaller differences, ERGs 
could be repeated on more animals. Rp2h E135G/Y retinas did not exhibit any 
significant difference in 3cd ERG response, despite showing significant thinning of 
ONL and rhodopsin mislocalisation, however a significant reduction in cone A-wave 
amplitude at 9 months and 12 months of age was observed. Only 3% of all 
photoreceptors in mice are cones therefore the differences in histology observed are 
unlikely to be attributed to cone degeneration alone (Carter-Dawson and LaVail 
1979). To detect smaller differences in rod responses a scotopic ERG program could 
be run on these mice which exposes mice to multiple low intensity flashes allowing 
detection of small defects in rod function. The ERG set up used for my study did not 
have this programme therefore this analysis was not carried out on Rp2h DEL26/Y 
and Rp2h E135G/Y mice.  
3.7.2 Mislocalisation of M/L Opsin and Rhodopsin in Rp2h DEL26/Y and Rp2h 
E135G/Y Retinas 
 
In the previously described Rp2null mouse model mislocalisation of cone opsin was 
reported at age 1 month. In Rp2h DEL26/Y and Rp2h E135G/Y mutants no cone 
opsin mislocalisation was detected until 6 months and 9 months of age respectively. 
These differences may reflect the differences in the technique used to generate the 
mice as one was generated using the cre lox system and the other generated using 
CRISPR genome editing. Reduced M/L opsin staining was observed in Rp2h 
DEL26/Y and Rp2h E135G/Y mutants from age 9 months and 12 months of age, 
which may reflect loss of cone photoreceptors as retinal degeneration progresses 
however the number of cones was not counted in this experiment and a retinal whole 
mount section could be used to answer this question directly.   
Cone opsin trafficking to the OS is thought to occur through intraflagellar transport 
(IFT) mediated by the heterotrimeric kinesin II motor complex containing kinesin family 
member 3a (Kif3a), kinesin family member 3b (Kif3b) or kinesin family member 3c 
(Kif3c) and kinesin associated protein 3 (KAP3) subunits (Takeda et al. 1999). A cone 
specific knockout for Kif3a demonstrated that cones developed normally however by 
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p30 no photopic ERG responses were recorded and M/L opsin was absent from the 
cone OS and mislocalised to the IS, axons and synaptic pedicles (Avasthi et al. 2009). 
A Kif17 knockout zebrafish demonstrated that Kif17 was required for OS formation 
and for cone opsin trafficking as extensive mislocalisation of cone opsin to the cone 
photoreceptor cell body and synaptic region was detected (Insinna et al. 2008) 
however a Kif17 null mouse demonstrated Kif17 is not required for M/L opsin 
trafficking (Jiang et al. 2015). Recently it has been shown that RP2 and ARL3 can 
interact with KIF17 and that knockdown of RP2 or ARL3 disrupted KIF17 localisation 
in cells (Schwarz et al. 2017) suggesting RP2 and ARL3 could mediate cone opsin 
trafficking through interaction with KIF17 in cells. Although KIF17 is not thought to be 
required for the trafficking of M/L opsin in mice (Jiang et al. 2015), the localisation of 
KIF17 could be tested in Rp2h DEL26/Y and Rp2h E135G/Y retina sections to 
determine whether KIF17 is mislocalised and whether this may explain why M/L opsin 
is mislocalised. 
In Rp2h DEL26/Y and Rp2h E135G/Y mutants rhodopsin was mislocalised 
throughout the IS, ONL and synaptic layer demonstrating loss of OS targeting as a 
consequence of RP2 dysfunction. At some stages the levels of rhodopsin appeared 
reduced in mutant compared to WT however the protein levels of rhodopsin were not 
examined. The other major gene which causes X-linked Retinitis Pigmentosa (XLRP) 
is Retinitis Pigmentosa GTPase Regulator (RPGR) and the Rpgr knockout mouse 
demonstrated mislocalisation of cone opsin and reduced rhodopsin expression 
suggesting that the trafficking of M/L opsin and rhodopsin may be key pathways 
affected in XLRP (Hong et al. 2000). 
Mislocalisation of rhodopsin was not described in either previously published Rp2h 
knockout mouse (Li et al. 2013; Zhang et al. 2015) but mutations in the C-tail of 
rhodopsin, which control its localisation cause autosomal dominant Retinitis 
Pigmentosa (ADRP) in humans (Berson et al. 2002). Rhodopsin is trafficked from the 
Golgi in rhodopsin laden vesicles to the IS (Papermaster et al. 1986). The sorting of 
rhodopsin into these vesicles has been shown to require the small GTPase ARF4 
which interacts specifically with the C-terminal tail of rhodopsin (Deretic et al. 2005). 
The docking of these vesicles has been shown to involve another small GTPase rab8, 
demonstrating small GTPases may play an essential role in rhodopsin trafficking 
(Moritz et al. 2001) however knockout of both Arf4 and Rab8 in mice had no effect on 
rhodopsin localisation (Sato et al. 2014; Pearring et al. 2017) demonstrating the exact 
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mechanisms which regulate rhodopsin trafficking to the OS in vivo are not well 
understood. After docking at the IS rhodopsin was shown to be trafficked to the OS 
by IFT, involving the subunit of kinesin 2, KIF3a and intraflagellar transport protein 88 
(IFT88), as knockouts of these genes in mice caused mislocalisation of rhodopsin 
(Jimeno et al. 2006; Pazour et al. 2002). Although no direct interaction between RP2 
and IFT88 has been detected it is possible that RP2 could still function in this pathway 
as it has been reported that a retinal specific knockout of Arl3 has a similar phenotype 
to Kif3a and Ift88 knockout mice (Hanke-Gogokhia et al. 2016; Jimeno et al. 2006; 
Pazour et al. 2002). 
3.7.3 Mislocalisation of GRK1 in Rp2h DEL26/Y and Rp2h E135G/Y Retinas 
 
Mislocalisation of GRK1 was detected in the Rp2h -/-  mouse however in this mouse 
mislocalisation of cone GRK1 was observed from one month of age but in Rp2h 
DEL26/Y and Rp2h E135G/Y mice changes in GRK1 localisation was not observed 
until 3 months of age (Zhang et al. 2015). This difference likely reflects differences in 
the progression of retinal degeneration as in the Rp2h -/- mouse differences in ERG 
response were detected from 1 month of age however differences in ERG response 
in Rp2h DEL26/Y and Rp2h E135G/Y mice were only detected in older animals 
(Houbin Zhang et al. 2015). GRK1 is thought to be trafficked to the photoreceptor OS 
by the photoreceptor chaperone PDE6δ, RP2 and ARL3 (Zhang et al. 2007; Zhang et 
al. 2015; F. Liu et al. 2015). Therefore, mislocalisation of GRK1 in Rp2h DEL26/Y and 
Rp2h E135G/Y mice suggests that disruption of RP2 function causes an increase in 
ARL3-GTP levels and aberrant regulation of PDE6δ. In order to confirm that knockout 
or mutation of RP2 causes mislocalisation of other lipid modified proteins by affecting 
the function of PDE6δ, through increased levels of ARL3-GTP, the localisation of 
PDE6 could be examined as it has also been shown to be trafficked to the OS by 
PDE6δ (Zhang et al. 2007). RP2 and ARL3 have also been shown to interact with the 
other identified photoreceptor chaperone Uncoordinated 119 (UNC119) which 
controls the localisation of transducin α and nephrocystin 3 (NPHP3) (Veltel, 
Kravchenko, et al. 2008; Zhang et al. 2011). Mislocalisation of transducin α or NPHP3 
was not detected in either previously published Rp2h knockout mouse suggesting 
compensatory mechanisms may exist to regulate the trafficking of proteins in the 
absence of RP2 (Li et al. 2013; Zhang et al. 2015). It was suggested that transducin 
α may still traffic to the OS in the absence of RP2 through rhodopsin transport vesicles 
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(Zhang et al. 2015), therefore as rhodopsin is mislocalised in Rp2h DEL26/Y and 
Rp2h E135G/Y mice it is possible localisation of transducin α is also affected. RP2 
and ARL3 have also been shown to regulate the trafficking of the beta subunit of 
transducin (Gβ1) by controlling loading of Gβ1 to Rab11 vesicles suggesting RP2 and 
ARL3 may regulate trafficking to the OS through vesicular transport as well as through 
PDE6δ and UNC119 (Schwarz et al. 2012). If localisation of lipid modified proteins to 
the OS is exclusively controlled by RP2 and levels of ARL3-GTP then Rp2h E135G/Y 
mice should phenocopy Rp2h knockout, however in Rp2h E135G/Y retinas GRK1 
localisation was affected at a later stage than in the Rp2h DEL26/Y suggesting other 
functions of RP2 independent of ARL3 are also important for proper localisation of 
GRK1 and potentially other lipid modified proteins or that RP2 E135G may have 
partial GAP activity for ARL3,  and that this may facilitate localisation of  GRK1 at the 
OS temporarily despite the assumed increase in levels of ARL3-GTP.  
3.7.4 Effects Independent of ARL3 
 
The RP2 E135G mutation is predicted to reduce RP2’s affinity for ARL3 150 fold 
compared to WT however, another patient pathogenic mutation, R118H, reduces 
RP2’s affinity for ARL3 300 fold (Kühnel et al. 2006). As these predictions have been 
carried out in vitro it is possible that in vivo additional mechanisms exist and RP2 
E135G could still have partial GAP activity meaning that the E135G mutation is 
hypomorphic which may explain why Rp2h E135G/Y do not have a severe phenotype. 
Previous studies have demonstrated that RP2 can interact with NSF however RP2 
E135G does not interact with NSF (Holopainen et al. 2010). This suggests that the 
effects observed in my study may not be solely attributed to loss of ARL3-GAP activity 
and may also be attributed to loss of interaction with NSF. Arrestin-1 has been shown 
to interact with NSF in the photoreceptor synapse where NSF and the SNARE 
complex regulate synaptic transmissions (S.P. Huang, Brown, and Craft 2010).  
Arrestin-1 was shown to increase SNARE complex disassembly by increasing the 
GTPase activity of NSF, demonstrating NSF plays a functional role in the 
photoreceptor. Although mutations in Arr1 have been shown to be causative of a rare 
form of CSNB (Congenital Stationary Night Blindness), Oguchi disease, and RP 
(Fuchs et al. 1995; Nakawaza et al. 1997) no direct link between NSF and retinal 
degeneration has been established.  
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ARL2 also interacts with PDE6δ and UNC119 and can stimulate cargo release from 
these proteins however it has been shown that ARL2 can stimulate release of cargo 
bound with low affinity however only ARL3 can release cargo bound with high affinity 
(Ismail et al. 2011). Recently a transgenic model was generated which expressed 
ARL2-Q70L under the rhodopsin promoter, RodARL2Q70L ,  this mouse displayed 
progressive rod degeneration and interestingly unlike the RodARL3-Q71L transgenic 
model this mouse displayed normal localisation of prenylated OS proteins but had 
mislocalised rhodopsin (Wright et.al 2018) suggesting ARL2 plays a role in rhodopsin 
trafficking. The shared phenotype of rhodopsin mistrafficking between RodARL2Q70L 
mice and Rp2h DEL26/Y and Rp2h E135G/Y mice may suggest RP2 mutation may 
cause dysregulation of ARL2 leading to rhodopsin mislocalisation, however RP2 has 
been only been identified as a GAP for ARL3 not ARL2 therefore the potential link 
RP2 and ARL2 requires further investigation. If mutation of RP2 also disrupted the 
function of ARL2 causing rhodopsin mistrafficking then mice carrying Arl3 Q71L would 
not be expected to display this phenotype however as discussed in chapter 4 Arl3 
Q71L mice do display rhodopsin trafficking defects (see figure 4.9) suggesting 
mutation of Rp2h may cause rhodopsin mistrafficking through increased levels of 
ARL3-GTP or other mechanisms but this effect is not specific to ARL2. 
3.7.5 Discrepancies Between Previously Published RP2 Knockout Animal 
Models 
 
The two previously generated Rp2h knockout mice have differential phenotypes and 
suggest different mechanisms that cause retinal degeneration when RP2 is mutated. 
The first RP2 knockout mouse was generated by the cre-lox system and displayed 
early M/L opsin mislocalisation and reduced photopic ERG responses from 1 month 
of age and reduced scotopic ERG responses at 4 months of age. When analysing 
which proteins were  mislocalised in the Rp2null mice the authors examined localisation 
of M/L opsin, rhodopsin, transducin subunits and arrestin alongside the localisation of 
NPHP3 and ARL3 (Li et al. 2013). No mislocalisation of transducin subunits, arrestin 
or rhodopsin was reported (Li et al. 2013). NPHP3 is reportedly trafficked by RP2, 
ARL3 and UNC119 however no defect in trafficking NPHP3 was observed suggesting 
that mislocalisation of M/L opsin was the defect which was causative of retinal 
degeneration (Li et al. 2013). In this model the localisation of GRK1 and PDE6 which 
are trafficked by PDE6δ was not investigated therefore these mice could display 
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mislocalisation of these OS proteins which may also contribute to retinal 
degeneration. The second Rp2h knockout mouse, Rp2h -/-, was generated via a gene 
trap cassette and displayed normal localisation of M/L opsin with mislocalisation of 
GRK1 and PDE6 (Zhang et al. 2015) a phenotype which was also observed in the rp2 
knockout zebrafish (Liu et al. 2015). As discussed, this suggests a mechanism of 
retinal degeneration by which increased levels of ARL3-GTP stimulates release of 
cargo from PDE6 in regions outside the OS. Both models used C57BL6/J as the 
background strain so the differences are not due to genetic background but they may 
be due to how the mice were generated. The Rp2h -/- mouse was generated by 
targeting the first intron of the Rp2h gene (Zhang et al. 2015) however the Rp2null 
mouse was generated by targeting exon 2 of the Rp2h (Li et al. 2013) gene it is 
possible in this case a small truncated protein may remain which is not detected by 
the RP2 antibody and this therefore may explain the differences between the 
previously published models. Rp2h DEL26/Y mice were generated using CRIPSR 
cas9 and gRNA injection into an embryo at the single cell stage therefore in theory 
every cell in the mouse produced from this procedure should carry the Rp2h DEL26 
mutation. These mice were also generated on a C57BL6/J background so 
background strain does not explain the differences in phenotype observed between 
Rp2h DEL26/Y and other published Rp2h knockout mice. Mice were outbred for 
multiple generations and only mice from at least the F2 generation were used as 
experimental animals to decrease the chance that any phenotypes were attributed to 
off-target effects and not Rp2h deletion. Interestingly Rp2h DEL26/Y mice displayed 
features associated with both the previously generated Rp2h knockout mouse models 
with mislocalisation of GRK1 and M/L opsin suggesting each of these phenotypes 
does occur as a result of Rp2h knockout, therefore differences observed between 
models may be the result of different techniques used to generate each model.  
3.8 Conclusions 
 
In this chapter, I demonstrated that CRISPR genome editing successfully generated 
a Rp2h knockout mouse and a mouse carrying the Rp2h E135G/Y mutation. These 
mice had a late onset progressive retinal degeneration with the Rp2h DEL26/Y mouse 
more severely affected than the Rp2h E135G/Y mouse as shown by the increased 
rate of ONL thinning and reduction of both rod and cone photoreceptor ERG 
responses. Rp2h DEL26/Y mice had mislocalisation of rhodopsin and loss of GRK1 
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OS localisation aged three months prior to major loss of photoreceptors suggesting 
both these mechanisms may be driving retinal degeneration in these mice. Rp2h 
E135G/Y mice had mislocalisation of GRK1 at age 3 months and mislocalisation of 
rhodopsin did not occur until 6 months of age suggesting that in these mice 
mislocalisation of lipid-modified proteins may be the driver mechanism. Both Rp2h 
DEL26/Y and Rp2h E135G/Y mice had mislocalisation of M/L opsin as retinal 
degeneration progressed suggesting a role for RP2 and ARL3 in the trafficking of M/L 
opsins. Overall Rp2h E135G/Y mice had less severe retinal degeneration and later 
mislocalisation of OS proteins than Rp2h DEL26/Y mice demonstrating that loss of 
ARL3 GAP activity is not equivalent to loss of RP2 expression suggesting RP2 may 
have other roles independent of ARL3 which are important for trafficking OS proteins 

















 Phenotype Analysis of Arl3 









Arf-like 3 (ARL3) is a small GTPase that is regulated by its GTPase Activating Protein 
(GAP) RP2 and its guanine nucleotide exchange factor (GEF) ARL13B. ARL3 is 
enriched in primary cilia in cell culture systems and is expressed at the connecting 
cilia (CC) in the human retina (Enjalbert et al. 2006; Avidor-Reiss et al. 2004; Grayson 
et al. 2002). An Arl3 -/- mouse was generated and displayed a severe ciliopathy like 
phenotype further supporting a role for ARL3 in cilia function (Schrick et al. 2006). A 
role for ARL3 in the trafficking of cilia proteins was elucidating by studying the 
mechanism by which chaperone proteins phosphodiesterase 6δ (PDE6δ) and 
uncoordinated 119 (UNC119) traffic proteins from the cytoplasm to the cilia. It was 
demonstrated that ARL3-GTP localised within the cilia facilitated cargo release from 
these chaperones. The Rp2h -/- mouse displayed mislocalisation of G- coupled 
receptor kinase 1 (GRK1) and phosphodiesterase 6 (PDE6) and as these proteins are 
thought to be trafficked to the OS by PDE6δ it was hypothesised that increased levels 
of ARL3-GTP were present as Rp2h was knocked out and therefore this was able to 
stimulate release of cargo from PDE6δ and UNC119 outside the CC and outer 
segment (OS) leading to mistrafficking of OS proteins and ultimately cell death. As 
this is thought to model the disease mechanism which occurs in human X-linked 
Retinitis Pigmentosa (XLRP) patients with RP2 mutations an understanding of the 
consequences of increased levels of ARL3-GTP in the retina is essential for 
understanding disease pathogenesis in patients. 
In order to access the effect of increased levels of ARL3-GTP in photoreceptors a 
mouse expressing constitutively active ARL3, ARL3 Q71L, under the rhodopsin 
promoter was generated (Z. C. Wright et al. 2016). ARL3 Q71L was FLAG and  HA 
tagged at it’s C-terminus and was overexpressed  compared to the WT locus (Z. C. 
Wright et al. 2016).  RodARL3Q71L retinas developed normally however subtle defects in 
the OS were detected at PN20 with severely reduced ERG responses and 
photoreceptor death evident from PN70. GRK1 was lost from the rod OS, fully 
assembled PDE6 (PDE6αβγ) and transducin γ accumulated in endosomal structures 
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within the IS. Retinal lysates from these mice were used to show that ARL3Q71L is able 
to sequester PDE6δ in vivo demonstrating that proteins are likely mislocalised in these 
mice due to ARL3-GTP locking PDE6δ in the closed conformation (Z. C. Wright et al. 
2016). This phenomenon is thought to be identical to that that which occurs in mice 
where Rp2h expression is knocked out, however RodARL3Q71L mice do not phenocopy 
previously described Rp2h knockout mice. Rp2h -/- mice generated by a gene trap 
cassette showed progressive rod/cone dystrophy with little difference in ONL 
thickness even at 2 years of age (Houbin Zhang et al. 2015). However, similar to 
RodARL3Q71L mice, mislocalisation of GRK1 and PDE6 was detected (Houbin Zhang et 
al. 2015). The protein levels of GRK1 were not reduced in Rp2h -/- mice however a 
reduction of GRK1 protein levels was reported in RodARL3Q71L mice (Zhang et al. 2015; 
Wright et al. 2016). A second Rp2h knockout mouse, Rp2null, generated using the 
Cre/lox system also did not phenocopy the RodARL3Q71L mouse. The Rp2null mouse had 
thinning of the ONL present from 5 months of age and had early mislocalisation of 
M/L opsin. No mislocalisation of the lipid modified proteins investigated was reported, 
suggesting that mislocalisation of lipid modified proteins due to increased levels of 
ARL3-GTP may not be the only mechanism which drives retinal degeneration in mice 
deficient of RP2 ( Li et al. 2013).  
These studies provide evidence for the role of ARL3-GTP in the trafficking of 
specifically GRK1 and PDE6 to the outer segments of photoreceptors. The 
differences observed between the Rp2h-/- mice and the RodARL3Q71L mice may be 
attributed to the fact that ARL3 Q71L was expressed from the rhodopsin promoter 
and therefore only expressed in rods and at a level much  higher than the endogenous 
locus (Wright et al. 2016).  The expression of ARL3 Q71L appeared 2.5x higher than 
the endogenous locus by western blot but as the rhodopsin promoter is a very strong 
promoter it is possible that ARL3 Q71L is expressed much higher and then degraded. 
Interestingly it appears that RP2 may have specific functions in cones demonstrated 
by mislocalisation of cone opsins in Rp2null mice (Li et al. 2013). Therefore, to address 
this discrepancy in the field and to establish the effects of ARL3 Q71L in the retina, 
CRISPR genome editing was used to generate an endogenous knock in of the Q71L 
gain-of-function mutation into the endogenous Arl3 gene. This approach was 
designed to overcome issues associated with overexpression and to provide a more 
accurate model to compare to RP2 knockout mice in order to establish if increased 
levels of ARL3-GTP may be the major defect driving retinal degeneration.  
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4.2 Arl3 Q71L/+ and Arl3 Q71L/Q71L mice have Progressive Retinal 
Degeneration 
 
4.2.1 ARL3 Q71L is Stable and Leads to Increased ARL3-GTP Levels in Tissues 
 
In order to generate mice carrying the Arl3 Q71L mutation a single guide RNA, 
conventional cas9 mRNA and a repair template designed to introduce the Q71L 
mutation were injected by cytosolic injection into C57BL6/J single cell embryos (see 
2.1.2 for detailed methods and sequences of guide RNAs and the repair template). 
F0 founder animals were outbred with C57BL6/J animals to generate F1 Q71L/+ mice 
which were used to establish the line. The line was maintained by crossing Arl3 
Q71L/+ mice to C57BL6/J control animals. F2 Q71L/+ mice were mated together to 
generate Q71L/Q71L mice. Q71L/+ x Q71L/+ mating’s only involved mice derived 
from different parents to avoid inbreeding of the colony. In order to ensure any 
phenotypes detected were attributed to the Arl3 Q71L mutation and not off target 
effects from the CRISPR cas9 process only mice derived from at least the F2 
generation were used in experiments. Only male Arl3 Q71L+ and Arl3 Q71L/Q71L 
mice were used as experimental animals to enable the most accurate comparison to 
Rp2h DEL26/Y and Rp2h E135G/Y mice. The distribution of male and female WT, 
Arl3 Q71L/+ and Arl3 Q71L/Q71L mice that survived to genotyping is shown in Table 
4.1. Chi squared analysis demonstrated genotypes were detected at a Mendelian 
1:2:1 ratio with no difference in the number of mice born to each genotype in males 
and females (Table 4.1).  
To confirm that the Arl3 Q71L mutation introduced by CRISPR genome editing (Figure 
4.1 A) did not affect ARL3 protein expression, a western blot for ARL3 was performed. 
ARL3 expression was confirmed in WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L kidney 
lysates. Levels of ARL3 expression were comparable in WT, Arl3 Q71L/+ and Arl3 
Q71L/Q71L samples demonstrating that ARL3 Q71L was does not affect ARL3 
expression (Figure 4.1 B). ARL3 expression was then analysed in whole eye lysates 
from WT, Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L mice. 
ARL3 expression was detected in all lysates at levels comparable to WT confirming 
that the Q71L mutation does not affect stability of the protein. ARL3 was expressed 
at low levels in the eye and was only detectable using Femto ECL (Figure 4.1 C).  
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After establishing, that ARL3 Q71L was expressed and tolerated in tissues an assay 
was designed to determine whether expression of ARL3 Q71L increased the levels of 
ARL3-GTP in vivo. RP2 only interacts with ARL3 when it is in the GTP bound state, 
therefore GST-tagged RP2 recombinant protein and glutathione beads were used to 
isolate ARL3-GTP. Firstly, this assay was performed on kidney lysates as a large 
quantity of protein can be extracted from kidneys. As expected ARL3-GTP was not 
detected in WT lysates as at any one time, only a very small percentage of ARL3 in 
cells is likely in the active GTP-bound state. Arl3 Q71L/+ and Arl3 Q71L/Q17L lysates 
displayed an enrichment of ARL3-GTP in the RP2-GST lanes (+) and not in the lanes 
where no RP2-GST was added (-) demonstrating increased levels of ARL3-GTP were 
present in these lysates and that ARL3-GTP specifically interacted with RP2 and not 
glutathione beads (Figure 4.2 A). After demonstrating that this assay was able to 
isolate ARL3-GTP, the levels of ARL3-GTP in whole eye lysates from WT, Rp2h 
DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L mice were analysed. In 
WT lysates, no enrichment of ARL3-GTP was detectable reflecting the low level of 
ARL3-GTP that exists at any one time in the eye. Arl3 Q71L/+ and Arl3 Q71L/Q71L 
lysates again displayed enrichment of ARL3-GTP in the RP2- GST (+) lanes and not 
the lanes where no RP2-GST was added (-). Arl3 Q71L/+ lysates had roughly half the 
levels of ARL3-GTP than the Arl3 Q71L/Q71L lysates demonstrating each allele 
contributed to levels of ARL3-GTP. Interestingly, Rp2h DEL26/Y and Rp2h E135G/Y 
did not have any detectable increase in levels of ARL3-GTP compared to WT 
demonstrating that expression of ARL3 Q71L increases levels of ARL3-GTP 
substantially more than loss of GAP activity due to knockout or mutation of RP2 












(A) Schematic of ARL3 Q71L mutation introduced by CRISPR genome editing.  
(B) Western blot analysis of ARL3 expression in WT, Arl3 Q71L/+ and Arl3 
Q71L/Q71L kidney lysates. ARL3 expression was detected in WT, Arl3 
Q71L/+ and Arl3 Q71L/Q71L lysates. Actin blot used as a loading control.  
(C) Western blot analysis of ARL3 expression in WT, Rp2h DEL26/Y, Rp2h 
E135G/Y, Arl3 Q71L/+, Arl3 Q71L/Q71L whole eye lysates. ARL3 
expression was detected in all lysates. Expression of ARL3 was only 
detectable using ECL Femto. Actin used as loading control. 



















 Table 4.  1 Distribution of Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L Mice 
Sex WT Q71L/+ Q71L/Q71L 
Male 32 48 27 
Female 25 47 16 
Male ratio 1.19 1.79 1.01 
Female ratio 1.14 2.13 0.73 
T.Test Males v 
Females 
0.15 0.46 0.07 
Arl3 line sex and allele ratios. χ2 values: males = 1.59 Females = 2.26 (2 degrees 
of freedom critical value for significance <0.05 = 5.59 so distribution fits Mendelian 
1:2:1 ratio for males and females). No significant difference in the number of male 
vs female WT, Q71L/+ or Q71L/Q71L animals were born, statistics calculated by 
students T.Test.  
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(A) RP2-GST was used to pulldown ARL3-GTP from kidney lysates. ARL3 was 
detected in only the Arl3 Q71L/+ and Arl3 Q71L/Q71L RP2-GST (+) lanes and 
not the no RP2-GST (-) lanes demonstrating ARL3-GTP specifically interacts 
with RP2 recombinant protein and not the glutathione beads. No ARL3-GTP 
was detectable in WT lysates. ARL3 was detected in input samples. Actin used 
as loading control.  
(B) RP2-GST pulldown in WT, Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+, Arl3 
Q71L/Q71L whole eye lysates. ARL3-GTP was detected in Arl3 Q71L/+ and 
Arl3 Q71L/Q71L RP2-GST (+) lanes and not in no RP2-GST (-) lanes. No 
ARL3-GTP was detected in WT, Rp2h DEL26/Y and RP2h E135G/Y RP2-GST 
lanes. ARL3 was detected in input samples. Actin used as loading control.   
A 
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4.2.2 Histological Analysis of Arl3 Q71L/+ and Arl3 Q71L/Q71L Retinas 
 
In order to establish whether Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas exhibit retinal 
degeneration paraffin sections were stained with haematoxylin and eosin and the 
histology analysed. Retinas were prepared in an identical fashion to Rp2h retinas (as 
described (3.2.2), see 2.1.4 for detailed methods). Retina sections were analysed 
from mice aged 1 month, 3 months, 6 months, 9 months and 12 months as described 
in 3.2.2. At 1 month and 3 months of age Arl3 Q71L/+ retinas were comparable to WT 
retinas and no significant difference in ONL thickness was detected (Figure 4.3 A, B, 
Figure 4.4 A (i), (ii)). At 6 months of age Arl3 Q71L/+ had thinning of the ONL in central 
regions (Figure 4.3 C, Figure 4.4 A (iii)). At 9 months of age Arl3 Q71L/+ retinas were 
thinner than WT, and significant thinning of the ONL was measured across the retina 
(Figure 4.3 D, Figure 4.4 A (iv)). By 12 months of age Arl3 Q71L/+ retinas were thinner 
than WT retinas and significant thinning of the ONL was observed in inner, central 
and peripheral regions (Figure 4.3 E, Figure 4.4. A (v)) demonstrating expression of 
Arl3 Q71L acts as dominant allele causing retinal degeneration. 
Arl3 Q71L/Q71L retinas were  comparable to WT retinas at age 1 month and 3 months 
however significant thinning of the ONL was detected in peripheral regions (Figure 
4.3 A, B Figure 4.4 A (i), (ii)). At 6 months of age Arl3 Q71L/Q71L retinas did appear 
thinner than WT and thinning of the ONL was evident in inner, central and peripheral 
regions (Figure 4.3 C, Figure 4.4 A (iii)). By 9 months and 12 months of age Arl3 
Q71L/Q71L retinas appeared significantly thinner than WT and thinning of the ONL 
was detected across the retina (Figure 4.3 D, E, Figure 4.4 A (iv), (v)). Arl3 Q71L/Q71L 
retinas were thinner than Arl3 Q71L/+ retinas at age 9 months and 12 months and 
increased thinning of the ONL was observed (Figure 4.3 D, E, Figure 4.4 A (iv), (v)). 
The ONL thickness was reduced in some regions at 1 month of age in Arl3 
Q71L/Q71L retinas and was thinner than Arl3 Q71L/+ retinas at every age examined 
demonstrating that Arl3 Q71L/Q71L retinas exhibit more severe degeneration than 
Arl3 Q71L/+ retinas, likely due to increased levels of ARL3-GTP (Figure 4.3, Figure 
4.4 A). Progressive thinning of the INL was not detected in Arl3 Q71L/+ or Arl3 
Q71L/Q71L retinas demonstrating retinal degeneration was specific to the 
photoreceptor layer (Figure 4.4 B (i-v)). However, the INL was found to be thinner in 
some regions in older Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas (Figure 4.4 B (iv), (v)). 
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This may represent sectioning artefacts or thinning of the entire retina as retinal 

















































































































H&E staining of paraffin sections of Rp2h WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L 
retinas. Aged 1 month (A), 3 months (B), 6 months (C), 9 months (D) and 12 months 
(E). Thinning of the retina was apparent from 3 month of age in Arl3 Q71L/Q71L 




(A) ONL thickness measurements at specific distances from ON in WT, Arl3 Q71L/+ 
and Arl3 Q71L/Q71L retinas aged 1 month (i), 3 months (ii), 6 months (iii), 9 months 
(iv) and 12 months (v). Significant reductions in ONL thickness was present in Arl3 
Q71L/+ retinas from 6- 12 months. Significant reduction in ONL thickness was 
present in Arl3 Q71L/Q71L retinas at 1 month in peripheral regions and 3 -12 
months across the retina.  
(B) INL thickness measurements at specific distances from the ON in WT, Arl3 Q71L/+ 
and Arl3 Q71L/Q71L retinas ages 1 month (i), 3  months (ii), 6 months (iii), 9 months 
(iv) and 12 months (v). INL thickness is not significantly different from WT in Arl3 
Q71L/+ and Arl3 Q71L/Q71L. At 9 months of age some significant differences were 
observed however these may reflect sectioning artefacts. 










































4.2.3 ERG Analysis of Arl3 Q71L/+ and Arl3 Q71L/Q71L Mice 
 
To examine the function of rod and cone photoreceptors in Arl3 Q71L/+ and Arl3 
Q71L/Q71L mice electroretinography (ERG) recordings from a dark-adapted 3cd 
flash and light adapted 10cd flash ERG were performed and analysed as described 
in 3.2.3. Arl3 Q71L/+ had no significant reduction in A-wave amplitude compared to 
WT at 3 months and 6 months of age however the A-wave amplitude that was 
recorded appeared reduced but did not reach statistical significance (Figure 4.5 A (i), 
(ii), B). At 9 months and 12 months of age, a reduction in A-wave amplitude was 
recorded demonstrating significantly reduced photoreceptor responses (Figure 4.5 A 
(iii), (v), B). The 10cd flash test which analyses function of cone photoreceptors 
revealed Arl3 Q71L/+ mice had a reduction in A-wave amplitude at 3 months of age 
which was maintained until 12 months of age (Figure 4.6 A, B). This demonstrates 
that Arl3 Q71L/+ mice had reduced cone function from 3 months of age and that this 
occurred prior to defects in rod function. This suggests that these mice suffer from a 
cone-rod dystrophy and implies that increases in ARL3-GTP levels are more 
deleterious to cones than rod photoreceptors. 
Dark adapted 3cd flash ERG responses from Arl3 Q71L/Q71L mice revealed these 
mice had a reduced A-wave amplitude from 3 months to 12 months of age 
demonstrating reduced photoreceptor responses from age 3 months (Figure 4.5 A (i-
v), B). The 10cd light adapted ERG also showed that Arl3 Q71L/Q71L mice had a 
reduction in A-wave amplitude from 3 to 12 months of age demonstrating reduced 
cone photoreceptor responses (Figure 4.6 A (i-v), B). These results reveal that 
exceptionally high levels of ARL3-GTP is damaging to both rod and cone 
photoreceptors. In Arl3 Q71L/+ mice a significant reduction in 3cd A-wave amplitude 
was not detected until 9 months of age demonstrating that prior to 9 months, despite 
having increased levels of ARL3-GTP rods are able to survive and function. However, 
in Arl3 Q71L/Q71L mice, which have further elevated levels of ARL3-GTP, rod 
function is reduced from 3 months of age, suggesting that increased levels of ARL3-
GTP may be compatible with normal function until a certain level of ARL3-GTP is 
reached. The 10cd flash ERG revealed that in both Arl3 Q71L/+ and Arl3 Q71L/Q71L 
mice, cone function was significantly reduced from 3 to 12 months of age. The 
reduction in cone responses from age 3 months in both Arl3 Q71L/+ and Arl3 
Q71L/Q71L mice demonstrates that cones may be more sensitive to increases in 
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ARL3-GTP levels than rods, as rod function is maintained until 9 months of age in 
Arl3 Q71L/+ mice. As a progressive reduction of cone function was not recorded it 
suggests that progressive cone cell death may not occur making it possible that less 
functional cones are able to survive until 12 months of age or before 3 months of age 
some cone cell death occurred and surviving cones were present until 12 months of 
age. This suggests the levels of ARL3-GTP may be more tightly regulated in cones 
compared to rods and differential mechanisms may exist in each cell type to regulate 




Figure 4.  5 ERG Analysis of Arl3 Q71L/+ and Arl3 Q71L/Q71L Mice 3cd Flash 
Test 






















(A) Representative traces from 3cd flash dark adapted ERGs for Arl3 Q71L/+ 
compared to WT and Arl3 Q71L/Q71L compared to WT aged 3 months 
(i), 6 months (ii), 9 months (iii) and 12 months (iv). 
(B) Quantification of average A-wave amplitude in Arl3 Q71L/+ and WT aged 
3, 6, 9 and 12 months. Significant reduction in A-wave amplitude in Arl3 
Q71L/+ mice detected from age 9 months.  
(C) Quantification of average A-wave amplitude in Arl3 Q71L/Q71L and WT 
mice aged 3,6,9 and 12 months. Significant reduction in A-wave 
amplitude was detected from 3 months of age.  
N=5 for each genotype at each age, statistics calculated by students 
















(A) Representative traces from light adapted 10cd Test ERGs for Arl3 Q71L/+ 
compared to WT and Arl3 Q71L/Q71L compared to WT aged 3 months (i), 
6 months (ii), 9 months (iii) and 12 months (iv). 
(B) Quantification of average A-wave amplitude in Arl3 Q71L/+ and WT aged 
3, 6, 9 and 12 months. Significant reduction in A-wave amplitude in Arl3 
Q71L/+ mice detected from age 3 months.  
(C) Quantification of average A-wave amplitude in Arl3 Q71L/Q71L and WT 
mice aged 3,6,9 and 12 months. Significant reduction in A-wave amplitude 
detected at 3 months.  
N=5 for each genotype at each age, statistics calculated by students 
T.Test. Arl3 Q71L/+ and Arl3 Q71L/Q71L mice compared to WT CTRL 




4.3 Arl3 Q71L/+ and Arl3 Q71L/Q71L Retinas Show Retinal Stress at Age 1 
month 
As the retinas of Arl3 Q71L/+ and Arl3 Q71L/Q71L mice aged one month did not 
exhibit signs of retinal degeneration and given that Rp2h DEL26/Y and Rp2h E135G/Y 
retinas showed signs of retinal stress at one month of age (see Figures 3.3, 3.4) I 
analysed the localisation of glial fibrillary acidic protein (GFAP) in Arl3 Q71L retinas. 
As described in 3.5 GFAP expression is present in the ganglion cell layer (GCL) under 
normal conditions however upon stress GFAP positive retinal stress fibres extend 
throughout the upper layers of the retina. In central regions WT and Arl3 Q71L/+ 
retinas had GFAP staining detected in the GCL however in Arl3 Q71L/Q71L retinas, 
reactive gliosis was observed throughout the inner plexiform layer (IPL), inner nuclear 
layer (INL), outer plexiform layer (OPL) and outer nuclear layer (ONL) demonstrating 
retinal stress (Figure 4.7 A-C). At peripheral regions in WT retinas GFAP staining was 
confined to the GCL (Figure 4.7 D). In Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas GFAP 
staining was detected throughout the IPL, INL, OPL and ONL indicative of retinal 
stress. Arl3 Q71L/Q71L retinas appeared to have increased gliosis in peripheral 
regions compared to Arl3 Q71L/+ retinas, however GFAP intensity levels were not 
quantified. These results demonstrate that Arl3 Q71L/Q71L mice had increased 
retinal stress compared to Arl3 Q71L/+ mice, establishing very high levels of ARL3-





(A) GFAP expression in WT central retina was exclusive to the GCL.  
(B) GFAP expression in Arl3 Q71L/+ central retina. GFAP expression was 
confined to the GCL.  
(C) GFAP expression in Arl3 Q71L/Q71L central retina. GFAP expression was 
observed throughout the ONL, OPL, INL, IPL and GCL.  
(D) GFAP expression in WT peripheral retina. GFAP expression was detected 
in the GCL only.  
(E) GFAP expression in Arl3 Q71L/+ peripheral region. GFAP expression was 
detected throughout the ONL, OPL, INL, IPL and GCL indicating retinal 
stress.  
(F) GFAP expression in Arl3 Q71L/Q71L peripheral retina. GFAP expression 
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Figure 4.  7 GFAP Expression in Arl3 Q71L/+ and Arl3 Q71L/Q71L Retinas 
Aged 1 Month 
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4.4 M/L Opsin is Mislocalised in Arl3 Q71L/+ and Arl3 Q71L/Q71L Retinas After 
onset of Retinal Degeneration 
 
The role of ARL3 in cones was not addressed in RodArl3Q71L mice as ARL3 Q71L 
expression was driven by the rhodopsin promoter and therefore only expressed in 
rods. A retina specific knockout of Arl3, retArl3-/-, revealed that ARL3 may have a role 
in  the development of the cone OS as these mice developed cones lacking OS’s, 
however in peripheral regions some cones developed OS’s and had normal M/L opsin 
localisation (Hanke-Gogokhia et al. 2016). As discussed in chapter 3, Rp2h DEL26/Y 
and Rp2h E135G/Y mice displayed M/L opsin mislocalisation at later stages of retinal 
degeneration (see 3.4), therefore given this result I analysed the localisation of M/L 
opsin in Arl3 Q71L mice. Arl3 Q71L/+ mice displayed normal M/L opsin localisation, 
with M/L opsin localised to the OS of cone photoreceptors, at 1 to 6 months of age 
(Figure 4.8 A-C). At 3 months of age the OS of cones appeared longer than WT, 
however the length of cone OS was not measured (Figure 4.8 B). At 9 months of age 
M/L opsin mislocalisation was observed as staining was detected in the OS, IS, Cell 
body and OPL of cone photoreceptors (Figure 4.8 D). At 12 months of age M/L opsin 
staining was detected in the IS and cell body of cone photoreceptors however the 
staining intensity appeared reduced compared to WT retinas (Figure 4.8 E), 
suggesting loss of cone photoreceptors as retinal degeneration progressed. Thinning 
of the ONL was first detected in Arl3 Q71L/+ retinas aged 6 months (Figure 4.3 C, 
Figure 4.4 A (iii)), as was mislocalised M/L opsin, however cone ERG response was 
reduced from 3 months of age (Figure 4.6 A,B). This indicates that there may be 
another mechanism which is contributing to reduced cone function at 3 months of age 
and suggests that in Arl3 Q71L/+ mice mislocalisation of M/L opsin is not a 
mechanism driving cone degeneration.  
Arl3 Q71L/Q71L retinas had M/L opsin localised to the OS of cone photoreceptors, 
similar to WT retinas, at 1 month and 3 months of age (Figure 4.8 A, B). At 3 months 
of age OS appeared longer than WT however, this was not quantified (Figure 4.8 B). 
At 6 months of age M/L opsin was not localised to the OS but M/L opsin staining was 
detected in the cell body and OPL of cone photoreceptors (Figure 4.8 C). At 9 months 
of age M/L opsin staining was detected in the cell body and OPL of cone 
photoreceptors however the staining intensity appeared reduced compared to WT 
(Figure 4.8 D). At age 12 months, M/L opsin staining appeared reduced compared to 
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WT suggesting loss of cone photoreceptors. Some residual staining was detected in 
the cell body and OPL (Figure 4.8 E). Thinning of the ONL in Arl3 Q71L/Q71L retinas 
was first detected in peripheral regions at 1 month of age with more widespread 
thinning observed at 3 and 6 months. A reduction in cone photoreceptor function was 
detected from 3 months of age, when normal M/L opsin localisation was observed. 
This suggests that another mechanism is driving dysfunction of cones in Arl3 
Q71L/Q71L retinas.  
M/L opsin was mislocalised in Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas after onset of 
retinal degeneration suggesting another factor is driving retinal degeneration in Arl3 
Q71L mutant mice. Mislocalisation of M/L opsin was detected at later stages and 
therefore may contribute to the dysfunction of cones in older Arl3 Q71L mutant mice. 
M/L opsin mislocalisation was detected at 6 months in Arl3 Q71L/Q71L retinas but 
was not detected until 9 months of age in Arl3 Q71L/+ retinas demonstrating that 
levels of ARL3-GTP may affect M/L opsin trafficking. As this was not an early event 
initiating retinal degeneration it demonstrates that M/L opsin trafficking can be 
maintained despite high levels of ARL3-GTP however after onset of retinal 


























































(A) M/L opsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged one month. M/L opsin staining was detected in the OS of cone 
photoreceptors.  
(B) M/L opsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
age 3 months. M/L opsin was localised to the OS of cone photoreceptors.  
(C) M/L opsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 6 months. In WT and Arl3 Q71L/+ retinas M/L opsin was localised to 
the OS of cone photoreceptors. In Arl3 Q71L/Q71L retinas M/L opsin 
staining was observed in the cell body and OPL of cone photoreceptors.  
(D) M/L opsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 9 months. In Arl3 WT retinas M/L opsin staining was detected in the 
OS of cone photoreceptors. In Arl3 Q71L/+ retinas M/L opsin staining was 
detected in the OS, IS, cell body and OPL of cone photoreceptors. In Arl3 
Q71L/Q71L retinas appeared reduced compared to WT with some staining 
detected throughout the IS, cell body and OPL.  
(E) M/L opsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 12 months. In Arl3 WT retinas M/L opsin was detected in the OS of 
cone photoreceptors. In Arl3 Q71L/+ retinas M/L opsin staining appeared 
reduced compared to WT with some staining remaining in the IS. In Arl3 
Q71L/Q71L retinas M/L opsin staining appeared reduced compared to WT 






























4.5 Rhodopsin is Mislocalised in Arl3 Q71L/+ and Arl3 Q71L/Q71L Mice 
 
Rhodopsin mislocalisation was not detected in rods deficient of ARL3 (RodArl3-/-) mice 
despite progressive rod degeneration (Hanke-Gogokhia et al. 2016). RetArl3-/- mice 
demonstrated that ARL3 may have a role in ciliogenesis and OS formation as no 
connecting cilia or OS’s were formed in these mice and therefore rhodopsin was 
mislocalised throughout the ONL (Hanke-Gogokhia et al. 2016). In RodARL3Q71L mice 
rhodopsin localisation was not examined but the levels of rhodopsin expression were 
comparable to WT suggestive of normal rhodopsin trafficking. This implies that 
mutation of ARL3 does not disrupt rhodopsin trafficking. As previously discussed in 
chapter 3, Rp2h DEL26/Y and Rp2h E135G/Y mice displayed rhodopsin 
mislocalisation demonstrating increased levels of ARL3-GTP may affect rhodopsin 
localisation. Therefore to investigate whether high levels of ARL3-GTP causes 
mislocalisation of rhodopsin, rhodopsin localisation was examined in Arl3 Q71L/+ and 
Arl3 Q71L/Q71L retinas.  
Arl3 Q71L/+ retinas presented with normal rhodopsin localisation to the OS of rods, 
identical to WT retinas, at 1 month and 3 months of age (Figure 4.9 A, B). At 6 months 
of age rhodopsin staining was observed in the OS, IS, ONL and OPL of the retina 
reflecting mislocalised rhodopsin (Figure 4.9 C). At 9 months and 12 months of age 
rhodopsin staining intensity appeared reduced in Arl3 Q71L/+ retinas compared to 
WT (Figure 4.9 D, E) however neither the signal intensity nor the protein levels were 
quantified. Arl3 Q71L/Q71L retinas displayed reduced rhodopsin staining compared 
to WT from age 1 month (Figure 4.9 A-E). The staining that was detected was present 
throughout the photoreceptor layer (OS, IS, ONL, OPL) (Figure 4.9 A-E). This 
suggests that elevated levels of ARL3-GTP cause mislocalisation of rhodopsin which 
then may be degraded.  
In Arl3 Q71L/+ retinas thinning of the ONL was first detected at 6 months with more 
substantial thinning detected at 9 months of age (Figure 4.4 A (iii), (iv)) along with 
reduced rod photoreceptor responses (Figure 4.5 A, B).  Rhodopsin was mislocalised 
at 6 months of age prior to the observed reduction in rod photoreceptor function. As 
rhodopsin is a key component of phototransduction this was unexpected but may 
imply that some rhodopsin was still localised to the OS and was therefore able to be 
activated and generate an A-wave response. Arl3 Q71L/+ mice aged 9 months had 
reduced rod photoreceptor responses and reduced rhodopsin immunostaining 
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suggesting that the possible reduction in rhodopsin expression may contribute to the 
reduction in rod photoreceptor function that was recorded. As thinning of the ONL was 
observed at the same age as mislocalisation of rhodopsin, this advocates that 
rhodopsin mislocalisation may contribute to retinal degeneration. In Arl3 Q71L/Q71L 
retinas rhodopsin mislocalisation and potential reduction in expression was detected 
from age one month. Thinning of the ONL was first detected at one month of age in 
Arl3 Q71L/Q71L retinas with more substantial thinning observed from age 3 months 
(Figure 4.3 A, B). ERGs were only performed on mice from age three months and 
demonstrated reduced rod photoreceptor responses in these mice (Figure 4.5 A, C). 
This again demonstrates that rhodopsin mislocalisation and reduced expression was 
likely a mechanism which contributed to reduced photoreceptor responses and 
photoreceptor cell death in Arl3 Q71L mice.  
This data proposes a role for ARL3-GTP in rhodopsin trafficking. The later 
mislocalisation of rhodopsin in Arl3 Q71L/+ mice compared to Arl3 Q71L/Q71L mice 
demonstrates that despite elevated levels of ARL3-GTP rhodopsin can be trafficked 
correctly but rhodopsin trafficking cannot be maintained when high levels of ARL3-
GTP persist indicating this could be secondary to mislocalisation of other OS proteins 




























































(A) Rhodopsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 1 month. In WT and Arl3 Q71L/+ retinas rhodopsin was localised to 
the OS of rod photoreceptors. In Arl3 Q71L/Q71L retinas rhodopsin 
staining was detected throughout the OS, IS, ONL and OPL of 
photoreceptors. The signal intensity appeared reduced compared to WT 
and Arl3 Q71L/+ retinas.  
(B) Rhodopsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 3 months. In WT and Arl3 Q71L/+ retinas rhodopsin staining was 
detected in the OS of rod photoreceptors. In Arl3 Q71L/Q71L retinas 
rhodopsin staining was detected throughout the OS, IS and ONL of 
photoreceptors reflecting mislocalised rhodopsin. The staining intensity 
appeared reduced compared to WT and Arl3 Q71L/+ retinas.  
(C) Rhodopsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 6 months. In Arl3 WT retinas rhodopsin was detected in the OS of 
rod photoreceptors. In Arl3 Q71L/+ retinas rhodopsin staining was 
detected in the OS, IS and ONL of photoreceptors. The staining intensity 
appeared reduced compared to WT. In Arl3 Q71L/Q71L retinas rhodopsin 
staining was detected in the OS, IS, ONL and OPL however the staining 
was markedly reduced compared to WT and Arl3 Q71L/+ retinas. 
(D) Rhodopsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 9 months. In Arl3 WT retinas rhodopsin was detected in the OS of 
rod photoreceptors. In Arl3 Q71L/+ retinas rhodopsin staining was reduced 
compared to WT with some staining detected throughout the OS, IS and 
ONL. In Arl3 Q71L/Q71L retinas staining intensity was also reduced 
compared to WT with some staining in the OS, IS and ONL.  
(E) Rhodopsin staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 12 months. In Arl3 WT retinas rhodopsin was detected in the OS of 
rod photoreceptors. In Arl3 Q71L/+ retinas rhodopsin staining appeared 
reduced compared to WT with some staining remaining in the OS, IS, ONL. 
In Arl3 Q71L/Q71L retinas rhodopsin staining appeared reduced 
compared to WT with some staining remaining in the OS, IS, ONL and 




4.6 GRK1 Immunostaining is Reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L 
Retinas 
 
Many studies have implicated ARL3 and levels of ARL3-GTP in the trafficking of 
GRK1 to the photoreceptor OS (Hanke-Gogokhia et al. 2016; Z. C. Wright et al. 2016; 
Houbin Zhang et al. 2015). RodArl3-/-, RetArl3-/- and Pde6δ -/- mice displayed GRK1 
mislocalisation suggesting GRK1 is trafficked to the OS by PDE6δ and ARL3. PDE6δ 
is known to be regulated by ARL3-GTP suggesting that in Arl3 Q71L retinas this may 
be disrupted (Hanke-Gogokhia et al. 2016; H Zhang et al. 2007). The phenotype 
reported in RodARL3Q71L mice supports this hypothesis as loss of GRK1 
immunostaining in the OS and reduction in GRK1 expression  was observed (Wright 
et al. 2016). As previously discussed in chapter 3 Rp2h DEL26/Y and Rp2h E135G/Y 
retinas displayed mislocalisation and reduction of GRK1 immunostaining. Therefore 
to elucidate whether this was directly attributed to levels of ARL3-GTP, the localisation 
of GRK1 in Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas was analysed.  
In WT retinas, GRK1 was localised to OS of photoreceptors at ages 1, 3, 6, 9 and 12 
months of age (Figure 4.10 A-E). Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas displayed 
reduced GRK1 immunostaining compared to WT from 1 month to 12 months of age 
although the levels observed appeared to be higher than background levels 
demonstrated by the secondary only control (Figure 4.10 A-F). Western blot analysis 
of whole eye lysates demonstrated that at one month of age WT, Rp2h DEL26/Y, 
Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L had equivalent levels of GRK1 
expression (Figure 4.10 G). At 3, 6 and 9 months of age GRK1 expression was 
reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L compared to WT, Rp2h DEL26/Y and 
Rp2h E135G/Y eyes (Figure 4.10 G). GRK1 expression was not detected in Arl3 
Q71L/Q71L eyes post 3 months of age, however some expression was detected in 
Arl3 Q71L/+ eyes up to 9 months of age (Figure 4.10 G). This demonstrates that high 
levels of ARL3-GTP leads to mislocalisation and eventual degradation of GRK1.  
Reduced GRK1 immunostaining was observed in Arl3 Q71L/+ retinas from age 1 
month with reduced protein levels detected from age 3 months (Figure 4.10 A-G).  
ERG analysis revealed that Arl3 Q71L/+ retinas had no significant reduction in rod 
photoreceptor function until age 9 months demonstrating that in young mice reduction 
of GRK1 expression did not affect activation of photoreceptors. However, in older 
mice as levels of GRK1 became further reduced this may have contributed to the 
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reduction in photoreceptor function observed. Thinning of the ONL was first detected 
in Arl3 Q71L/+ mice aged 6 months with more substantial thinning of the ONL 
detected from 9 months, after mislocalisation of GRK1 was observed. This suggests 
that in Arl3 Q71L/+ retinas mislocalisation of GRK1 may be a mechanism which drives 
retinal degeneration despite having a minimal effect on photoreceptor function.  
Arl3 Q71L/Q71L mice also displayed reduction in GRK1 immunostaining from 1 
month of age and a reduction of GRK1 expression from age 3 months. ERGs were 
only performed on mice from age 3 months therefore in these mice it is possible that 
the large reduction in GRK1 expression did contribute to the reduced ERG responses. 
Thinning of the ONL was detected from 1 month of age with more widespread thinning 
present from 3 months of age in Arl3 Q71L/Q71L retinas. As GRK1 mislocalisation 
was also observed at one month of age it is possible that this is a mechanism that 
initiated retinal degeneration and functional defects in Arl3 Q71L/Q71L retinas. This 
demonstrates that high levels of ARL3-GTP can cause mislocalisation of GRK1, with 
extremely elevated levels of ARL3-GTP ultimately leading to degradation of GRK1 
































































(A-E) GRK1 staining in Arl3 WT, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
aged 1 month (A), 3 months (B), 6 months (C), 9 months (D) and 12 months 
(E). In WT retinas GRK1 was detected in the OS of photoreceptors. In Arl3 
Q71L/+ and Arl3 Q71L/Q71L retinas GRK1 staining was reduced compared 
to WT with no staining detected in the OS.  
(F) Secondary Antibody only control on WT retina section demonstrating 
background staining from unspecific binding of the secondary antibody. 
Background levels of staining were lower than those detected in Arl3 
Q71L/+ and Arl3 Q71L/Q71L retinas suggesting signal in these samples 
may be attributed to residual GRK1.  
(G) Western blot analysis of GRK1 expression in Arl3 WT, Rp2h DEL26/Y, 
Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L eyes aged 1 month, 3 
months, 6 months and 9 months. GRK1 expression was detected in all 
samples at equivalent level at 1 month of age. At 3 months of age GRK1 
expression was reduced in Arl3 Q71L/+ lysates compared to WT, Rp2h 
DEL26/Y and Rp2h E135G/Y eyes. Arl3 Q71L/Q71L lysates displayed 
reduced GRK1 expression compared to all other samples. At 6 months 
GRK1 staining was detected in WT, Rp2h DEL26/Y, Rp2h E135G/Y retinas 
at comparable levels. In Arl3 Q71L/+ retinas GRK1 expression was 
detected but was reduced compared to WT, Rp2h DEL26/Y and Rp2h 
E135G/Y samples. In Arl3 Q71L/Q71L eyes GRK1 expression was not 
detected. At 9 months of age GRK1 expression was detected in WT, Rp2h 
DEL26/Y, Rp2h E135G/Y and Arl3 Q71L/+ eyes with expression reduced in 
Arl3 Q71L/+. In Arl3 Q71L/Q71L eyes GRK1 expression was not detected. 
Actin used as a loading control.  
 






























4.7 STAT3 Phosphorylation is Reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L Eyes 
 
STAT3 (signal transducer and activator of transcription 3) is a transcription factor 
which plays a central role in transmitting signals from the membrane to the nucleus 
after Interleukin 6 (IL-6) cytokine signalling (Hirano, Ishihara, and Hibi 2000). STAT3 
has been shown to regulate cell growth, differentiation, migration, cell survival and the 
inflammatory response, and as such is found mutated in many malignancies (Pilati et 
al. 2011; Koskela et al. 2012; H. Yu, Pardoll, and Jove 2009; Hirano, Ishihara, and 
Hibi 2000). STAT3 signalling is induced by binding of cytokine IL-6 to its receptor on 
the cell surface which leads to dimerisation of glycoprotein 130 (Gp130). Gp130 is the 
common subunit of the receptor complexes of the interleukin 6 (IL6) family of 
cytokines (Hirano, Ishihara, and Hibi 2000) which upon dimerisation results in 
activation of Gp130 associated Janus associated kinases (JAK1, Jak2, TYK2) 
(Lutticken et al. 1994; Matsuda, Yamanaka, and Hirano 1994; Stahl et al. 1994). 
Gp130 is then phosphorylated by the JAK kinases and subsequently recruits signal 
transducing molecules such as STAT3 (Stahl et al. 1995; T. Fukada et al. 1996). 
STAT3 then becomes phosphorylated at Tyrosine705 (Y705) and forms a homodimer 
or a heterodimer with STAT1 (J E Darnell, Kerr, and Stark 1994; James E Darnell 
1997). STAT3 nuclear translocation requires a Nuclear Localisation Signal on 
STAT3’s coiled coiled domain and interaction with Importin α3 and α6 (L. Liu, 
McBride, and Reich 2005). More recently it was revealed that the small GTPase Ran 
and Importin β1 also regulate STAT3 nuclear localisation (Cimica et al. 2011). 
Interestingly both of these studies revealed STAT3 nuclear accumulation did not 
require tyrosine phosphorylation and that unphosphorylated STAT3 also localised to 
the nucleus, demonstrating tyrosine phosphorylation may not be essential for STAT3 
nuclear accumulation (L. Liu, McBride, and Reich 2005; Cimica et al. 2011). Once in 
the nucleus STAT3 is phosphorylated on Serine 727 (S727) which is required for the 
activation of STAT3 controlled gene expression (Schindler, Levy, and Decker 2007). 
Recently it was demonstrated that ARL3 interacts with STAT3 and that upon 
stimulation by IL-6, ARL3-GTP interacts with phosphorylated STAT3 and increases 
its nuclear translocation (Togi et al. 2016). Expression of ARL3 Q71L in cells 
increased STAT3 transactivation while knockdown of ARL3 reduced STAT3 mediated 
gene expression demonstrating that levels of ARL3-GTP may affect downstream 
STAT3 signalling (Togi et al. 2016). Therefore given this finding, I investigated the 
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levels of STAT3 and phosphorylated STAT3 (pY705 and pS727) in WT, Arl3 Q71L/+, 
Arl3 Q71L/Q71L, Rp2h DEL26/Y and Rp2h E135G/Y mice.  
In order to control for photoreceptor number, eyes from Rp2h DEL26/Y, Rp2h 
E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L mice aged one month were used, as no 
retinal degeneration was detected at this stage in any  Rp2h or Arl3 mutants. After 
electrophoresis and transfer, membranes were probed for both total STAT3 and 
STAT3 with phosphorylated Y705 (pY705) and the same samples run on subsequent 
blots and probed for STAT3 and STAT3 phosphorylated S727 (pS727) in order to 
avoid ambiguity associated with membrane stripping and re-probing. Total STAT3 
levels were equivalent in each sample (Figure 4.11 A, B) demonstrating mutation of 
Rp2h or expression of ARL3 Q71L did not disrupt STAT3 expression or stability. 
Analysis of STAT3 pY705 revealed that in WT, Rp2h DEL26/Y and Rp2h E135G/Y 
eyes STAT3 was phosphorylated however in Arl3 Q71L/+ and Arl3 Q71L/Q71L 
lysates reduced STAT3 phosphorylation was observed (Figure 4.11 A). This suggests 
that increased levels of ARL3-GTP decreased STAT3 phosphorylation in eyes. 
Similarly analysis of STAT3 pS727 demonstrated that reduced levels were present in 
Arl3 Q71L/+ and Arl3 Q71L/Q71L eyes compared to WT, Rp2h DEL26/Y and Rp2h 
E135G/Y eyes. These results suggest that increased levels of ARL3-GTP lead to 
decreased levels of active STAT3 in vivo. As no difference in STAT3 pY705 or pS727 
phosphorylation was detected in Rp2h DEL26/Y or Rp2h E135G/Y mutants this 
demonstrated a specific effect stemming from mutation of ARL3 and may highlight a 











Figure 4.  11 STAT3 Phosphorylation is Reduced in Arl3 Q71L/+ and Arl3 

















(A) STAT3 protein expression and pSTAT3 Y705 levels In WT, Rp2h 
DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L eye lysates 
aged 1 month. In WT, Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and 
Arl3 Q71L/Q71L eyes STAT3 is expressed at the same level as WT. 
STAT3 pY705 was detected in WT, Rp2h DEL26/Y and Rp2h E135G/Y 
at levels equivalent to WT but was not detected in Arl3 Q71L/+ and Arl3 
Q71L/Q71L mice.  
(B) STAT3 and pS727 protein expression in WT, Rp2h DEL26/Y, Rp2h 
E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L eyes aged 1 month. STAT3 
expression was detected in every sample however STAT3 pS727 was 
detected in WT, Rp2h DEL26/Y and Rp2h E135G/Y lysates but not in Arl3 
Q71L/+ and Arl3 Q71L/Q71L lysates.  





4.8.1 Arl3 Q71L/+ and Arl3 Q71L/Q71L have Progressive Retinal Degeneration 
 
In order to assess whether increased levels of ARL3-GTP were present in Arl3 Q71L 
mutant mice an assay was designed using RP2 recombinant protein to isolate ARL3-
GTP. This assay revealed that Arl3 Q71L expressing lysates have substantially higher 
levels of ARL3-GTP than WT, Rp2h DEL26/Y and Rp2h E135G/Y lysates (Figure 
4.2). As ARL3 Q71L was expressed at the same level as ARL3 WT and as RP2 is the 
only known GAP for ARL3 the levels of ARL3-GTP were expected to be equivalent in 
Arl3 Q71L/Q71L, Rp2h DEL26/Y and Rp2h E135G/Y lysates, therefore as this was 
not observed, this could suggest that in tissues lacking RP2 another GAP exists which 
regulates the levels of ARL3-GTP. It is also possible that in lysates with RP2 function 
disrupted levels of ARL3-GTP are regulated through the GEF, ARL13b, such that the 
activity of ARL13b may be reduced in order to prevent increases in levels of ARL3- 
GTP. In this assay no ARL3-GTP was detected in WT lysates despite the fact some 
must be present in vivo therefore it is possible that in Rp2h DEL26/Y and Rp2h 
E135G/Y lysates levels of ARL3-GTP are increased compared to WT but are not high 
enough to be detected by this assay.  
In Arl3 Q71L/+ retinas thinning of the ONL was detected at 6 months of age but was 
not established in most regions until 9 to 12 months of age (Figure 4.3, 4.4). ERG 
results demonstrated a reduction in cone function from age 3 months and no reduction 
in rod photoreceptor function until 9 months of age (Figure 4.5, 4.6). This suggests 
that the retinal degeneration detected by ONL thinning prior to 9 months is due to loss 
of cone photoreceptors only. As discussed in chapter 3, ERG experiments were quite 
variable therefore ERGs could be repeated in more animals from each genotype. 
ERGs could be performed on younger mice to establish if normal cone function is 
present.  
In Arl3 Q71L/Q71L retinas, thinning of the ONL was first detected at 1 month and was 
widespread from 6 months of age (Figure 4.3, 4.4). ERG results demonstrated a 
significant reduction in rod and cone function from 3 months of age (Figure 4.5, 4.6). 
Although some thinning of the ONL was detected at 1 month and 3 months in these 
mice, severe retinal degeneration was not observed demonstrating that high levels of 
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ARL3-GTP adversely affects photoreceptor function without promoting massive 
photoreceptor cell death. The RodARL3Q71L mouse exhibited severe retinal 
degeneration by PN70 with only one nuclei left in the ONL (Wright et al. 2016) 
however in Arl3 Q71L/Q71L mice aged 3 months (PN90) retinas did not appear 
significantly thinner than WT. This highlights the potential issues created by use of 
the rhodopsin promoter to express ARL3 Q71L, as it is possible that massive 
overexpression of this protein triggered ER stress and ultimately photoreceptor cell 
death, rather than expression of ARL3 Q71L itself. For instance to detect ARL3 in eye 
lysates on western blot ECL Femto was used demonstrating endogenous ARL3 is not 
highly expressed in the eye. 
Overall, this data demonstrates that expression of ARL3-GTP in the retina increases 
levels of ARL3-GTP hundreds of fold higher than WT and that this is relatively well 
tolerated as some photoreceptors survived up to 12 months of age. These mice 
demonstrate that increased levels of ARL3-GTP cause defects in both rod and cone 
photoreceptors and that cone photoreceptors may be more sensitive than rods. This 
agrees with a review of XLRP patient phenotypes, where patients with RP2 mutations 
had a severe cone phenotype (Jayasundera et al. 2010).  
4.8.2 Mislocalisation of M/L Opsin and Rhodopsin in Arl3 Q71L/+ and Arl3 
Q71L/Q71L Retinas 
 
In Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas mislocalisation of M/L opsin was observed 
at 9 months and 6 months of age respectively (Figure 4.8). ERG results demonstrated 
reduced cone function from 3 months signifying that mislocalisation of M/L opsin is 
not causative of the reduced cone function, however it may contribute to reduced cone 
function in older Arl3 Q71L mice (Figure 4.6). Prior to mislocalisation of M/L opsin the 
length of the cone OS appeared longer in Arl3 Q71L mutants compared to WT 
however, this was not quantified (Figure 4.8 B,C). Previously it has been shown that 
knockout of Rp2h in cones resulted in increased cone OS length, suggesting ARL3-
GTP may be involved in this process (L. Li et al. 2015). As discussed in chapter 3, 
RP2 and ARL3 regulate the trafficking of KIF17, a homomeric kinesin which is 
required for M/L opsin trafficking to the cone OS indicating this could be a mechanism 
by which ARL3-GTP regulates M/L opsin localisation (Schwarz et al. 2017; Insinna et 
al. 2008). KIF17 has been shown to play a role in disc shedding in zebrafish cones, 
with loss of KIF17 reducing disc shedding in cones (Lewis et al. 2018), therefore RP2 
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and ARL3 may also influence disc shedding through KIF17 as disc shedding is 
required for normal photoreceptor function this may be linked to the photoreceptor 
degeneration phenotype (Kevany and Palczewski 2010). In older Arl3 Q71L mice loss 
of M/L opsin staining was detected as photoreceptor degeneration progressed 
suggesting loss of cones (Figure 4.8). However, ERG results demonstrated that cone 
function is reduced from 3 months of age and this reduction in function is maintained 
until 12 months of age as the A-wave amplitude recorded at 12 months of age is not 
substantially reduced compared to 3 months of age, arguing against progressive cell 
death (Figure 4.6). Therefore, it is possible that less functional cones can survive in 
these mice, thus retinal whole mounts with PNA staining could be used to quantify the 
number of cones present in these mice and address whether cone photoreceptor cell 
death occurs over time.  
In Arl3 Q71L/+ and Arl3 Q71L/Q71L mice rhodopsin mislocalisation was detected 
from 6 months and 1 month of age prior to reduced rod photoreceptor function and 
retinal degeneration suggesting this may be an early event which initiates retinal 
degeneration (Figure 4.9). In rodARL3Q71L mice mislocalisation of prenylated proteins 
was detected but no mislocalisation of rhodopsin was shown (Wright et al. 2016). In 
rodArl3-/- mice rhodopsin was mislocalised throughout the IS and ONL of rod 
photoreceptors suggesting ARL3 may play a role in rhodopsin trafficking (Hanke-
Gogokhia et al. 2016). After loading into vesicles rhodopsin is trafficked to the base 
of the connecting cilia via microtubules and the dynein motor (Pearring et al. 2013). 
Recently it was shown that ARL3 interacts with the p150Glu domain of the dynein 
motor and this interaction disrupts the dynein- dynactin complex and leads to release 
of cargo during vesicular trafficking (Jin et al. 2014). Furthermore pulldowns using 
ARL3 Q71L revealed that GTP bound ARL3 facilitates this function (Jin et al. 2014) 
suggesting increased levels of ARL3-GTP may cause disruptions in vesicular 
trafficking in vivo.  
IFT occurs in photoreceptors and has important roles in the morphogenesis and 
maintenance of the OS (Marszalek et al. 2000; Pazour et al. 2002). Rhodopsin 
trafficking involves IFT as retinal knockouts of Kif3a, Ift88 and Ift20 result in rhodopsin 
mislocalisation. Interestingly it has also been shown that rhodopsin directly interacts 
with intraflagellar transport protein 20 (IFT20) (Keady, Le, and Pazour 2011; 
Marszalek et al. 2000; Pazour et al. 2002). Furthermore it has been demonstrated in 
cells, that depletion of RP2, ARL3 or Kif3a cause Golgi fragmentation and dispersion 
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of IFT20, interestingly this result was also observed when ARL3 Q71L was expressed 
in cells (Evans et al. 2010), suggesting in Arl3 Q71L mice IFT20 may be mislocalised 
and this may result in rhodopsin mislocalisation. In Ift20-/- cones M/L opsin was also 
mislocalised suggesting that expression of Arl3 Q71L could also cause M/L opsin 
mislocalisation through this mechanism (Keady, Le, and Pazour 2011). It has been 
demonstrated in C.elegans Arl-13 and ARL3 regulate IFT and ciliogenesis by 
regulating the interaction between IFTA and IFTB (Yujie Li et al. 2010). Arl-13 is a 
homologue of human ARL13B a gene which when mutated causes Joubert Syndrome 
(Cantagrel et al. 2008) and it has been established that ARL13B has GEF activity for 
ARL3 in vitro (Gotthardt et al. 2015), implying levels of ARL3-GTP may regulate this 
process. In order to generate further evidence that IFT may be disrupted in Arl3 Q71L 
mice the localisation of  Guanyl Cyclase 1 (GC1) could also be investigated as it has 
also been shown to require IFT for trafficking to the OS (Insinna and Besharse 2008). 
Interestingly Arl3 Q71L mice did not display any other obvious defects as they 
survived until 12 months of age and were indistinguishable from WT mice however 
the motors and proteins which regulate IFT are expressed in all ciliated cells 
demonstrating that in other cilia mechanisms exist which maintain IFT regulation 
despite high levels of ARL3-GTP.  
4.8.3 GRK1 Immunostaining is Reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L 
Retinas 
 
GRK1 immunostaining was reduced compared to WT in Arl3 Q71L/+ and Arl3 
Q71L/Q71L retinas from age 1 month however no reduction in GRK1 protein level 
was detected at this age (Figure 4.10). This is similar to the results discussed in 
chapter 3, where in Rp2h DEL26/Y and Rp2h E135G/Y retinas GRK1 immunostaining 
was reduced but protein levels were not and suggests mislocalisation of GRK1. From 
3 months of age the protein levels of GRK1 were reduced in Arl3 Q71L/+ and Arl3 
Q71L/Q71L retinas suggesting degradation of mislocalised GRK1 (Figure 4.9 G). In 
Arl3 Q71L/Q71L retinas the protein levels of GRK1 were reduced compared to Arl3 
Q71L/+ and WT at all the ages examined demonstrating levels of ARL3-GTP were 
directly related to rate of GRK1 loss (Figure 4.10 G). This result is similar to that 
reported in RodARL3Q71L mice in which GRK1 protein levels were reduced ~40% 
compared to WT (Wright et al. 2016). In this model levels of PDE6 and Transducin γ 
(Tγ) were also reduced compared to WT retinas (Wright et al. 2016) however I was 
149 
 
unable to investigate these proteins in the Arl3 Q71L mice. In RodArl3-/- retinas GRK1, 
PDE6, Tα and Tγ were all mislocalised to the IS, ONL and synaptic layer of the retina 
however a reduction in protein levels was not reported.  
GRK1 is also expressed in cone photoreceptors, in Arl3 Q71L/+ and Arl3 Q71L/Q71L 
mice the loss of GRK1 immunostaining was consistent across the retina suggesting 
GRK1 expression was also lost in cones. In order to confirm GRK1 expression was 
reduced in cones as well as rods co-staining with PNA could be used to label the cone 
photoreceptors. It was established that cone GRK1 was mislocalised in Rp2h -/- mice 
(Houbin Zhang et al. 2015) and that rod and cone GRK1 localisation was disrupted in 
the PDE6δ -/- knockout mouse (H Zhang et al. 2007) implying that when RP2 is 
absent and ARL3-GTP levels increased PDE6δ function was compromised in cones. 
In a double knockout Pde6δ-/- Unc119-/-  localisation of cone GRK1 was partially 
rescued (Houbin Zhang, Frederick, and Baehr 2014) suggesting GRK1 in rods and 
cones may be differentially regulated. Given that cone photoreceptor function is 
disrupted from 3 months of age in Arl3 Q71L retinas this could be an interesting lane 
for further investigation as it is possible localisation and expression of cone GRK1 
may be affected prior to rod GRK1. Interestingly in RodArl3-/- retinas GRK1, PDE6, Tα 
and Tγ were still partially localised to the OS as well as the IS and ONL suggesting 
that in the absence of ARL3 compensatory mechanisms may exist to maintain 
trafficking of proteins to the OS (Hanke-Gogokhia et al. 2016).  
Reduced GRK1 expression would be expected to directly affect levels of rhodopsin 
phosphorylation and therefore result in changes in photoreceptor responses. ERG 
results demonstrated that in Arl3 Q71L/+ mice 3cd A-wave amplitudes were not 
reduced compared to WT until 9 months of age, however a reduction in GRK1 
immunostaining was observed from 1 month and reduced protein levels were 
observed from 3 months demonstrating that in younger Arl3 Q71L/+ mice GRK1 
reduction does not affect A-wave amplitude (Figure 4.5, Figure 4.10). However as 
GRK1 is involved in rhodopsin recycling during phototransduction it would be 
expected that reduced GRK1 expression would result in decreased rate of recovery 
of photoresponses after phototransduction. This effect was detected in both the 
RodARL3Q71L mice and Rp2h -/- mice where GRK1 expression and localisation was 
disrupted (Wright et al. 2016; Zhang et al. 2015). In order to test whether the observed 
reduction in GRK1 expression has a functional consequence on phototransduction, 
scotopic ERG recovery could be measured using two low intensity flashes with 
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varying delays between and the time required for the A-wave amplitude to recover 
recorded in Arl3 Q71L mutants compared to WT.  
It has been shown that GRK1 can be trafficked to the OS by PDE6δ and that cargo 
release from PDE6δ can be stimulated by ARL3-GTP and not ARL3-GDP (Linari, 
Hanzal-Bayer, and Becker 1999; H Zhang et al. 2007). ARL13B, the GEF for ARL3, 
is localised to primary cilia (Gotthardt et al. 2015; Cantagrel et al. 2008) and RP2 also 
localises to primary cilia in cultured cells (T. W. Hurd, Fan, and Margolis 2011).  
Therefore as the OS is a modified cilium (Besharse and Horst 1990) this suggests 
that in WT retinas ARL3-GTP is restricted to the OS and CC ensuring release of cargo 
from PDE6δ can only occur in this region. In Arl3 Q71L retinas, where ARL3 is 
constitutively GTP bound, cargo may be released from PDE6δ in all regions of the 
photoreceptor cell leading to cell stress and ultimately photoreceptor cell death.  
4.8.4 STAT3 phosphorylation is Reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L 
Eyes Aged 1 month 
 
STAT3 expression and phosphorylation status was examined in eyes aged 1 month 
as no reduction in photoreceptor number or changes in retinal morphology were 
present at this age in either Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 
Q71L/Q71L retinas. As retinal degeneration progresses microglial activation occurs 
and triggers an inflammatory response which is thought to contribute to photoreceptor 
cell death (Langmann 2007; Zeng et al. 2005; Hollyfield et al. 2008). Therefore as 
STAT3 is involved in inflammatory signalling only mice aged one month were 
analysed to prevent detection of changes in STAT3 activation associated with 
increased inflammation (Heinrech et al., 1998; Hirano, Ishihara and Hibi, 2000; Yu, 
Pardoll and Jove, 2009; Pilati et al., 2011). Togi et.al demonstrated that ARL3 
interacts with STAT3 and that ARL3-GTP interacts with STAT3 phosphorylated at 
Y705 resulting in increased STAT3 nuclear accumulation and STAT3 mediated gene 
expression in HeLa cells (Togi et al. 2016). In Arl3 Q71L/+ and Arl3 Q71L/Q71L mice, 
which have highly elevated levels of ARL3-GTP (Figure 4.2), levels of STAT3 
phosphorylation at Y705 and S727 were reduced (Figure 4.11). As Y705 
phosphorylation is thought to be required for dimerisation and nuclear translocation 
and phosphorylation of S727 is thought to be required for activation of STAT3 
mediated gene expression, reduced phosphorylation of these residues would be 
predicted to result in reduced STAT3 activity in vivo (Z. Wen, Zhong, and Darnell 
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1995). This result contrasts the results described by Togi et.al in which ARL3-GTP 
increased phosphorylation of STAT3 and increased its nuclear accumulation, leading 
to increased STAT3 mediated gene expression (Togi et al. 2016). The reasons for 
this difference could be that to detect the ARL3 and STAT3 interaction and increased 
STAT3 phosphorylation in HeLa cells leukaemia inhibitory factor (LIF) stimulation was 
required and the interaction was undetectable in the absence of LIF (Togi et al. 2016). 
In 1 month old eyes without retinal degeneration IL6 receptors may not be stimulated 
and this may explain the differences in findings between this work and my study. 
Importantly, HeLa cells are an immortalised human cancer cell line and as STAT3 
expression has been shown to be upregulated in many malignancies these cells may 
not accurately reflect STAT3 interactions under normal physiological conditions (H. 
Yu, Pardoll, and Jove 2009). In the retina STAT3 signalling can also be stimulated by 
ciliary neurotrophic factor (CNTF), another member of the IL6 family of cytokines,  
which is upregulated through retinal stress (Stahl et al. 1994; R. Wen et al. 1995; Cao 
et al. 1997; Rose-John 2018). CNTF binds its receptor CNTFα which binds Gp130 
and leukaemia inhibitory factor receptor (LIFR) and stimulates phosphorylation of 
Y705 on STAT3 (Stahl et al. 1994) .Multiple studies have demonstrated that 
expression of CNTF in the retina is protective in models of inherited retinal 
degeneration (Cayouette and Gravel 1997; Tao et al. 2002; Chong et al. 1999) and 
CNTF expression may be particularly beneficial for cone survival  making it an 
attractive avenue for therapeutic treatment in patients (Yiwen Li et al. 2010). In 
transgenic rats carrying the rhodopsin S334ter-3 mutation, which generates a 
truncated rhodopsin which is not trafficked to the OS (Martinez-Navarrete et al. 2011), 
CNTF expression rescued secondary degeneration of cones (Yiwen Li et al. 2010). 
Transplantation of a microdevice which secretes CNTF at PN20 rescued cone OS 
degeneration and treated eyes at PN160 had increased cone ERG responses 
compared to untreated eyes (Yiwen Li et al. 2010). A phase 1 clinical trial 
demonstrated that expression of CNTF via an ocular implant is safe for patients and 
although clinical efficacy was not assessed in this trail 7 of the patients treated did 
display a 2-3 line improvement in vision after treatment (Sieving et al. 2006).  
In Arl3 Q71L eyes phosphorylation of STAT3 was reduced this could result from 
reduced CNTFα or IL6 receptor activation or it may be that receptors are activated 
but downstream signalling prevented. In order to test whether CNTF or IL6 expression 
is affected in Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas western blots for CNTF or IL6 
could be performed or their expression could be analysed by RNA sequencing of 
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whole retinas. Expression of CNTF is increased with GFAP expression in neuronal 
cells  (Cao et al. 1997) and if this occurs in the retina then it may be that CNTF 
expression is increased in Arl3 Q71L/Q71L mice as these retinas had the highest 
levels of GFAP expression, and subsequently ARL3 Q71L expression prevents 
STAT3 phosphorylation by an undetermined mechanism. Expression of ARL3 Q71L 
lead to accumulation of STAT3 in the nucleus even in the absence of LIF stimulation 
in HeLa cells (Togi et al. 2016), therefore it could be that in the retina ARL3-GTP 
shuttles STAT3 into the nucleus in the absence of phosphorylation resulting in STAT3 
no longer being able to interact with the membrane localised Gp130. This hypothesis 
could be tested by analysing the localisation of STAT3 in WT and Arl3 Q71L/+ and 
Arl3 Q71L/Q71L retinas.  
In this experiment whole eye lysates were used therefore these results do not 
specifically reflect the levels of STAT3 in photoreceptors. Multiple studies have 
demonstrated a role for STAT3 in rod photoreceptor development  (S. S.-M. Zhang et 
al. 2005; Ozawa et al. 2004; S. S. M. Zhang et al. 2004) and it has been suggested 
that STAT3 is expressed in the nuclei of Muller cells, ganglion cells and astrocytes 
with some expression in the IS of photoreceptors (Samardzija et al. 2006; Peterson 
et al. 2000). It has been shown in zebrafish that high levels of STAT3 are expressed 
in the eye and that when photoreceptors are exposed to high levels of light, levels of 
total and activated STAT3 are increased in microglial and photoreceptor cells (Oates 
et al. 1999; Kassen et al. 2007).  In order to establish where STAT3 is expressed in 
the mouse retina immunofluorescence experiments were attempted on retinal 
sections with STAT3, STAT3 pY705 and STAT3 pS727 antibodies, however these 
were unsuccessful. In order to improve specificity of this experiment retinas could be 
dissociated from whole eyes and levels of STAT3 expression and activation 
examined. STAT3 expression in the retina could also be confirmed by RNA 
sequencing and to specifically identify expression in photoreceptors single cell RNA 
sequencing techniques could be used to separate the transcriptome of specific retinal 
cell types. RNA sequencing could also be used to examine the expression of STAT3 
target genes in photoreceptors in order to demonstrate if decreased STAT3 
phosphorylation effects downstream signalling in Arl3 Q71L/+ and Arl3 Q71L/Q71L  
photoreceptors. Any downstream targets could be further investigated in order to 
determine whether they may affect function of photoreceptors and whether they may 
contribute to photoreceptor cell death.  
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Knockout of endogenous Lif expression in mouse retina revealed that LIF protects 
against light induced photoreceptor cell death (Bürgi, Samardzija, and Grimm 2009). 
LIF is member of the IL6 family of cytokines which is expressed in Muller cells and 
expression of endogenous LIF has been shown to increase with retinal stress (Bürgi, 
Samardzija, and Grimm 2009; Rose-John 2018). VPP mice contain a transgene 
encoding mutant rhodopsin (V20G, P23H, P27L), after which they are named, that 
causes rapid rod degeneration followed by secondary cone cell death which models 
Autosomal Dominant Retinitis Pigmentosa (ADRP) (Naash et al. 1993; Qtaishat et al. 
1999). In Vpp mice  which had endogenous LIF expression knocked out, Vpp Lif -/-, 
it was shown that LIF is protective against photoreceptor cell death as Vpp Lif -/- mice 
had more rapid retinal degeneration than mice expressing the VPP transgene only 
(Joly et al. 2008). The effect of STAT3 expression on photoreceptor survival was 
assessed in a transgenic model expressing mutant rhodopsin (RHO P347S) and in a 
peripherin knockout mouse, Prph2/rds+. Overexpression of STAT3 by insertion of a 
transgene expressing either STAT3WT constitutively active STAT3, STAT3C or 
dominant negative STAT3 Y705F demonstrated expression of WT and STAT3C 
improved photoreceptor cell survival. STAT3C has higher DNA binding efficiency than 
STAT3WT due stabilisation of the active tyrosine phosphorylated homodimer on DNA, 
cysteine residues introduced at 662 and 664 reduce the efficiency of 
dephosphorylation of tyrosine 705. The highest improvement in cell survival was 
detected in mice expressing STAT3C and no effect was observed when the STAT3 
Y705F mutant was expressed demonstrating that Y705 phosphorylated STAT3 has a 
pro survival effect in vivo (K. Jiang et al. 2014). Together this suggests that loss of 
STAT3 activation may contribute to retinal degeneration due to loss of pro survival 
signalling. In models of light induced and inherited retinal degeneration it was 
demonstrated that STAT3 signalling was stimulated upon photoreceptor cell death 
however the downstream signalling targets were different. The model of light induced 
retinal degeneration was the BALB/c mouse which is an albino mouse that develops 
rapid photoreceptor degeneration when exposed to bright light (LaVail and Gorrin 
1987), the models of inherited retinal degeneration were the rd1 mouse which 
contains a null allele for the β subunit of PDE6 (Bowes et al. 1990) and the VPP 
mouse (Samardzija et al. 2006).   In the model of light induced degeneration JAK2, 
STAT3 and extracellular- signal related kinase 1/2  (ERK1/2) phosphorylation was 
induced after initiation of photoreceptor degeneration however in the model of 
inherited retinal degeneration phosphorylation of JAK2 was only mildly induced but 
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phosphorylation of cellular homolog of murine thymoma virus akt8 oncogene (Akt) 
was increased (Samardzija et al. 2006). Inhibition of JAK2 in an induced model of 
retinal degeneration increased photoreceptor survival but no benefit was observed in 
the inherited model (Samardzija et al. 2006). Furthermore, expression of CTCF is 
upregulated in mouse models of light induced retinal degeneration and in the rd1 
mouse but is not induced in the VPP mouse. Fibroblast growth factor 2 (FGF-2) is 
induced in the VPP mouse but not in the rd1 mouse (Samardzija et al. 2006). This 
validates that mutations in different genes which cause retinal degeneration, can 
perturb the same pathways in different ways that can influence disease progression. 
Consequently this finding has important implications for disease mechanism in 
patients which have RP2 mutations, as it provides evidence that Rp2h mutation and 
increased levels of ARL3-GTP may not drive retinal degeneration through identical 
pathogenic mechanisms. This also has significant consequences in terms of potential 
treatment options as treatments designed to increase STAT3 signalling in the retina 
may prove ineffective in patients with RP2 mutations if levels of STAT3 expression 
and activation are not affected.  
4.9 Conclusions 
 
In this chapter, I demonstrated that CRISPR mediated knock in of ARL3 Q71L in the 
endogenous locus in mice resulted in high levels of ARL3-GTP in tissues and caused 
a progressive retinal degeneration with no other adverse phenotypes. Arl3 Q71L 
retinas displayed early mislocalisation of GRK1, a farnesylated protein trafficked to 
the OS by PDE6δ, which is regulated by ARL3-GTP suggesting that increased levels 
of ARL3-GTP cause disruption of PDE6δ, leading to mistrafficking of GRK1 and 
potentially other OS proteins. Arl3 Q71L mice also displayed mislocalisation of 
rhodopsin prior to reduced photoreceptor function and photoreceptor degeneration 
demonstrating that increased levels of ARL3-GTP also effect trafficking of rhodopsin. 
Interestingly Arl3 Q71L mice displayed reduced cone function from 3 months of age 
signifying cones may be more sensitive than rods to increased levels of ARL3-GTP. 
Mislocalisation of M/L opsin was not detected until later stages demonstrating this 
was not the initial functional defect in cones and another mechanism may cause early 
defects in cone function. I also demonstrated that Arl3 Q71L/+ and Arl3 Q71L/Q71L 
eyes had reduced STAT3 activation prior to retinal degeneration and this effect was 
not detected in Rp2h DEL26/Y and Rp2h E135G/Y mice revealing a pathway, which 
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may drive retinal degeneration, that is specifically regulated by levels of ARL3-GTP. 
Taken together this data suggests a role for ARL3-GTP in the trafficking of lipid-
modified proteins to the OS, and in opsin trafficking and that Rp2h mutants and Arl3 
mutants may drive retinal degeneration through multiple mechanisms that are not 
necessarily identical, implying increased levels of ARL3-GTP in patients with RP2 
mutations may not fully explain the downstream phenotype. Never the less these mice 
demonstrate that increased levels of ARL3-GTP is a driver for retinal degeneration 
and they facilitate direct comparison to other Rp2h mouse models providing insights 
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Protein complexes can be very dynamic in vivo with alterations in post translational 
modifications and activity of the proteins involved altering the stability and 
conformation of the complex (Wang et.al 2017). Identification of protein-protein 
interactions in vitro is commonly carried out using Yeast 2 Hybrid (Y2H) or co-
immunoprecipitation assays. Y2H studies utilise the DNA binding domain (BD) and 
the activating domain (AD) of a transcription factor which activates expression of a 
reporter gene. The BD is fused to the protein of interest (the bait) and the AD is fused 
to the potentially interacting protein (the pray). Expression of the transgene is 
activated if the bait and pray proteins interact (Brückner et.al 2009). The advantage 
of Y2H is that it identifies direct protein interactions, but the major caveat with these 
assays is that they rely on the interactions taking place in the unnatural environment 
of a yeast cell. Immunoprecipitation assays often involve overexpressed or tagged 
proteins, which do not always replicate the localisation of the endogenous proteins, 
followed by pulldown to identify interactors. The major issue with immunoprecipitation 
assays is difficulty in solubilising proteins and the resulting loss of transient or weak 
interactions as the conditions required to solubilise proteins may not be compatible 
with maintaining these weak interactions (Roux et.al 2012).   
RP2 likely functions in many transient interactions, which cannot always be detected 
by traditional immunoprecipitation assays, therefore it is likely that many of the 
proteins RP2 interacts with in cells remain unknown. In order to identify proteins with 
which RP2 interacts and to overcome the limitations of traditional IP approaches, a 
strategy was designed based on the BIO-ID method (Roux et.al 2012). Using this 
assay, zinc finger DHHC-Type containing 5 (ZDHHC5) was identified as a novel 
potential interactor of RP2. ZDHHC5 is one of the 23 human palmitoyltransferases 
(PATs) and as RP2 is itself palmitoylated, this was believed to be an interesting hit to 
investigate further. 
BIO-ID is a recently developed technique, which utilises a promiscuous prokaryotic 
biotin ligase to label proximal and interacting proteins of a protein of interest in 
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mammalian cells. This assay involves the fusion of a mutant BIRA, BIRA R118G, a 
promiscuous biotin ligase known as BIRA*, to the protein of interest and expression 
of this fusion protein in cells. BIRA* biotinylates proteins by the generation of biotinoyl-
5-AMP from biotin and ATP (Roux et al. 2012). This activated biotin radical 
biotinylates peptides by reacting with lysine residues. Upon addition of biotin to the 
cell culture media the BIRA* promiscuously biotinylates proteins interacting and 
proximal to the protein of interest. Cells are then lysed and biotinylated proteins 
purified using streptavidin beads and identified via mass spectrometry (Roux et.al, 
2012) (Figure 5.1). 
Protein fatty acid acylations are a group of dynamic post translational modifications 
which affect protein stability, trafficking and interaction with the plasma membrane 
(Hannoush 2015). Palmitoylation acts as an anchor for proteins to attach to the 
plasma membrane as well as a plasma membrane trafficking signal, as many 
membrane associated proteins are palmitoylated at the Golgi then trafficked to the 
plasma membrane (Rocks et al. 2010). The two most common fatty acid modifications 
are S-Palmitoylation and N-myristoylation. S-Palmitoylation is the attachment of a 16 
carbon fatty acid chain onto a free cysteine residue (by a thioester bond) while N-
myristoylation involves the addition of a 14 carbon fatty acid chain (Hannoush 2015) 
to the N terminal glycine (Farazi, Waksman, and Gordon 2001). The 23-
palmitoyltransferase (PAT) enzymes in humans catalyse protein palmitoylation of 
cytoplasmic and membrane bound proteins. The second family of  PAT’s, the 
membrane bound O-acyl transferase (MBOAT) family catalyse the addition of 
palmitate and other fatty acids to lipid and protein substrates (C. C. Y. Chang, Sun, 
and Chang 2011). The MBOAT family members Hhat, Porcupine, and ghrelin O-
acyltransferase (GOAT) are responsible for fatty acylation of secreted proteins 
(Buglino and Resh 2008). Hhat is required for palmitoylation of sonic hedgehog which 
is essential for its signalling function (Buglino and Resh 2008) and porcupine 
palmitoylates members of the Wnt signalling pathway which is again essential for their 
function as a knockout of Porcn in mice causes embryonic lethality due to absence of 
Wnt signalling (Galli et.al 2007; Gao & Hannoush, 2014).   
PAT proteins all contain the catalytic zinc finger cysteine rich Asp-His-His-Cys 
(DHHC) domain and four transmembrane domains (Mitchell et.al 2006). Most human 
PAT enzymes are localised to the ER and Golgi however ZDHHC5, 2, 20, 23 and 24 
are plasma membrane localised (Korycka et al. 2012). All of the PATs that have been 
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identified are themselves palmitoylated and it is thought that this plays a role in 
regulating enzyme activity and/or substrate specificity (Greaves et.al 2011; Yang et.al 
2010). Recent co-expression and co- repression studies have demonstrated that most 
ZDHHCs can palmitoylate a broad range of substrates with a few showing more 
specificity. For example depletion of ZDHHC3 or ZDHHC17 was required to reduce 
palmitoylation of synaptosomal-associated protein of 25kDa (SNAP25) however co-
repression of ZDHHC3, 5, 9 and 17 was required to reduce palmitoylation of the 
STREX domain of BK potassium transport channel in HEK293 cells (Huang et al., 
2009; Tian, et.al 2010). These studies demonstrate that in cell types that express 
multiple ZDHHCs it is possible for functional redundancy to exist and that a regulated 
array of multiple ZDHHCs are likely required for proper regulation of protein 
palmitoylation in cells.  
ZDHHC5 is ubiquitously expressed across multiple tissues with high expression 
observed in testes, brain and lung (Human Protein Atlas, 
https://www.proteinatlas.org/ENSG00000156599-ZDHHC5/tissue). ZDHHC5 has 
been shown to be enriched in the brain and to localise to synaptic membranes. 
Multiple neuronal substrates have been identified including Flotillin2, glutamate 
receptor interacting protein 1 (GRIP1), postsynaptic density 95kDa (PSD-95) and δ- 
catenin and mice homozygous for a hypomorphic null ZDHHC5 allele have defects 
associated with hippocampal learning, supporting the view that ZDHHC5 has an 
important role in neurons  (Brigidi et al., 2014; Li et al., 2010; Li, Martin et.al 2012; 
Thomas et.al 2012). Photoreceptor enriched expression of ZDHHC5 has been 
recently demonstrated by comparison of the gene expression profiles from WT and 
aryl hydrocarbon receptor interacting protein like 1 (Aipl1) knockout mice. Aipl1 
knockout mice develop a retina devoid of photoreceptors, ZDHHC5 expression was 
reduced > four fold in these mice compared to WT (Murphy et.al 2016).  
The mechanism by which ZDHHC5 recognises substrates is not well understood but 
has been shown to involve both the PDZ binding domain and the disorganised C-tail 
region. Palmitoylation of PSD-95 by ZDHHC5 was shown to be dependent on 
ZDHHC5’s PDZ domain however pulldown experiments using ZDHHC5 truncations 
demonstrated that the C-terminal tail only was required for recognition of PLM and for 
palmitoylation of Flotillin 2 (Howie et al. 2014; Yi Li et al. 2010). A recent study in 
hippocampal neuron cells demonstrated that upon neuronal stimulation ZDHHC5 is 
dynamically trafficked within the cell. Brigidi et.al demonstrated that under non- 
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stimulated conditions ZDHHC5 is anchored at the postsynaptic membrane through 
interaction with PSD-95, Fyn and adaptor complex 2 (AP2) (a protein that inhibits 
endocytosis). Upon neuronal stimulation Fyn phosphorylates ZDHHC5 reducing its 
affinity for AP2 leading to dissociation, which causes endocytosis of ZDHHC5 and 
trafficking to dendritic shafts allowing it to come into close contact with its substrate 
δ- catenin. ZDHHC5 palmitoylates δ-catenin and traffics with it to the synaptic 
membrane. This activity-regulated trafficking of ZDHHC5 demonstrates that the 
localisation of ZDHHC5 and its substrates are tightly regulated and can be co-
dependant (Brigidi et.al  2015) eluding to the possibility ZDHHC5 may have roles in 
trafficking substrates as well as palmitoylating them.  
RP2 localisation in cells is controlled by the addition of two post translational 
acylations, myristoylation at Glycine 2 (G2) and palmitoylation at Cysteine 3 (C3) 
(Chapple et al. 2000). WT RP2 localises to the plasma membrane of cells, however, 
mutation of C3 prevents palmitoylation therefore RP2 cannot anchor to the cell 
membrane and becomes localised within the cytoplasm on intracellular membranes 
(Chapple et al. 2000). Mutation of G2 results in RP2 failing to be myristoylated or 
palmitoylated and results in nuclear and cytoplasmic localisation of RP2, (Chapple et 
al. 2000) thought to be due to the presence of a NLS-like signal on RP2’s N terminus 
(Hurd et.al, 2011). Mutations of both C3 and G2 have been identified in patients 
(Jayasundera et al. 2010) confirming that these post translational modifications are 
essential for normal RP2 function and that the mechanisms which regulate RP2 post 












(A) Model of BIO-ID method using RP2-BIRA fusion protein. RP2-BIRA and 
BIRA only control constructs were transfected into cells. Upon addition of 
biotin to the cell culture media BIRA biotinylated interacting and proximal 
proteins. 
(B) BIO-ID method workflow. RP2 null RPE1 cells were infected with RP2-
BIRA retroviral constructs to generate stable cell lines. Cells were then 
incubated in media containing 50μM biotin to induce BIRA biotinylation. 
Proteins were then isolated by lysis and pulldown with streptavidin beads 
and identified by mass spectrometry.  
 
Figure adapted from Roux et.al 2012 
 
 
(C) Model of BIO-ID Method Using RP2-BIRA Fusion Protein. RP2-BIRA and 
BIRA only control constructs were transfected into cells. Upon addition of 
Biotin to the cell culture media BIRA biotinylated interacting and proximal 
proteins. 
(D) BIO-ID Method Workflow. RP2 null RPE1 cells were infected with RP2-
BIRA retroviral constructs to generate stable cell lines. Cells were then 
incubated in media containing 50μM biotin to induce BIRA biotinylation. 
Proteins were then isolated by lysis and pulldown with streptavidin beads 
and identified by mass spectrometry.  
























Figure 5.  1 Application of BIO-ID Method to the study of RP2 in vitro 
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5.2 Identification and Conformation of Interaction between ZDHHC5 and RP2 
 
5.2.1 Generation and Validation of RP2-BIRA and BIRA RPE1 RP2 Null Cell Lines 
 
A BIO-ID assay was initially designed to identify interactors of RP2 WT as well as 
interactors of RP2 proteins carrying the human pathogenic mutations RP2 E135G, 
RP2 R211L, RP2 C3S and RP2 G2A in the hopes of identifying novel interactors 
which are relevant to disease pathogenesis. To generate RP2 BIRA cell lines for the 
BIO-ID assay RP2-BIRA retroviral constructs were firstly prepared. The initial step 
involved the generation of a retroviral construct carrying the BIRA (R118G) mutation. 
PCR amplification was used to generate a PCR product which contained BIRA 
(R118G) with a Myc tag, to enable easy detection of expression via western blot and 
immunofluorescence, and BamH1 and EcoR1 restriction sites. This product was 
ligated into the PQCXIN plasmid via the BamH1 and EcoR1 restriction sites. PQCXIN 
is a retroviral construct that carries a neomycin selection marker (G418), allowing 
infected cells to be cultured in G418 containing media to select for cells expressing 
the construct. RP2 pEntry plasmids containing RP2 WT and RP2 point mutations, 
RP2 E135G, RP2 R211L, RP2 C3S, RP2 G2A were used as templates and a PCR 
strategy was used to produce products containing each RP2 sequence and Not1 and 
Pac1 restriction sites. As the PQCXIN- BIRA (R118G)- Myc plasmid also contained 
Not1 and Pac1 restriction sites, digestion then ligation of sticky ended products 
produced PQCXIN- BIRA (RG118)-Myc constructs containing RP2 WT, RP2 E135G, 
RP2 R211L, RP2 C3S and RP2 G2A sequences. These constructs were transfected 
into HEK293- ET cells to generate virus which was used to infect RP2 null RPE cells 
which produced the RP2 BIRA cell lines used in this assay.  
As it is not possible to culture photoreceptor cells in vitro RPE cells were used. The 
RPE is the single layer of cells which function to convert retinyl esters to 11-cis retinal 
and to engulf the OS of photoreceptors during daily photoreceptor disc renewal 
(Moiseyev et.al 2005; Redmond. et al., 1998). Some inherited retinal degenerations 
are caused by mutations in genes exclusively expressed in the RPE such as RPE65 
mutations which cause Leber Congenital Amaurosis (LCA). As RP2 is expressed in 
the RPE it is possible that in XLRP attributed to RP2 mutation some component of 
pathogenesis may be related to dysfunction of RP2 in the RPE, therefore interactors 
identified in these cells may be relevant to disease pathogenesis. RP2 null RPE cells 
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were used in order to avoid any contamination from endogenous RP2. RP2 null RPE 
cells were made as described ((Lyraki et al. 2018). 
To confirm that RP2 WT-BIRA, RP2 E135G-BIRA, RP2 R211L-BIRA, RP2 G2A-
BIRA, RP2 C3S-BIRA and BIRA RP2 Null Cell lines could be used to identify potential 
interactors of RP2 via BIO-ID, I first assessed whether RP2-BIRA fusion constructs 
and BIRA were expressed and whether they were capable of biotinylating proteins 
(Figure 5.2 A, B). RP2 WT-BIRA, RP2 E135G-BIRA, RP2 R211L- BIRA, RP2 G2A –
BIRA, RP2 C3S-BIRA and BIRA only RP2 null RPE1 cells were grown to confluence 
then treated with or without 50μM biotin for 24 hours. These cells were then lysed and 
immunoblotted for Myc tag to confirm expression of the BIRA constructs (Figure 5.2 
A). Streptavidin HRP was used to visualise the presence of biotinylated proteins 
(Figure 5.2 A). These blots demonstrated that the RP2-BIRA fusion proteins and BIRA 
were expressed and the proteins were of the expected size (Figure 5.2 A). 
Streptavidin-HRP blotting demonstrated that the RP2-BIRAs and BIRA biotinylated 
proteins in the presence of 50μM biotin and not when biotin was absent from the 
media (Figure 5.2 A). Stronger streptavidin HRP signal was present in the BIRA only 
cells compared to the RP2-BIRA fusion construct expressing cells, suggesting the 
RP2-BIRA fusions were only biotinylating a subset of proteins in the cell. 
Encouragingly, there was also a distinct streptavidin- HRP band at ~70kDa in all the 
RP2-BIRA lysates; this is the same molecular weight as the RP2-BIRA fusions 
suggesting that the RP2-BIRAs were biotinylating themselves, which was expected 
as BIRA can only biotinylate proteins within a 10nm radius (Figure 5.2 A).  
In order to confirm that the RP2-BIRA fusion was localised to the same regions in the 
cell as endogenous RP2, RP2 WT-BIRA, RP2 E135G- BIRA, RP2 R211L-BIRA, RP2 
G2A-BIRA, RP2 C3S-BIRA and BIRA only RPE1 cells were treated with or without 
50µM biotin (as above), fixed and stained with anti-Myc, to visualise the localisation 
of BIRA fusions, and streptavidin -Alexa 594 to visualise the localisation of biotinylated 
proteins (Figure 5.2 B). Immunofluorescence for the Myc tag demonstrated that RP2 
WT-BIRA, RP2 E135G-BIRA and RP2 R211L-BIRA were localised at the plasma 
membrane, as is RP2 WT (Chapple et al. 2000). RP2 C3S-BIRA and RP2-G2A BIRA 
were localised to the ER and internal membranes and nucleus in line with the 
previously described localisation of these mutants (Chapple et al. 2000). Localisation 
of constructs was unchanged upon addition of biotin and BIRA was diffusely localised 
throughout the cell in the presence and absence of 50µM biotin. The streptavidin-HRP 
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conjugate again confirms the presence of biotinylated proteins only upon the addition 
of biotin to the cell culture media. The co-localisation between the Myc tag and 
streptavidin-594 confirmed that biotinylated proteins were present where the RP2-























Figure 5.  2 Validation of RP2 WT- BIRA, RP2 E135G-BIRA, RP2 R211L- BIRA, 





































(A) RP2 WT- BIRA, RP2 E135G-BIRA, RP2 R211L- BIRA, RP2 G2A-
BIRA, RP2 C3S –BIRA and BIRA only RP2 null RPE cells were grown 
to confluence and treated with (+) or without (-) 50μM biotin for 24 hours 
prior to lysis. Cell lysates were analysed for the presence of biotinylated 
proteins by immunoblotting with streptavidin-HRP. Biotinylated 
proteins were detected in the biotin treated lysates and minimally in the 
untreated lysates. The presence of some bands in the RP2 G2A and 
RP2 C3S (–) biotin samples represents background levels of activity in 
BIRA*. Lysates were immunoblotted with anti-Myc antibody to analyse 
expression of RP2-BIRA and BIRA only. All the RP2-BIRA lysates had 
a band correlating to the molecular weight of RP2-BIRA fusion ~70kDa 
and the BIRA only lysates had a band ~30kDa correlating with the 
molecular weight of BIRA.  
(B) Representative images of RP2 WT- BIRA, RP2 E135G-BIRA, RP2 
R211L-BIRA, RP2 G2A-BIRA, RP2 C3S–BIRA and BIRA 
immunofluorescence analysis for the presence of biotinylated proteins 
and expression of RP2-BIRA or BIRA. Cells were cultured to 
confluence and treated with (+) or without (-) 50μM biotin 24 hours prior 
to fixation. The presence of biotinylated proteins was visualised using 
streptavidin- 594 conjugate. In the absence of biotin no streptavidin-
594 staining was observed in any cell line. Cells treated with biotin had 
streptavidin -594 staining showing the presence of biotinylated 
proteins. Anti-Myc was used to visualise localisation of RP2-BIRA 
fusion construct and BIRA. RP2 WT-BIRA, RP2 E135G-BIRA and RP2 
R211L- BIRA localised to the plasma membrane with some signal in 
the cytoplasm. RP2 G2A –BIRA localised to the nucleus. RP2 C3S-
BIRA localised within the cytoplasm. BIRA had a diffuse localisation 
throughout the cell. Merge images show that green and red channels 
overlap demonstrating that biotinylated proteins are present in regions 
of the cell where RP2-BIRA fusions and BIRA are expressed. 
168 
 
5.2.2 BIO-ID Assay and Conformation of ZDHHC5-RP2 Interaction 
 
After generation of RP2 WT-BIRA, RP2 E135G-BIRA, RP2 R211L-BIRA, RP2 G2A-
BIRA and RP2 C3S-BIRA RP2 null RPE cell lines, to ease identification of novel 
potential interactors, that interact specifically with RP2 and not with BIRA, the BIO-ID 
assay was performed in only RP2 WT–BIRA (from here on RP2-BIRA), BIRA and 
RP2 null RPE cells (Figure 5.3). Conformation of expression and function of RP2-
BIRA fusion construct and BIRA only was confirmed by western blot for streptavidin-
HRP and the Myc Tag (as before) (Figure 5.3 B). Expression and function of RP2-
BIRA and BIRA was confirmed by immunofluorescence analysis of streptavidin- Alexa 
594 and the Myc Tag (as before) (Figure 5.3 C).   
The BIO-ID assay was performed in triplicate and involved treating confluent RP2-
BIRA, BIRA and RP2 null RPE cells with 50μM biotin 24 hours prior to lysis. Cells 
were lysed in RIPA buffer to solubilise all proteins in the cell. Lysates were then 
incubated with streptavidin beads for 1 hour to isolate biotinylated proteins. 
Biotinylated proteins were identified by mass spectrometry. To establish potential 
candidate RP2 interactors over proteins non-specifically biotinylated by BIRA*, 
proteins were sorted such that any hit that was ≥ 5-fold enriched in the RP2-BIRA 
lysates compared to the BIRA only lysate and absent in the parental control cell line 
was considered. This provided a list of ~60 proteins the top 15 of which are listed in 
Table 5.1. As expected RP2 was the top hit with known interactor ARL3 also detected 
as one of the top hits. ZDHHC5 was detected only in the RP2-BIRA lysates and not 
in the BIRA or the RP2 null RPE1 parental cell line control (Table 5.1). ZDHHC5 is a 
PAT which is localised to the plasma membrane in cells (Korycka et al. 2012). RP2 is 
known to be palmitoylated and this is thought to be essential for its function and as 
the mechanisms which regulate RP2 palmitoylation are yet to be identified I decided 
to investigate this hit further. 
In order to confirm RP2-ZDHHC5 interaction in cells RP2-BIRA and BIRA only cells 
were treated with 50μM biotin to facilitate biotinylation of proteins. Streptavidin beads 
were used to isolate biotinylated proteins and lysates were immunoblotted for 
ZDHHC5 (Figure 5.3 D). ZDHHC5 was detected only in the RP2-BIRA lysate and not 
in the BIRA only lysate confirming ZDHHC5 was interacting specifically with RP2 and 
not the BIRA. The localisation of RP2 and ZDHHC5 was analysed in HeLa cells 
transfected with V5 tagged RP2 and HA tagged ZDHHC5. Immunofluorescence of 
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the V5 and HA tags demonstrated that ZDHHC5 and RP2 are localised to the plasma 
membrane in HeLa cells, strong co-localisation of the V5 and HA signals was detected 
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Figure 5.  3 Conformation of RP2-ZDHHC5 Interaction 
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(A) Schematic of RP2-BIRA and BIRA constructs. Stable cell lines were 
generated using retroviral transfection of these constructs into RP2 Null 
RPE1 cells.  
(B) Validation of RP2-BIRA and BIRA Cell Lines. RP2-BIRA, BIRA and 
parental RP2 Null RPE1 cells were treated with 5μm biotin (+) or without (-
) for 24 hours. After lysis and electrophoresis, membranes were blotted 
with Streptavidin HRP to visualise the presence of biotinylated proteins. 
Biotinylated proteins were detected in the RP2-BIRA and BIRA (+) lanes 
and not the RP2-BIRA, BIRA (-) lanes or in the parental RPE1 RP2 Null 
cell line. Lysates were also immunoblotted for the presence of Myc tag.  
(C) Immunofluorescence images of RP2-BIRA and BIRA cell lines. Cells were 
cultured in + or – biotin conditions for 24hrs prior to fixation. Myc Tag 
immunofluorescence (green channel) shows the localisation of the RP2-
BIRA and BIRA constructs in cells. Streptavidin- 594 conjugate was used 
to visualise the presence of biotinylated proteins. Cells cultured with biotin 
have intense streptavidin 594 staining demonstrating the presence of 
biotinylated proteins. Co-localisation of red and green channels was 
observed indicating biotinylation of proteins is specific to regions where the 
BIRA constructs are localised.  
(D) Streptavidin pulldown of RP2-BIRA RPE1 cells. RP2-BIRA and BIRA 
RPE1 cells were treated with Biotin for 5hrs to allow biotinylation of 
proteins. Lysates were incubated with streptavidin beads for 1 hour and 
immunoblotted for ZDHHC5. ZDHHC5 was biotinylated in the RP2-BIRA 
sample not the BIRA sample, demonstrating ZDHHC5 was specifically 
interacting with RP2-BIRA not BIRA alone.  
(E) RP2-V5 and ZDHHC5-HA colocalisation in HeLa cells. Representative 
immunofluorescence images of V5 and HA staining show RP2-V5 and 
ZDHHC5-HA colocalised at the plasma membrane of HeLa cells.  
 
 
(F) Schematic of RP2-BIRA and BIRA constructs. Stable cell lines were 
generated using retroviral transfection of these constructs into RP2 Null 
RPE1 cells.  
(G) Validation of RP2-BIRA and BIRA Cell Lines. RP2-BIRA, BIRA and 
parental RP2 Null RPE1 cells were treated with 5μm Biotin (+) or without 
(-) for 24 hours. After lysis and electrophoresis, membranes were blotted 
with Streptavidin HRP to visualise the presence of biotinylated proteins. 
Biotinylated proteins were detected in the RP2-BIRA and BIRA (+) lanes 
and not the RP2-BIRA, BIRA (-) lanes or in the parental RPE1 RP2 Null 
cell line. Lysates were also immunoblotted for the presence of Myc tag.  
(H) Immunofluorescence images of RP2-BIRA and BIRA cell lines. Cells were 
cultured in + or – biotin conditions for 24hrs prior to fixation. Myc Tag 
immunofluorescence (green channel) shows the localisation of the RP2-
BIRA and BIRA constructs in cells. Streptavidin- 594 conjugate was used 
to visualise the presence of biotinylated proteins. Cells cultured with biotin 
have intense streptavidin 594 staining demonstrating the presence of 
biotinylated proteins. Co-localisation of red and green channels was 
observed indicating biotinylation of proteins is specific to regions where the 
BIRA constructs are localised.  
(I) Streptavidin Pulldown of RP2-BIRA RPE1 cells. RP2-BIRA and BIRA 
RPE1 cells were treated with Biotin for 5hrs to allow biotinylation of 



























Top hits were calculated as any protein more that 5-fold enriched over the BIRA 
sample and not present in the RP2 null RPE parental cell line control. RP2 was 
the top hit as expected. ZDHHC5 was absent in both the BIRA only and parental 
cell line controls demonstrating it was specifically interacting with RP2 not BIRA. 
173 
 
5.3 ZDHHC5 is not required for RP2 Palmitoylation  
 
As RP2 is palmitoylated and ZDHHC5 is a palmitoyltransferase, I decided to 
investigate whether ZDHHC5 is required for RP2 palmitoylation. To analyse the 
palmitoylation of RP2, the incorporation of 17-ODYA (a palmitate analogue) was 
analysed. HeLa cells were transiently transfected with RP2-V5. Twenty-four hours 
post transfection cells were incubated in fresh media supplemented with 1% fatty acid 
free BSA containing 100mM 17-ODYA. 17-ODYA was diluted in serum free media 
supplemented with 1% fatty acid free BSA so that no other fatty acids present in the 
media could be incorporated by proteins and therefore reduce the signal from 17-
ODYA incorporation. Cells were cultured with 17-ODYA for 24 hours allowing any 
proteins that were palmitoylated in this time to incorporate 17-ODYA. Cells were then 
lysed and a V5 IP performed to isolate RP2-V5. 17-ODYA incorporation was assayed 
via a click chemistry reaction in which 17-ODYA was labelled with an Infrared azide 
dye that fluoresces in the 800nm channel. To visualise 17-ODYA incorporation these 
IP reactions were analysed by immunoblotting and imaged using the LICOR system. 
To image immunoblots on the LICOR florescent imaging system, Alexa dye 
conjugated secondary antibodies were used. For this assay, RP2-V5 was detected 
using an anti V5 primary antibody and an anti-mouse Alexa 680 secondary antibody 
allowing RP2-V5 to be visualised in the 700nm channel. 17-ODYA incorporation was 
quantified as a ratio of 800nm (green) signal/ 700nm (red) signal to normalise to the 
amount of RP2-V5 isolated by V5-IP. Each experiment was repeated 3 times and an 
average 800nm/700nm ratio was calculated for each condition.  
In order to analyse whether co-expression of ZDHHC5 and RP2 increases RP2’s 17-
ODYA incorporation, HeLa cells were transfected with RP2-V5, ZDHHC5-HA or co-
transfected with both RP2-V5 and ZDHHC5-HA and then incubated with media 
supplemented with 100mM 17-ODYA. When RP2- V5 and ZDHHC5- HA were co-
transfected in HeLa cells no significant difference in RP2 palmitoylation was observed 
compared to cells where only RP2 was transfected (Figure 5.4 A, B). As HeLa cells 
express endogenous ZDHHC5 it is possible that this endogenous expression was 
enough to palmitoylate RP2 therefore to observe if reduction of ZDHHC5 perturbed 
RP2 palmitoylation HeLa cells were treated with siRNAs for ZDHHC5 to knockdown 
endogenous ZDHHC5 expression (Figure 5.4 C). Upon knockdown of ZDHHC5, no 
significant reduction in 17-ODYA incorporation by RP2 was observed compared to 
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control siRNA treated cells (Figure 5.4 C, D). These results together suggest that 







































(A) HeLa Cells transiently transfected with RP2-V5 and ZDHHC5-HA were 
incubated with 17- ODYA overnight. Cells were lysed and a V5 COIP used 
to immunoprecipitate RP2 V5. A Click Chemistry reaction was used to label 
ODYA with an Azide dye, which fluoresces in the 800W channel to allow 
visualisation of RP2 palmitoylation. After electrophoresis, membranes were 
immunoblotted for V5 and imaged using the LICOR system. Red channel 
shows RP2-V5 expression, Green channel shows 17- ODYA incorporation. 
Input samples were immunoblotted for HA and Actin. 
(B) Quantification of 17- ODYA signal in RP2 and RP2 +ZDHHC5 IP lanes. 
The RP2 V5 IP lane and the RP2 +ZDHHC5 COIP lane show no significant 
differences in 17- ODYA incorporation suggesting ZDHHC5 is not directly 
responsible for palmitoylation of RP2. 17- ODYA signal was normalised to 
V5 signal, statistical significance analysed by students T.Test n=3.   
(C) HeLa cells were transfected with ZDHHC5 siRNA and CTRL siRNA to 
knockdown endogenous ZDHHC5. RP2-V5 was transiently transfected into 
these cells and analysis of palmitoylation carried out as in (A).  
(D) Quantification of 17- ODYA signal in ZDHHC5 siRNA and CTRL siRNA IP 
lanes. No significant difference in RP2 17- ODYA incorporation was 
detected in the ZDHHC5 siRNA treated lane suggesting ZDHHC5 is not 




(E) HeLa Cells transiently transfected with RP2-V5 and ZDHHC5-HA were 
incubated with 17- ODYA overnight. Cells were lysed and a V5 COIP used 
to immunopercipitate RP2 V5. A Click Chemistry reaction was used to label 
ODYA with an Azide dye, which fluoresces in the 800W channel to allow 
visualisation of RP2 palmitoylation. After electrophoresis, membranes were 
immunoblotted for V5 and imaged using the LICOR system.  Red channel 
shows RP2-V5 expression, Green channel shows 17- ODYA incorporation. 
Input samples were immunoblotted for HA and Actin. 
(F) Quantification of 17- ODYA signal in RP2 and RP2 +ZDHHC5 IP lanes. 
RP2 V5 IP lane and RP2 +ZDHHC5 COIP lane show no significant 
differences in 17- ODYA incorporation suggesting ZDHHC5 is not directly 
responsible for palmitoylation of RP2. 17- ODYA signal was normalised to 
V5 signal, statistical significance analysed by students T.Test n=3.   
(G) HeLa cells were transfected with ZDHHC5 siRNA and CTRL siRNA to 
knockdown endogenous ZDHHC5. RP2-V5 was transiently transfected into 
these cells and analysis of palmitoylation carried out as in (A).  
(H) Quantification of 17- ODYA signal in ZDHHC5 siRNA and CTRL siRNA IP 
lanes. No significant difference in RP2 17- ODYA incorporation was 
detected in the ZDHHC5 siRNA treated lane suggesting ZDHHC5 is not 





5.4 ZDHHC5 is required for RP2 Plasma Membrane Localisation 
 
5.4.1 RP2 C3S and RP2 G2A Localisation with ZDHHC5 Overexpression 
 
As ZDHHC5 was not required for RP2 palmitoylation but did interact and co-localise 
with RP2, ZDHHC5 and non-palmitoylated RP2 mutants, RP2 C3S and RP2 G2A, 
were transfected into Hela cells to establish whether they co-localised. To assess co-
localisation, HeLa cells were transfected with WT RP2-V5, C3S RP2-V5, G2A RP2-
V5 alone or in conjunction with ZDHHC5-HA. Cells transfected with WT RP2-V5 or 
ZDHHC5-HA only again confirmed WT RP2-V5 and ZDHHC5-HA were localised to 
the plasma membrane in HeLa cells (Figure 5.5 A, B). C3S RP2-V5 and G2A RP2- 
V5 localised to the cytoplasm on intracellular membranes and nucleus respectively 
(as previously described (Chapple et al. 2000)), when transfected alone. However, 
co-transfection with ZDHHC5-HA revealed RP2 C3S was present at the plasma 
membrane, resembling RP2 WT (Figure 5.5 A,C,D). Co-transfection of G2A RP2-V5 
and ZDHHC5-HA revealed a significant reduction in cells with RP2 G2A –V5 nuclear 
localisation compared to G2A RP2-V5 only transfected cells, with G2A RP2-V5 
localisation detected at the plasma membrane and cytoplasm (Figure 5.5 E, F, and 
G). To quantify the change in localisation observed in between G2A RP2-V5 only 
transfected cells and cells transfected with G2A RP2-V5 and ZDHHC5-HA the 
number of cells with purely nuclear V5 staining was counted for each condition. One 
hundred cells were counted in each of 3 technical replicates, and an average 
percentage of cells with V5 nuclear staining when G2A RP2-V5 was transfected alone 
or with ZDHHC5 was calculated (Figure 5.5 G) and a significant reduction was 
detected. This demonstrated that ZDHHC5 overexpression rescued the mistrafficking 




(A) WT RP2-V5 is localised to the plasma membrane of HeLa cells.  
(B) ZDHHC5-HA is localised to the plasma membrane of HeLa Cells.  
(C) C3S RP2-V5 is localised in the cytoplasm of HeLa cells.  
(D) Co-expression of C3S RP2-V5 (green) and ZDHHC5-HA (Red) rescues the 
localisation of C3S RP2-V5 back to the plasma membrane.  
(E) G2A RP2- V5 is localised within the nucleus of HeLa cells.  
(F) Co-expression of G2A RP2-V5 (green) and ZDHHC5-HA (red) leads to loss 
of nuclear localisation of RP2 G2A and an enrichment at the plasma 
membrane.  
(G) Quantification of nuclear localisation in G2A RP2- V5 and ZDHHC5-HA co-
transfected cells. Cells co-expressing G2A RP2- V5 and ZDHHC5-HA have 
significantly less cells with V5 nuclear immunostaining than G2A RP2-V5 
only cells. Statistical analysis by students 100 cells counted for each 
condition over 3 repeats T.Test *P ≤0.05, **P ≤0.01, ***P ≤ 0.001. 
 
 
(H) WT RP2-V5 is localised to the plasma membrane of HeLa cells.  
(I) ZDHHC5-HA is localised to the plasma membrane of HeLa Cells.  
(J) C3S RP2-V5 is localised in the cytoplasm of HeLa cells.  
(K) Co-expression of C3S RP2- V5 (green) and ZDHHC5-HA (Red) rescues 
































5.4.2 Rescue of Mistrafficking does not Requires ZDHHC5 Catalytic Activity 
 
In order to assess whether the ability of ZDHHC5 to rescue mistrafficking of RP2 C3S 
and RP2 G2A required ZDHHC5 catalytic activity, I transfected HeLa cells with C3S 
RP2-V5, G2A RP2-V5 only or with catalytically dead ZDHHC5 (ZDHHS5-HA) and the 
localisation of C3S RP2- V5 and G2A RP2- V5 was analysed. The DHHC domain is 
required for the catalytic activity of ZDHHC’s as it is thought to be directly involved in 
the palmitoyl transfer reaction. Therefore mutation of the catalytic cysteine residue to 
a serine generates a catalytically dead ZDHHC (Mitchell et al. 2006). Transfection of 
ZDHHS5-HA only revealed ZDHHS5-HA was also localised to the plasma membrane 
in HeLa cells similar to the wild type (Figure 5.6 A). Co-transfection of C3S RP2-V5 
and ZDHHS5-HA displayed C3S RP2-V5 localised to the plasma membrane, 
demonstrating ZDHHC5 catalytic activity is not required for rescue of mistrafficking 
(Figure 5.5 C). Similarly, co-transfection of G2A RP2-V5 and ZDHHS5-HA revealed 
significantly less cells with G2A RP2-V5 nuclear staining compared to G2A RP2-V5 
only transfected cells, with G2A RP2-V5 localised to the plasma membrane and 
cytoplasm (Figure 5.6 D, E,F). To quantify rescue of mistrafficking the percentage of 
cells containing V5 nuclear only staining was counted when G2A RP2-V5 was 
transfected alone and when G2A RP2-V5 and ZDHHC5 were co-transfected. This 
assay was repeated 3 times and 100 cells per replicate were counted after which an 
average percentage of cells with V5 nuclear staining in each case was calculated 




(A) ZDHHS5-HA is localised to the plasma membrane of HeLa Cells.  
(B) RP2-C3S- V5 is localised in the cytoplasm of HeLa cells.  
(C) Co-expression of C3S RP2-V5 (green) and ZDHHS5-HA (Red) rescues the 
localisation of RP2-C3S back to the plasma membrane.  
(D) G2A RP2- V5 is localised within the nucleus of HeLa cells.  
(E) Co-expression of G2A RP2-V5 (green) and ZDHHS5-HA (red) leads to loss 
of nuclear localisation of RP2 G2A and an enrichment at the plasma 
membrane.  
(F) Quantification of nuclear localisation in G2A RP2- V5 and ZDHHS5-HA co-
transfected cells. Cells co-expressing G2A RP2-V5 and ZDHHS5-HA have 
significantly less cells with V5 nuclear immunostaining than G2A RP2- V5 
only cells. Statistical analysis by students T.Test 100 cells counted for each 
condition per replicate *P ≤0.05, **P ≤0.01, ***P ≤ 0.001. 
 
 
(G) ZDHHS5-HA is localised to the plasma membrane of HeLa Cells.  
(H) RP2-C3S- V5 is localised in the cytoplasm of HeLa cells.  
(I) Co-expression of C3S RP2- V5 (green) and ZDHHS5-HA (Red) rescues 
the localisation of RP2-C3S back to the plasma membrane.  
(J) G2A RP2- V5 is localised within the nucleus of HeLa cells.  
(K) Co-expression of G2A RP2- V5 (green) and ZDHHS5-HA (red) leads to 
loss of nuclear localisation of RP2 G2A and an enrichment at the plasma 
membrane.  
(L) Quantification of nuclear localisation in G2A RP2- V5 and ZDHHS5-HA co-
transfected cells. Cells co-expressing G2A RP2-V5 and ZDHHS5-HA have 
significantly less cells with V5 nuclear immunostaining than G2A RP2- V5 












5.4.3 ZDHHC5 Knockdown Changes RP2 Localisation in Cells 
 
After establishing ZDHHC5 could rescue mistrafficking of RP2 C3S and RP2 G2A the 
effect of ZDHHC5 expression on RP2 WT localisation was examined. To ascertain if 
ZDHHC5 has a role in trafficking RP2 to the plasma membrane, I knocked down 
expression of endogenous ZDHHC5 in HeLa cells using siRNAs and the localisation 
of WT RP2-V5 was observed. HeLa cells were transfected with siRNAs targeting 
ZDHHC5 or control scrambled siRNAs and successful knockdown was confirmed by 
immunoblot for ZDHHC5 (Figure 5.7 B), 48 hours post knockdown cells were 
transiently transfected with WT RP2-V5. Immunofluorescence of V5 revealed that in 
cells treated with CTRL siRNA, WT RP2-V5 localised exclusively to the plasma 
membrane, however, in cells treated with ZDHHC5 siRNAs WT RP2-V5 had a more 
cytoplasmic localisation (Figure 5.7 A, C). Quantification of the percentage of cells 
that had exclusive WT RP2-V5 membrane localisation when transfected with CTRL 
siRNA vs ZDHHC5 siRNA confirmed knockdown of ZDHHC5 reduces WT RP2-V5 
membrane localisation (Figure 5.7 C). This suggests that ZDHHC5 could play a role 
in trafficking RP2 to the cell membrane. In the human retina RP2 has been reported 
to localise to the plasma membrane of rods and cones (Grayson et al. 2002) therefore 
as ZDHHC5 is also expressed in photoreceptors (Murphy et al., 2016) it is possible 












(A) Representative images of V5 immunostaining in ZDHHC5 siRNA treated 
and CTRL siRNA treated HeLa cells. Knockdown of ZDHHC5 leads to 
increased intracellular localisation of RP2-V5.  
(B) Immunoblot of ZDHHC5 siRNA and CTRL siRNA treated lysates for 
ZDHHC5 expression. ZDHHC5 expression is absent in the ZDHHC5 
siRNA treated lysates demonstrating efficient knockdown of endogenous 
ZDHHC5.  
(C) Quantification of RP2-V5 localisation in ZDHHC5 siRNA treated cells and 
CTRL siRNA treated cells. Cells treated with ZDHHC5 siRNA have 
significantly less cells with RP2-V5 membrane localisation. Statistical 
analysis by students T.Test 100 cells counted for each condition per 
replicate *P ≤0.05, **P ≤0.01, ***P ≤ 0.001. 
 
 
(D) Representative images of V5 immunostaining in ZDHHC5 siRNA treated 
and CTRL siRNA treated HeLa cells. Knockdown of ZDHHC5 leads to 
increased intracellular localisation of RP2-V5.  
(E) Immunoblot of ZDHHC5 siRNA and CTRL siRNA treated lysates for 
ZDHHC5 expression. ZDHHC5 expression is absent in the ZDHHC5 
siRNA treated lysates demonstrating efficient knockdown of endogenous 
ZDHHC5.  
(F) Quantification of RP2-V5 localisation in ZDHHC5 siRNA treated cells and 
CTRL siRNA treated cells. Cells treated with ZDHHC5 siRNA have 
significantly less cells with RP2-V5 membrane localisation. Statistical 
analysis by students T.Test 100 cells counted for each condition over 3 
repeats *P ≤0.05, **P ≤0.01, ***P ≤ 0.001. 
 




























5.5 ZDHHC5 Knockdown Reduces Ciliogenesis in RPE1 Cells 
 
Given that ZDHHC5 had a role in regulating RP2 localisation I investigated whether 
knockdown of ZDHHC5 influenced other palmitoylated proteins. It has been 
calculated that a large proportion of cilia proteins are palmitoylated. Roy et.al used 
Swisspalm, a database of palmitoylated proteins, and found that 35% of high 
confidence (Tier 1) cilia proteins are palmitoylated and 32% of Tier 2 cilia proteins 
were also found to be palmitoylated (Roy et al. 2017). Therefore, to establish if 
ZDHHC5 has a role related to cilia proteins, ZDHHC5 was knocked down using 
siRNAs in RPE cells and the effect on ciliogenesis was analysed. WT RPE1 cells 
were used for these assays as they undergo efficient ciliogenesis when serum 
starved. These cells were transfected with either ZDHHC5 siRNAs to knockdown 
endogenous ZDHHC5 or CTRL scrambled siRNAs. 48 hours post transfection cells 
were either lysed and analysed for ZDHHC5 expression by western blot to confirm 
knockdown (Figure 5.8 B) or incubated in serum free media to induce ciliogenesis. 
After growth in serum free media for 24 hours, cells were fixed and stained for the 
cilia markers acetylated tubulin and ARL13b. Cells transfected with ZDHHC5 siRNA 
produced significantly less cilia than cells treated with CTRL siRNA (Figure 5.8, C). 
The length of the cilia that was produced in ZDHHC5 knockdown cells was measured 
and was found to be equivalent in length to those produced by CTRL siRNA treated 




(A) Representative images of acetylated tubulin and ARL13b immunostaining 
in CTRL and ZDHHC5 siRNA treated RPE1 cells. Knockdown of ZDHHC5 
does not prevent ciliogenesis. 
(B) Immunoblot of ZDHHC5 siRNA and CTRL siRNA treated lysates. ZDHHC5 
is absent in the ZDHHC5 siRNA treated sample demonstrating efficient 
knockdown of endogenous ZDHHC5.  
(C) Quantification of percentage of cells with cilia in ZDHHC5 siRNA and CTRL 
siRNA treated cells. ZDHHC5 knockdown resulted in significantly reduced 
cilia compared to CTRL. 100 cells counted for each condition per replicate, 
statistical analysis by students T.Test *P ≤0.05, **P ≤0.01, ***P ≤ 0.001. 
(D) Quantification of cilia length in ZDHHC5 siRNA and CTRL siRNA treated 
cells. Knockdown of ZDHHC5 does not result in a change in cilia length in 
RPE1 cells. 100 cilia measured for each condition over 3 repeats, 
statistical analysis by students T.Test *P ≤0.05, **P ≤0.01, ***P ≤ 0.001.  
 
 
(E) Representative images of Acetylated Tubulin and ARL13b immunostaining 
in CTRL and ZDHHC5 siRNA treated RPE1 cells. Knockdown of ZDHHC5 
does not prevent ciliogenesis. 
(F) Immunoblot of ZDHHC5 siRNA and CTRL siRNA treated lysates. ZDHHC5 
is absent in the ZDHHC5 siRNA treated sample demonstrating efficient 
knockdown of endogenous ZDHHC5.  
(G) Quantification of percentage of cells with Cilia in ZDHHC5 siRNA and 
CTRL siRNA treated cells. ZDHHC5 knockdown resulted in significantly 
reduced cilia compared to CTRL. 100 cells counted for each condition over 
3 repeats, statistical analysis by students T.Test *P ≤0.05, **P ≤0.01, ***P 




5.5.1 ZDHHC5 does not Localise to Cilla 
 
As knockdown of ZDHHC5 reduced ciliogenesis in RPE1 cells I tested if ZDHHC5 
itself was localised to cilia. RPE1 cells were transiently transfected with ZDHHC5-HA 
and then serum starved for 24 hours to induce ciliogenesis. After fixation cells were 
stained with ARL13b to mark cilia and ZDHHC5 localisation was detected by anti-HA 
antibody staining. ZDHHC5 was localised more intracellularly in RPE1 cells compared 
to HeLa cells (Figure 5.9, Figure 5.3 E). HA immunostaining did not co-localise with 




















Representative immunofluorescence images of ZDHHC5-HA and ARL13b 
staining in RPE1 cells. Cells were serum starved to induce ciliogenesis and 
immunostained with anti ARL13b, to mark cilia, and anti HA. No colocalisation 
between ARL13b and HA was observed.  
 
 
Representative immunofluorescence images of ZDHHC5-HA and ARL13b 
staining in RPE1 cells. Cells were serum starved to induce ciliogenesis and 
immunostained with anti ARL13b, to mark cilia, and anti HA. No colocalisation 
between ARL13b and HA was observed.  
 















5.6 ARL3 is Palmitoylated in HeLa Cells 
 
The regulators of ARL3, ARL13B and RP2 are palmitoylated and membrane 
associated (Chapple et al. 2000; Roy et al. 2017). ARL3 has been reported to be 
localised to Golgi membranes therefore the palmitoylation status of ARL3 was 
assessed (Zhou et al. 2006; Roy et al. 2017; Chapple et al. 2000). To ascertain 
whether ARL3 was palmitoylated HeLa cells were transiently transfected with WT 
ARL3-GFP. Twenty-four hours post transfection cells were incubated in media 
containing 100mM 17-ODYA (as before). Cells were then lysed and lysates were 
incubated with anti-GFP beads to isolate ARL3-GFP. After immunoprecipitation these 
IP’s were subject to click chemistry labelling of 17-ODYA with an Infrared Azide dye 
(as before). After electrophoresis and transfer membranes were probed with a rabbit 
anti-ARL3 antibody and a rabbit –Alexa 680 secondary antibody. 17-ODYA 
incorporation and ARL3 expression were visualised on the LICOR imaging system 
(as before). 17-ODYA incorporation was quantified as before as a ratio of 800nm 
signal/700nm signal (Figure 5.10). WT ARL3-GFP incorporated 17-ODYA 
demonstrating ARL3 can be palmitoylated in vitro.  
After establishing ARL3 was palmitoylated the residues on ARL3 which were required 
for palmitoylation were investigated. ARL3 only contains 3 cysteine residues, the 
residue that is palmitoylated, so these were individually mutated to serine residues 
(constructs designed and generated by Isobel Robb, an honours student in the lab) 
and tagged with GFP. These constructs were transiently transfected into HeLa cells 
and 24 hours after transfection, these cells were incubated with media containing 
100mM 17-ODYA and lysates were subject to GFP IP followed by click chemistry (as 
above). ARL3 immunoblotting revealed each ARL3 cysteine mutant was stably 
expressed and successfully immunoprecipitated (Figure 5.10 A). Analysis of 17-
ODYA incorporation demonstrated that C158, C118 and C174 may be palmitoylated 
in vitro as mutation of each of these residues reduced the 17-ODYA incorporation by 
ARL3 (Figure 5.10 B). Each ARL3 C>S mutation construct incorporated some 17-
ODYA demonstrating one single residue may not responsible for ARL3 palmitoylation 
and that ARL3 could be palmitoylated on several residues. The average 
800nm/700nm signal from 3 assays is shown in Figure 5.10 B, even though this assay 
was repeated several times the levels of 17-ODYA incorporation in the ARL3 WT lane 
was variable suggesting that ARL3 may be dynamically palmitoylated.  
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As expression of each mutant ARL3-GFP construct consistently appeared to be less 
that WT ARL3-GFP and consequently GFP IP of WT ARL3- GFP was more efficient 
than C158S ARL3- GFP, C118S ARL3 GFP and C174S ARL3 GFP (Figure 5.10 A) 
the effect each of these mutations had on the structure of ARL3 was assessed. The 
effect of each mutation on the structure of ARL3 was modelled by Joe Marsh and all 
the mutations were predicted to be non-destabilising (Table 5.2) suggesting that the 
differences in palmitoylation might regulate ARL3 stability rather than the cysteine to 
serine mutation itself (Table 5.2). For example in yeast palmitoylation of Tlg1, a 
member of the yeast SNARE complex, prevents degradation by the proteasome 



















(A) HeLa cells transiently transfected with ARL3 WT-GFP, ARL3 C158S-GFP, 
ARL3 C118S-GFP or ARL3 C174S-GFP were incubated with 17-ODYA 
overnight. Cells were lysed and GFP COIP used to immunoprecipitate 
ARL3-GFP. A click chemistry reaction was used to label 17-ODYA with an 
Azide dye that fluoresces in the 800W channel to allow visualisation of 
ARL3 palmitoylation. After electrophoresis, membranes were 
immunoblotted for ARL3 and imaged using the LICOR system. Red 
channel shows ARL3 WT, C158S, C118S and C174S expression, Green 
channel shows 17-ODYA incorporation. Input samples were 
immunoblotted for Actin. 
(B) Quantification of 17- ODYA incorporation in ARL3 WT, C158S, C118S and 
C174S- GFP IP lanes. Average ODYA signal was normalised to levels of 
immunoprecipitated ARL3 in each lane. These values were then compared 
to ARL3 WT-GFP values. Mutation of C158, C118 and C174 leads to 
reduction of ARL3 ODYA incorporation. Statistical significance analysed by 
students T-Test n=3.  
 
 
(C) HeLa cells transiently transfected with ARL3 WT-GFP, ARL3 C158S-GFP, 
ARL3 C118S-GFP or ARL3 C174S-GFP were incubated with 17-ODYA 
overnight. Cells were lysed and GFP COIP used to immunopercipitate 































The effect of C158S, C118S and C174S mutation on the structure of 
ARL3 was predicted. All mutations had a ΔG score of >1 kcal/mol 







Table 5.  2 ARL3 Cysteine Mutation Stability Prediction 
ARL3 Mutation ΔG (kcal/mol) 







5.7.1 Identification and Characterisation of RP2-ZDHHC5 Interaction 
The BIO-ID method was to identify new potential interactors of RP2. This assay 
proved an effective method at identifying RP2 interactors as known interactor ARL3 
was detected as a top hit, whereas previously in our lab we have struggled to detect 
this interaction using traditional IP-mass spectrometry approaches, likely due to its 
transient nature. ZDHHC5 was identified as a novel interactor of RP2 that had not 
been previously identified using traditional IP/mass spec. ZDHHC5 is a multi-pass 
transmembrane protein which may explain why this interaction has failed to be 
detected using other approaches. Transmembrane proteins are highly hydrophobic 
and therefore hard to extract from cells therefore strong detergent buffers such as 
RIPA must be used to solubilise proteins, however these buffers due to their high SDS 
content are not compatible with IP. The BIO-ID assay therefore facilitates the 
identification of these interactions as interacting proteins are labelled with biotin and 
isolated using streptavidin beads and as the streptavidin-biotin interaction is a very 
strong covalent interaction high SDS content lysis buffers can be used to extract 
highly hydrophobic proteins. Many transmembrane proteins rely on lipid groups within 
the membrane for their stability and these can be lost during extraction from cells 
leading to destabilisation of the protein however as the BIO-ID technique labels 
interacting proteins in their natural environment interactions are not lost during 
extraction as in traditional IP/Mass spec approaches.  
This assay facilitated the identification of other novel potential interactors of RP2 
which were not investigated further (Table 5.1). Many of these interactions may be 
relevant to further understanding the function of RP2 in the retina, for example 
phospholipase C β1 (PLCβ1) has been shown to effect the expression of splicing 
factors in cells (Bavelloni et al. 2006) and mutations in genes which encode for 
splicing factors such as pre-mRNA-processing-splicing factor 8, 3 and 31 (PRPF8, 
PRPF3, PRPF31) and pim-1-associated protein (PAP-1) have been identified in 
patients with dominantly inherited Retinitis Pigmentosa (Vithana et al. 2001; McKie et 
al. 2001; Maita et al. 2004). Splicing of pre-mRNAs is catalysed by a large 
ribonucleoprotein complex known as the spliceosome. The spliceosome contains 
many small nuclear ribonuclear proteins (snRNPs) and splicing factors. Splicing of 
most introns involves five snRNPs U1, U2, U3, U4 and U5. U1 and U2 firstly bind the 
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pre- mRNA which is followed by binding of the U4/U6+U5 trimer to form the 
spliceosome (Will and Lührmann 2001). PRP31 is thought to function to bring together 
U5 and U4/U6 to form the trimer (Teigelkamp et al. 1998). PRP3 is associated with 
U4/U6 and PRP8 is thought to be a core component of U5 (Chakarova et al. 2002; 
McKie et al. 2001). Analysis of the effect of two human pathogenic mutations on 
PRP31 function demonstrated that neither mutation abolished the splicing function of 
PRP31 as no defect in splicing efficiency was detected. Both mutations did reduce 
the proteins ability to shuttle to the nucleus (Deery et al. 2002). It is hypothesised that 
mutations of these genes cause an eye specific phenotype as photoreceptors shed 
and renew their OS discs daily therefore the demand for newly synthesised proteins 
is exceptionally high meaning small defects in splicing efficiency are amplified (Deery 
et al. 2002). If RP2 has a role in regulating splicing or in regulating the function of 
proteins that regulate splicing this could be relevant to disease pathogenesis. It has 
been previously demonstrated that RP2 can shuttle to the nucleus after DNA damage 
and may have a role in the DNA damage response (Yoon et al. 2006), therefore this 
pathway in combination with splicing defects could explain why photoreceptors die 
when RP2 is mutated and could reveal a new avenue for the development of 
treatments for patients.  
Fermitin Family Member 2 (FERMT2) (also known as Kindlin 2) has been shown to 
be essential for the formation of cell-cell contacts in epithelial cells and to regulate 
podocyte formation (He et.al 2011; Yasuda-Yamahara et al., 2018). As RP2 can 
interact with microtubules (Bartolini et al. 2002) this could imply that Kindlin 2 and RP2 
may have a role in regulating microtubule dynamics in photoreceptors. FERMT2 has 
also been identified as a susceptibility locus for late onset Alzheimer’s disease 
therefore it’s functions may be required for the survival of neuronal cells with aging 
(Chapuis et al. 2017).    
Transmembrane protein 237 (TMEM 237) is a ciliary transition zone protein found to 
be mutated in families with the embryonic lethal Joubert Syndrome related disorder, 
Meckel Syndrome (Huang et al., 2011). Meckel syndrome is a rare lethal ciliopathy 
manifesting in renal cystic dysplasia and central nervous system defects (Leightner 
and Harris 2013). TMEM 237 localises to the transition zone of cilia and is essential 
for ciliogenesis in mammalian cells (L. Huang et al. 2011). TMEM 237 requires RPGR 
interacting protein 1 like (RPGRIP1L) for localisation to the transition zone in 
C.elegans (Huang et al., 2011). RPGR interacting protein 1 (RPGRIP1) is also 
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required for localisation of retinitis pigmentosa GTPase regulator (RPGR) to the 
connecting cilia of photoreceptors (Zhao et al. 2003). Interaction between RP2 and 
TMEM 237 implies a role for RP2 at the ciliary transition zone, where proteins are 
sorted for entry into the cilia, and in photoreceptors where the CC acts as a transition 
zone for regulating entry of proteins to the OS (Elliott and Brugmann 2018). This 
suggests that in vivo this interaction may play a role in sorting proteins to the OS 
which may be relevant to disease pathogenesis in vivo. 
To confirm the interaction between ZDHHC5 and RP2 an IP approach using 
transiently transfected RP2-V5 was attempted. Immunoprecipitation of V5 was 
followed by immunoblotting for endogenous ZDHHC5 in HeLa cells and in RPE1 cells, 
however these approaches failed to detect the interaction. This is likely due to 
ZDHHC5 lipid modifications and membrane association making extraction of the 
protein during cell lysis difficult as well as the potential transient nature of the 
interaction. As ZDHHC5 is a multi-pass transmembrane protein extracting this protein 
from the cell whilst maintaining its structure is difficult due to the need to use high 
SDS content lysis buffers.  RP2 BIRA RP2 null RPE1 and BIRA RP2 null RPE1 biotin 
treated cells were used to confirm this interaction as the biotin label was maintained 
even when cells were lysed with RIPA buffer however, as BIRA biotinylates proteins 
that are within a 10nm radius this does not confirm a direct interaction between 
ZDHHC5 and RP2 and it is possible that the two proteins come into close proximity 
transiently in a non-stable complex. To confirm a direct interaction a Y2H assay could 
be designed however the yeast cell may not facilitate proper folding or localisation of 
ZDHHC5 and as the ZDHHC5-RP2 interaction may be transient it is possible that this 
interaction may not be stable enough to facilitate BD and AD interaction and thus 
activation of reporter gene expression. A pulldown assay using RP2 recombinant 
protein and glutathione beads to extract ZDHHC5 from WT RPE cell lysates could be 
attempted as an alternative approach to detect a direct interaction. However, for this 
approach to be successful the same issues associated with conventional IP 
approaches would have to be overcome. An alternative approach that could be used 
to overcome some of these issues is a crosslinking immunoprecipitation mass 
spectrometry assay. The crosslinking step should preserve the interaction so that a 
stronger lysis buffer could be used to extract ZDHHC5 from cells and 
immunoprecipitation with anti V5 beads could be used to demonstrate a direct 
interaction between RP2 and ZDHHC5. 
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5.7.2 ZDHHC5 is not required for RP2 Palmitoylation  
In order to assay RP2 palmitoylation a click chemistry based assay which measured 
17-ODYA incorporation was performed. Similar assays have been published in 
multiple studies where the palmitoylation status of proteins have been examined (J. 
Murphy and Kolandaivelu 2016; Howie et al. 2014; Yi Li et al. 2012). Another assay 
commonly used to analyse the palmitoylation status of proteins is the acyl-Rac assay. 
Acyl- Rac involves the detection of palmitoylated proteins using a thiol-reactive 
sepharose resin. After cell lysis free thiols (which contain free unpalmitoylated 
cysteine residues) are blocked with MMTS (S-methylmethanethiosulfonate). 
Thioesters are then cleaved with neutral hydroxylamine (NH2OH), and the newly 
liberated thiols are captured with thiol-reactive sepharose resin. After washing, 
captured proteins are eluted  and analysed by SDS-PAGE and western blotting 
(Forrester et al. 2011). These techniques are largely comparable however, one 
benefit of 17-ODYA incorporation is that it allows for pulse-chase experiments to 
investigate palmitoylation dynamics. If the enzyme responsible for RP2 palmitoylation 
was identified then this assay could be used to analyse the dynamics of RP2 
palmitoylation to establish whether RP2 is dynamically or stably palmitoylated.  
Co-expression of RP2-V5 and ZDHCC5-HA should increase levels of RP2 
palmitoylation if ZDHHC5 is responsible for palmitoylation of RP2, however this does 
not exclude the possibility that the level of endogenous ZDHHC5 in HeLa cells was 
sufficient to palmitoylate overexpressed RP2 WT-V5. To address this issue, 
knockdown experiments were carried out using ZDHHC5 siRNAs. If ZDHHC5 is solely 
responsible for palmitoylation of RP2, then a reduction in RP2 palmitoylation would 
be expected upon ZDHHC5 knockdown. As no significant difference in RP2 
palmitoylation was detected in ZDHHC5 siRNA treated cells compared to CTRL 
siRNA treated cells this signified ZDHHC5 was not responsible for RP2 palmitoylation. 
This does not exclude the possibility that in the absence of ZDHHC5 there is 
compensation by another ZDHHC which maintains RP2 palmitoylation.  
Previously in Aipl1 -/- mice which have a retina devoid of photoreceptors, expression 
of ZDHHC5 was > 4-fold reduced compared to WT, demonstrating it is expressed in 
photoreceptors. However, the expression of the closely related membrane associated 
Palmitoyltransferase ZDHHC2 was reduced >8 fold compared to WT suggesting this 
protein is highly expressed in photoreceptors (Murphy et al., 2016). Therefore, it is 
possible that ZDHHC2 also plays a role in palmitoylation of RP2. As HeLa cells 
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express endogenous ZDHHC2 this could be investigated via knockdown of ZDHHC2 
and analysis of RP2’s 17-ODYA incorporation. As multiple ZDHHC enzymes have 
been shown to be able to palmitoylate the same substrates (K. Huang et al. 2009; 
Tian et al. 2010) it may be that  ZDHHC2, ZDHHC5 and potentially other ZDHHC’s 
are responsible for RP2 palmitoylation in vivo. This could be tested by knockdown of 
each of the 23 ZDHHC’s in cells followed by assay of RP2’s palmitoylation status. 
Alternatively, this experiment could be repeated in RPE cells and the ZDHHC’s which 
are expressed in RPE cells knocked down and the palmitoylation status of RP2 
examined in order to identify ZDHHC’s which are responsible for RP2 palmitoylation 
in a disease relevant cell type. 
5.7.3 ZDHHC5 is required for RP2 Membrane Localisation 
The observation that ZDHHC5 is able to rescue mistrafficking of RP2 C3S and RP2 
G2A in cells is striking as these are human pathogenic mutations hypothesised to be 
mislocalised in vivo (Chapple et al. 2000). The caveat to this experiment is that this 
finding is based on over expression therefore does not directly represent the in vivo 
situation. HeLa cells used in this assay express endogenous ZDHHC5 however 
transient transfection with only C3S RP2-V5 or G2A RP2-V5 in HeLa cells 
demonstrated C3S RP2-V5 and G2A RP2-V5 were mislocalised signifying 
endogenous levels of ZDHHC5 are not sufficient to rescue mistrafficking (Figure 5.4 
C,E). However, knockdown of endogenous ZDHHC5 is enough to cause 
mislocalisation of RP2 WT-V5 demonstrating that ZDHHC5 may well have a role in 
trafficking RP2 to the membrane. To further investigate the mechanism by which 
ZDHHC5 may traffic RP2 to the cell membrane imaging approaches could be used. 
Cells expressing RP2-V5 and ZDHHC5-HA could be analysed by imaging with 
markers for particular types of vesicles. ZDHHC5- HA and WT RP2-V5 could be 
imaged alongside a marker for post Golgi vesicles such as Rab11 (Takahashi et al. 
2012). This could demonstrate if RP2 and ZDHHC5 are trafficked in the same vesicles 
to the membrane. To determine whether RP2 and ZDHHC5 interact before vesicle 
sorting occurs co-staining with Golgi markers such as Giantin and TGN38 (Linstedt 
and Hauri 1993; Luzio et al. 1990) could be performed. To determine whether 
ZDHHC5 and RP2 may require actin for trafficking, cells could be co-stained with a 
dye that allows visualisation of the actin cytoskeleton such as rhodamine phalloidin 
and ZDHHC5-HA and RP2-V5. Live cell imaging could be used to track RP2-V5 and 
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ZDHHC5-HA as they move through the cell in order to observe where they interact 
and whether they traffic to the cell membrane together. 
5.7.4 Knockdown of ZDHHC5 Reduces Ciliogenesis in RPE1 Cells 
Ciliogenesis was not absent in cells treated with ZDHHC5 siRNAs as about 30% of 
cells were still formed cilia (Figure 5.8 C). To assess if these cilia were equivalent to 
WT cilia the length of cilia was measured and was shown to be equivalent to that in 
CTRL siRNA treated cells (Figure 5.8 D). This suggests that ZDHHC5 is required for 
ciliogenesis and that it may be required for palmitoylation and/ or trafficking of cilia 
proteins in vivo. Multiple proteins involved in cilia are palmitoylated and palmitoylation 
may be essential for  protein function for example palmitoylation of ARL13B is 
required for protein stability and cilia localisation (Roy et al. 2017). ARL13B C8S/C9S 
is not palmitoylated, does not localise to cilia and is unable to activate ARL3 (Roy et 
al. 2017). As knockdown of only ZDHHC5 caused ciliogenesis defects this implies 
that other ZDHHC’s in RPE cells cannot compensate for the function of ZDHHC5 
suggesting that it may have specific cilia substrates. Swisspalm is an online database 
of palmitoylated proteins therefore proteins essential for ciliogenesis could be 
checked as to whether they are predicted to be palmitoylated and the effect on 
ZDHHC5 knockdown on their palmitoylation status analysed. For example, CEP290 
regulates ciliogenesis and is predicted to be palmitoylated on at least one of its 7 
cysteine residues. As ZDHHC5 is not itself localised to cilia it is possible that it has a 
role in trafficking proteins to the base of the cilia as well as palmitoylating them which 
is required for attachment to the cilia membrane. Therefore, the effect of ZDHHC5 
knockdown on the localisation of proteins required for ciliogenesis could be analysed.  
ARL13B was used as a marker for cilia in my assays and in the 30% of ZDHHC5 
siRNA treated cells, which still developed cilia possibly as a result of inefficient 
knockdown of ZDHHC5, ARL13B localised normally to the cilia. In ZDHHC5 siRNA 
treated cells which did not develop cilia ARL13B localisation appeared to be diffused 
throughout the cell. This could be a direct result of no cilia formation therefore ARL13B 
was unable to localise there or it may be that ZDHHC5 is required to palmitoylate 
ARL13B and as this has been previously shown to be essential for cilia formation (Roy 
et al. 2017) this may be the reason why cells with ZDHHC5 knocked down failed to 
ciliate. This hypothesis could be tested by transiently transfecting cells with ARL13B 
tagged with GFP or V5 and using a 17-ODYA incorporation assay as described 
above. ARL13B 17-ODYA incorporation could be assayed in cells with ZDHHC5 
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overexpression and with ZDHHC5 knocked down, to assess whether ZDHHC5 may 
be required for ARL13B palmitoylation.  
5.7.5 ZDHHC5 is not localised to Cilia 
ZDHHC5 did not localised to cilia in RPE1 cells (Figure 5.9) however it was localised 
within the cell rather than exclusively at the cell membrane as in HeLa cells (Figure 
5.9, Figure 5.5 B). This may suggest that ZDHHC5 has differential roles in RPE1 cells 
and HeLa cells. It is possible that in RPE1 cells ZDHHC5 is located within intracellular 
membranes where it functions to regulate the palmitoylation and or trafficking of 
proteins destined for the plasma membrane, in theory ZDHHC5 could traffic with them 
in intracellular vesicles to the cell membrane analogous to the mechanism proposed 
for δ-catenin  and ZDHHC5 trafficking in synaptic neurons (Brigidi et al. 2015).  
5.7.6 ARL3 is Palmitoylated in HeLa Cells  
 
Palmitoylation status of ARL3 was assessed using the 17-ODYA click chemistry 
assay, after confirming that ARL3 was palmitoylated, the cysteine residues on ARL3’s 
surface were mutated to serine’s to test which cysteine residues are required for 
palmitoylation. This assay revealed that mutation of C158S, C174 and C118 reduced 
ARL3’s 17-ODYA incorporation compared to WT suggesting these residues are 
palmitoylated in vivo. This suggests that ARL3 is likely dynamically palmitoylated on 
multiple residues this hypothesis was supported by the data from ARL3 WT which 
was quite variable further suggesting that palmitoylation of ARL3 may be dynamic. It 
has been previously shown in drosophila that ARL3 is N-terminally acylated and in 
yeast this acylation was shown to be essential for Arl3p localisation to vesicles. 
Furthermore, human ARL8 is acylated at its N-terminus which is essential for its 
localisation to lysosomes (Hofmann 2006). 
If ARL3 is dynamically acylated this could be investigated using a pulse chase 17-
ODYA assay. Hela cells could be transfected with WT ARL3-GFP and treated with 
100mM 17-ODYA. Rather than waiting for 24 hours cells could be lysed at various 
times after treatment to observe if 17-ODYA incorporation varies overtime. Whether 
palmitoylation of ARL3 varies under other conditions could also be tested with this 
assay for example whether palmitoylation of ARL3 increases with overexpression of 
ARL13B or RP2 may imply whether palmitoylation is required for ARL3’s activity. The 
known regulators of ARL3, RP2 and ARL13B, are both palmitoylated and membrane 
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associated (Roy et al. 2017; Chapple et al. 2000) therefore palmitoylation of ARL3 
likely facilitates membrane associations which may be required for interaction with 
RP2 and ARL13B. Dynamic acylation of ARL3 may also serve as a means of 
regulating the activity of ARL3 in vivo, as if palmitoylation is required for ARL3 to 
associate with membranes and thus RP2 and ARL13B this infers that palmitoylation 
is required for its activity in vivo. My data also suggests that palmitoylation of ARL3 
may effect stability of ARL3, suggesting another mechanism by which palmitoylation 
of ARL3 may affect its activity in vivo. 
The PAT or PATs which are responsible for palmitoylation of ARL3 could be 
investigated through knockdown of ZDHHC’s and analysis of ARL3 palmitoylation 
through 17-ODYA incorporation. Whether ZDHHC5 also interacts with ARL3 could be 
investigated in cells expressing ARL3-GFP by GFP pulldown and blotting for 
ZDHHC5. The localisation of ARL3 in cells could be analysed when ZDHHC5 is 
knocked down to establish if like RP2 its localisation is regulated by ZDHHC5. If 
ARL3’s localisation is regulated by ZDHHC5 it may suggest that RP2 and ARL3 may 
traffic to the cell membrane together in vesicles, a hypothesis which could be further 
investigated using live cell imaging to visualise the two proteins interacting in cells. 
This experiment would demonstrate whether they are trafficked together in vesicles 
and whether their interaction only occurs once both proteins are membrane localised 
providing insights into the dynamics of ARL3 regulation in cells.  
5.8 Conclusions 
 
In this chapter, I utilised the BIO-ID method to identify ZDHHC5 as a novel interactor 
of RP2. I characterised this interaction demonstrating that surprisingly ZDHHC5 is not 
required for RP2 palmitoylation but is required for its membrane association. This 
suggests that ZDHHC5 may play a role in trafficking RP2 to the cell membrane. I also 
demonstrated that overexpression of ZDHHC5 is capable of rescuing mistrafficking of 
RP2 mutants, RP2 C3S and RP2 G2A, which are not post translationally palmitoylated 
or myristoylated respectively. These are human pathogenic mutations which are 
hypothesised to cause mislocalisation of RP2 in vivo (Chapple et al. 2000). I then 
demonstrated that knockdown of ZDHHC5 reduces ciliogenesis in RPE1 cells, this 
suggests that ZDHHC5 may have roles in palmitoylation and or trafficking of proteins 
required for ciliogenesis and that other ZDHHCs in the cell cannot compensate for 
this function. I then established that known interactor of RP2, ARL3 is also 
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palmitoylated potentially at multiple cysteine residues. Together this data suggests a 
role for ZDHHC5 in the trafficking of lipid-modified proteins. As it is well established 
that mistrafficking of lipid-modified proteins is a potential mechanism underlying 
photoreceptor cell death in Retinitis Pigmentosa, further understanding of the role 
ZDHHC5 plays in the eye may have important implications for the understanding of 


















The overarching aim of my PhD project was to assess whether the pathogenesis of 
X-linked Retinitis Pigmentosa (XLRP) caused by mutation of RP2 can be solely 
attributed to dysfunction of ARL3. I also aimed to address how RP2 itself is regulated 
by identification of novel interactors via a BIO-ID analysis. In order to address these 
aims new mouse models were generated using CRISPR- mediated genome editing. 
Rp2h DEL26/Y is a RP2 null mouse, Rp2h E135G/Y expresses a mutant RP2 which 
is unable to interact with ARL3, Arl3 Q71L/+ and Arl3 Q71L/Q71L mice express 
constitutively active ARL3. By comparing the phenotypes of these mice, the 
contribution of increased levels of ARL3-GTP to retinal degeneration was addressed. 
I observed that Arl3 Q71L/Q71L retinas had the most severe retinal degeneration of 
all the mouse models and the highest levels of ARL3-GTP demonstrating that 
increased levels of ARL3-GTP can drive retinal degeneration in mice. I designed an 
assay to detect increased levels of ARL3-GTP in mouse tissues that revealed that 
increased levels of ARL3-GTP were not detectable in Rp2h WT, Rp2h DEL26/Y and 
Rp2h E135G/Y tissues suggesting that other mechanisms may exist to regulate levels 
of ARL3-GTP in the absence of RP2 GAP activity. I demonstrated that all mice 
displayed mistrafficking of OS proteins rhodopsin, M/L opsin and G- coupled receptor 
kinase 1 (GRK1) which may contribute to retinal degeneration. In addition, I observed 
that signal transducer and activator of transcription 3 (STAT3) activation is lost in Arl3 
Q71L/+ and Arl3 Q71L/Q71L eyes but not Rp2h DEL26/Y or Rp2h E135G/Y eyes. 
This may represent a mechanism which drives retinal degeneration when levels of 
ARL3-GTP are high but not when RP2 function is disrupted, suggesting that 
expression of ARL3 Q71L may drive retinal degeneration through different 
mechanisms than loss of RP2 function.  
6.2 Rp2h DEL26/Y and Rp2h E135G/Y Mice 
 
As discussed in chapter 3, Rp2h DEL26/Y and Rp2h E135G/Y mice have progressive 
retinal degeneration as shown by decreased thickness of the ONL and decreased 
photoreceptor response measured by electroretinography (ERG). These mice 
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displayed mislocalisation of GRK1, rhodopsin and M/L opsin and consistently Rp2h 
DEL26/Y mice had a more severe phenotype than Rp2h E135G/Y. As the DEL26 
mutation results in no RP2 protein expression but the E135G mutation produces a 
RP2 protein that does not have GAP activity for ARL3 it suggests that the more severe 
phenotype observed in the RP2 DEL26/Y mutant may be due to functions of RP2 
which are independent of ARL3. Other studies have demonstrated that RP2 may have 
other roles in the cells independent to its roles in protein trafficking. RP2 has homology 
with tubulin specific chaperone C (TBCC) and RP2 can stimulate the intrinsic GTPase 
activity of tubulin but is unable to facilitate heterodimerisation of newly folded tubulin 
subunits (Bartolini et al. 2002). Furthermore, a study in Trypanosama Brucei 
demonstrated that RP2 is localised to the basal body of the flagellum, and that 
knockdown of RP2 resulted in flagellum defects (Andre et al. 2014). Mutation of 
Arg248 in the TBCC domain abolished RP2’s function in tubulin processing resulting 
in lengthened flagella. Additionally, knockdown of RP2 resulted in failure of the 
transition zone proteins Meckel syndrome type 1 (MKS1) and Meckel syndrome type 
6 MKS6 to localise to the basal body of flagella (Andre et al. 2014). This suggests a 
role for RP2 in the regulation of microtubules which is essential for cilia formation and 
function. However studies in human MDCK cells have demonstrated that siRNA 
knockdown of RP2 does not affect cilia formation (T. Hurd et al. 2010). Retinitis 
Pigmentosa 1 (RP1), a cause of ADRP is a microtubule associated protein which 
localises to the tip of the CC, at the base of the OS, in photoreceptors (Q. Liu, Zuo, 
and Pierce 2004). RP1 interacts with microtubules and regulates the length and 
stability of the photoreceptor axoneme suggesting RP in this case may be caused by 
microtubule defects (Q. Liu, Zuo, and Pierce 2004). As other RP associated genes 
such as  RPGR, RP2 and Family With Sequence Similarity 161 Member A (FAM161A) 
have been shown to associate with microtubules this suggests that microtubule 
organisation defects may be a common feature that is disrupted in RP (Grayson et al. 
2002; Khanna et al. 2005; Shu et al. 2005; Zach et al. 2012), although further research 
is required to assess whether microtubule defects contribute to the pathogenesis of 
RP.  
ARL3 has also been shown to have a role in microtubule regulation through its 
interaction with HDAC6. In C.elegans it was shown that ARL3 regulated ciliogenesis 
via a HDAC6 dependant pathway (Yujie Li et al. 2010). It has been reported that 
knockdown of ARL3 in mammalian cells leads to an increase in the levels of 
acetylated tubulin and that ARL3 colocalises with acetylated tubulin at the mitotic 
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spindle and in the cilia (Enjalbert et al. 2006).  In RPE-1 cells it has been shown that 
HDAC6 localises to the primary cilia and that activation of HDAC6 is required for ciliary 
disassembly during the cell cycle (Pugacheva et al. 2007). Overexpression of WT 
HDAC6 in NIH3T3 cells increased cell migration (Valenzuela-Fernández et al. 2008), 
likely through increased deactylation of microtubules which decreases microtubule 
stability  and increases cell motility (Wadsworth 1999). Additionally cells lacking 
ARL13b have been shown to have a defect in cell migration and have increased levels 
of stable microtubules (Pruski et al. 2016). These studies demonstrate that ARL3 as 
well as RP2 may have roles in regulating microtubules in vivo.  
The nucleoside diphosphate kinase-like domain (NDKL) domain of RP2 was shown 
to have exonuclease activity and to translocate to the nucleus in response to DNA 
damage (Yoon et al. 2006). It was demonstrated that RP2 can most efficiently  
translocate to the nucleus under oxidative stress and increased oxidative stress has 
been suggested to drive cell death in Retinitis Pigmentosa (Campochiaro and Mir 
2018; Mendes et al. 2005; Yoon et al. 2006). Furthermore a patient pathogenic 
mutation, L253R,  in this domain has reduced exonuclease activity (Yoon et al. 2006). 
Although this mutation has since been shown to destabilise RP2 protein expression 
suggesting the reduced exonuclease activity is due to reduced protein expression 
rather than disruption of exonuclease catalytic activity (F. Liu et al. 2017). 
Nevertheless, this suggests that RP2 may play a role in repairing oxidative stress 
induced DNA damage and may explain why Rp2h DEL26/Y mice have a more severe 
phenotype than Rp2h E135G/Y mice as knockout of RP2 may ablate RP2’s role in 
DNA damage as well as ARL3 GAP activity. In order to test this hypothesis, levels of 
DNA damage associated proteins, such as oxoguanine glycosylase (OGG) or γH2ax, 
could be examined in the retinas of Rp2h DEL26/Y and Rp2h E135G/Y retinas. This 
could be tested in vitro by assessing survival of WT, RP2 null RPE cells and RP2 
E135G RPE cells after oxidative stress induced DNA damage.  
The other explanation as to why Rp2h E135G/Y mice have a less severe phenotype 
than Rp2h DEL26/Y may be because RP2 E135G still has residual GAP activity. The 
RP2 E135G mutation is predicted to reduce RP2’s affinity for ARL3 150 fold compared 
to WT however, another patient pathogenic mutation, R118H, reduces RP2’s affinity 
for ARL3 over 800 fold (Kühnel et al. 2006). As these predictions have been carried 
out in vitro it is possible that in vivo additional mechanisms exist and RP2 E135G 
could still have partial GAP activity meaning that the E135G mutation is hypomorphic. 
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In order to test this hypothesis, a mouse expressing RP2 R118H could be generated 
and its phenotype compared to that of Rp2h E135G/Y. In order to assess whether 
mutation of both residues is required to ablate GAP activity female compound 
heterozygous mice (Rp2h E135G/R118H) could be generated and the phenotype 
compared to female homozygous single mutants, Rp2h DEL26/DEL26 and female 
WT mice.  
6.3 Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/71L Mice 
 
6.3.1 Elevated Levels of ARL3-GTP 
 
In chapter 4, a pulldown assay using RP2 recombinant protein was used to isolate 
ARL3-GTP, demonstrating that in Arl3 Q71L/+ and Arl3 Q71L/Q71L tissue extremely 
elevated levels of ARL3-GTP were present compared to WT and Rp2h DEL26/Y and 
Rp2h E135G/Y tissues. In Rp2h DEL26/Y and Rp2h E135G/Y tissues, levels of ARL3-
GTP were indistinguishable from WT. This result suggests that in tissues deficient in 
RP2 another GAP may exist which is able to regulate the levels of ARL3-GTP or levels 
of ARL3-GTP are regulated via another mechanism e.g. guanine nucleotide exchange 
factor (GEF) activity. Throughout my analysis I observed similar defects in protein 
trafficking between Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q17L 
retinas with M/L opsin, rhodopsin and GRK1 all mislocalised although specific 
differences in age of onset was observed. Overall, this suggests that the same 
trafficking pathways may be disrupted in each case implying that in Rp2h DEL26/Y 
and Rp2h E135G/Y eyes levels of ARL3-GTP may be increased slightly compared to 
WT but were not high enough to be detected in my assay. This infers that in vivo only 
a small increase in ARL3-GTP levels may be required to  cause issues with protein 
trafficking. It also implies that mechanisms exist which prevent a huge increase in 
ARL3-GTP levels in tissues that lack RP2, this could be another GTPase activating 
protein (GAP) for ARL3 or regulation of GEF activity so that less ARL3-GTP is 
produced. GEF’s for other small GTPase families have been shown to have domains 
which autoregulate their activity (Cherfils and Zeghouf 2013) so it is possible that GEF 
activity of ARL13B could be subject to autoregulation and it’s activity may be reduced 
when high levels of ARL3-GTP are present.  
As the mice generated in my study were created using CRISPR genome editing of 
single cell embryo, the mutations introduced should be present in every tissue in the 
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resulting mouse and as both RP2 and ARL3 are ubiquitously expressed, the resulting 
eye specific phenotype for Arl3 Q71L mice was unexpected. Mice from both the Rp2h 
and Arl3 lines displayed only retinal degeneration with no other adverse phenotypes 
as they survived until 12 months of age and were indistinguishable from WT mice 
apart from retinal degeneration. In both previously published Rp2h knockout mice only 
retinal degeneration is observed with no other adverse phenotypes (Houbin Zhang et 
al. 2015; L. Li et al. 2013) suggesting that in other ciliated tissues another GAP for 
ARL3 exists which compensates for RP2 function. In chapter 4, pulldown with RP2 
recombinant protein demonstrated that increased levels of ARL3-GTP were present 
in Arl3 Q71L kidney lysates with no obvious kidney phenotype detected. However, 
Arl3 -/- mice have a severe ciliopathy like phenotype and do not develop 
photoreceptor outer segments, have pancreatic lesions and cystic kidneys resulting 
in death by p21, knockout of Arl3 has also reported to be lethal on C57BL/J 
background strain (Schrick et al. 2006; Hanke-Gogokhia et al. 2016). This contrasting 
phenotype is attributed to the fact Arl3 -/- mice have defects in ciliogenesis but in Arl3 
Q71L mice photoreceptor outer segments develop normally and no lethality occurs 
suggesting ciliogenesis occurs normally potentially as ARL3-GTP is still present. In 
order to assess if ARL3-GTP is required for ciliogenesis the phenotype of an Arl3 
T31N mouse could be analysed as this mutation would generate an ARL3 which is 
constitutively bound to GDP (Linari, Hanzal-Bayer, and Becker 1999). Increased 
levels of ARL3-GTP would be expected to cause mistrafficking of proteins trafficked 
to the cilia by RP2-ARL3-PDE6δ such as INP55E however some evidence exists 
demonstrating other ARL’s can compensate for the function of ARL3 (Humbert et al. 
2012; Fansa et al. 2016). Therefore, in other ciliated tissues trafficking pathways may 
be able to compensate for the mistrafficking caused by increased levels of ARL3-
GTP. Humbert et.al demonstrated that ARL13b also regulates cilia localisation of 
INPP5E (Humbert et al., 2012). After knockdown of ARL3 in renal epithelial cells 
INPP5E is still partially localised within cilia (Fansa et al. 2016) however knockdown 
of ARL13b leads to loss of INP55E cilia localisation (Humbert et al. 2012). Mutation 
of ARL13B and ARL6 cause Joubert syndrome and Bardet Bidel syndrome 
respectively (Cantagrel et al. 2008; Khan et al. 2013), which are syndromic conditions 
affecting multiple ciliated tissues however the only reported human pathogenic 
mutation in ARL3, results in dominantly inherited Retinitis Pigmentosa (Strom et al. 
2016). This mutation is predicted to result in a ARL3 protein unable to interact with 
RP2 or UNC119 (Strom et al. 2016). This suggests that non- ocular tissues can 
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tolerate loss or mutation of ARL3 but this is not the case for other small GTPases 
such as ARL13B or ARL6. In the eye the heavy burden on protein trafficking resulting 
from daily renewal of OS discs may result in a small trafficking defect that is tolerable 
in other tissues being amplified resulting in a phenotype, analogous to the mechanism 
which is proposed to underlie Retinitis Pigmentosa in cases where splicing factors are 
mutated (Deery et al. 2002). Alternatively, ARL3 may have evolved specific functions 
trafficking OS proteins in the eye therefore other GTPases are unable to compensate 
for this function and eye specific phenotypes arise from both RP2 and ARL3 mutation.  
6.3.2 Cones are More Sensitive to Increases in ARL3-GTP 
 
In chapter 4, I demonstrated through 10cd flash ERGs that cone photoreceptor 
function was more sensitive than rods to elevated levels of ARL3-GTP. The reduction 
in cone function was detected prior to M/L opsin mislocalisation, this was also 
observed in Rp2h DEL26/Y and Rp2h E135G/Y mice demonstrating that 
mislocalisation of M/L opsin was not likely the cause of the functional defect detected. 
A reduction in photoreceptor function suggests that proteins that are involved in 
phototransduction such as PDE6, GRK1 and transducin may be defective. As these 
proteins are trafficked to the OS by PDE6δ in rods as well as cones, a cone 
autonomous effect would not be expected (H Zhang et al. 2007). However, previous 
studies have suggested that the trafficking of these proteins may be differentially 
regulated in cones and rods. For example it has been demonstrated that cone outer 
segment proteins PDE6, GRK1, cone transducin subunit α and GC1 are not trafficked 
to the OS in the absence of 11-cis retinal but rod OS proteins are unaffected (Houbin 
Zhang et al. 2008). Also knockout of GC1 (Guca2e -/-) in mice results in 
mislocalisation of cone OS membrane proteins with no effect on rod OS proteins 
however when a double knockout of GC1 and GC2 (Guca2e -/-, Guca2f -/-) was 
generated both rod and cone OS membrane proteins were affected (Karan et al. 
2008). Furthermore in the Pde6δ -/- mouse mislocalisation of GRK1 and PDE6 is 
observed in rods and cones however in the Pde6δ -/-, Unc119 -/- double knockout 
mouse cone GRK1 localisation to the OS is rescued demonstrating distinct 
mechanisms may exist which regulate the trafficking of cone OS proteins (H Zhang et 
al. 2007; Houbin Zhang, Frederick, and Baehr 2014). In order to test whether the 
increased levels of ARL3-GTP present in Arl3 Q71L mice causes mistrafficking of 
cone OS proteins the localisation of cone specific isoforms could be assessed by 
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specific antibodies or co-staining with PNA could be used to aid identification of cones. 
Furthermore, Rp2h DEL26/Y, Rp2h E135G/Y or Arl3 Q71L/+ mice could be crossed 
onto a Nrl -/- background to generate a mouse with a retina that contained only cones 
expressing RP2 DEL26, RP2 E135G or ARL3 Q71L (Mears et al. 2001).  
6.3.3 Rhodopsin Is Mislocalised in Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ 
and Arl3 Q71L/Q71L Retinas 
 
In chapter 3, I demonstrated that rhodopsin is mislocalised in Rp2h DEL26/Y and 
Rp2h E135G/Y retinas. In chapter 4, I also observed that Arl3 Q71L/+ retinas have 
mislocalised rhodopsin followed by reduced rhodopsin immunostaining and that Arl3 
Q71L/Q71L retinas have reduced rhodopsin immunostaining from 1 month of age. 
Presuming that reduced immunostaining equates to reduced expression (although 
this was not confirmed in my analysis) this suggests that mutation of RP2 and 
elevated levels of ARL3-GTP do not necessarily cause the same phenotype in terms 
of rhodopsin mislocalisation. As discussed previously it has been shown that the C 
terminus of rhodopsin interacts with IFT20 and that in cells when RP2 is knocked 
down IFT20 becomes dispersed and the Golgi becomes fragmented (Evans et al. 
2010; Keady, Le, and Pazour 2011). When ARL3-Q71L is expressed in cells, this 
phenotype is also observed (Evans et al. 2010), implying that RP2 mutation may 
cause Golgi fragmentation through increased levels of ARL3-GTP and consequently 
mis-sorting of OS destined proteins such as IFT20 and rhodopsin. In Arl3 Q71L/Q71L, 
mice where levels of ARL3-GTP are elevated hundreds of times more than in Rp2h 
DEL26/Y and Rp2h E135G/Y other mechanisms may contribute to rhodopsin 
mislocalisation. The trafficking of rhodopsin is regulated by many small GTPases 
(Moritz et al. 2001; Deretic et al. 2005) therefore it may be that  another aspect of 
rhodopsin trafficking is also affected when levels of ARL3-GTP are hugely increased. 
For example rhodopsin docking at the connecting cilia is  regulated by the small 
GTPase Rab8 (Moritz et al. 2001). If this were disrupted, rhodopsin would be unable 
to localise to the OS. Elevated levels of ARL3-GTP may disrupt kinesin motor 
transport of rhodopsin (Insinna et al. 2008; Schwarz et al. 2017) resulting in rhodopsin 
accumulation that stimulates ER stress and protein degradation. To investigate 
whether kinesin motor subunit function is disrupted in Arl3 Q71L mice the localisation 
of other proteins trafficked by this mechanism such as IFT proteins IFT88, IFT52 and 
IFT57 (Insinna and Besharse 2008) could be examined in these retinas. An interesting 
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further experiment would be to age Rp2h DEL26/Y and Rp2h E135G/Y mice longer 
to see if they ever display reduced rhodopsin immunostaining to the same extent as 
Arl3 Q71L/Q71L mice. 
6.3.4 GRK1 is mislocalised in Rp2h DEL26/Y and Rp2h E135G/Y mice but is 
degraded in Arl3 Q71L/+ and Arl3 Q71L/Q71L mice 
 
In chapter 3, I demonstrated that in Rp2h DEL26/Y and Rp2h E135G/Y retinas GRK1 
immunostaining is lost from the photoreceptor OS but protein expression is 
unaffected. In chapter 4, I revealed that in Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas 
GRK1 immunostaining was absent from the photoreceptor OS and the protein 
expression decreased with age. Rp2h mutants had mislocalised GRK1 and in Arl3 
Q71L mice GRK1 was degraded signifying that the mechanisms involved in 
mislocalisation or the mechanisms which are activated to combat accumulation of 
mislocalised proteins are not identical in each case. A study in the Lcat-/- mouse, 
which is a model of Leber Congenital Amaurosis (LCA), showed that in cones 
although both M/L and S opsin were mislocalised only S opsin was degraded and M/L 
opsin was resistant to degradation. This study showed that M/L opsin aggregates 
were resistant to proteasomal degradation whilst S opsin was labelled with ubiquitin 
and degraded. Accumulation of M/L opsin aggregates caused ER stress, activated 
the unfolded protein response (UPR), and ultimately caused rapid photoreceptor 
degeneration. In cells where S opsin was degraded, the burden on the cell was 
relieved and less ER stress was present. Cells with degraded S opsin did still 
degenerate but at a slower rate than cells with M/L opsin aggregates (T. Zhang et al. 
2011). This study demonstrated that mislocalised proteins can be managed by 
different mechanisms in vivo which influences cell survival. This proposes that in Rp2h 
retinas where GRK1 is not degraded the UPR is activated and may contribute to cell 
death but in Arl3 Q71L retinas where GRK1 is degraded less ER stress is present and 
apoptosis does not occur. However, consistently throughout my analysis Arl3 
Q71L/Q71L retinas had the most severe phenotype in terms of age of onset of 
photoreceptor functional defects and rate of ONL thinning suggesting degradation of 
GRK1 does not protect against cell death. This could be attributed to the fact that 
reduced GRK1 expression may cause increased levels of R* that may cause hyper-
activation of the phototransduction cascade, which could stimulate apoptosis. 
Alternatively, other mechanisms may drive retinal degeneration in Arl3 Q71L/+ and 
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Arl3 Q71L/Q71L mice. The UPR is activated by three ER transmembrane proteins 
inositol requiring 1 (IRE1), PKR-like ER kinase (PERK), and activating transcription 
factor 6 (ATF6), in order to detect if the UPR is activated in Rp2h DEL26/Y, Rp2h 
E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L the levels of IRE1 and PERK1 
phosphorylation or levels of ATF6α cleavage could be examined by western blot in 
retinal lysates (Oslowski and Urano 2013).  
6.3.5 STAT3 Activation is Reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L Eyes but 
not in Rp2h DEL26/Y and Rp2h E135G/Y Eyes 
 
The protein mislocalisation that was observed Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 
Q71L/+ and Arl3 Q71L/Q71L mice suggest that ER stress may contribute to retinal 
degeneration however differences in whether mislocalised proteins were degraded 
infers that other mechanisms may also contribute to photoreceptor cell death. In 
chapter 4, I demonstrated that phosphorylation of tyrosine 705 (Y705) and serine 727 
(S727) on STAT3 was reduced in Arl3 Q71L/+ and Arl3 Q71L/Q71L eyes but not in 
Rp2h DEL26/Y and Rp2h E135G/Y eyes. These residues are thought to be required 
for STAT3 dimerisation, nuclear accumulation and activation of STAT3 gene 
expression respectively (J E Darnell, Kerr, and Stark 1994; James E Darnell 1997; 
Schindler, Levy, and Decker 2007). This result suggested that in Arl3 Q71L/+ and Arl3 
Q71L/Q71L retinas cell death may be driven by loss of STAT3 signalling which is not 
the case in Rp2h DEL26/Y and Rp2h E135G/Y eyes, suggesting that increased levels 
of ARL3-GTP and mutation of RP2 may drive retinal degeneration through differential 
mechanisms.  
STAT3 does not only regulate cell survival signalling but also regulates cell migration 
and proliferation (Hirano, Ishihara, and Hibi 2000). Interestingly some evidence exists 
to suggest that levels of ARL3-GTP may also regulate cell migration. Togi et.al 
demonstrated that siRNA knockdown of ARL3 reduced levels of STAT3 gene 
expression which reduced the migration capacity of cells (Togi et al. 2016). 
RodARL3Q71L mice were reported to have defects in cell migration such that some rod 
photoreceptor nuclei were present in the INL and OPL (Z. C. Wright et al. 2016). This 
phenotype has not been reported in any previously generated Rp2h knockout mouse 
(L. Li et al. 2013; Houbin Zhang et al. 2015) therefore this may be another mechanism 
by which high levels of ARL3-GTP affect cell function independently of RP2 (Houbin 
Zhang et al. 2015; L. Li et al. 2013). In some cell types the microtubule organising 
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centre and the Golgi apparatus are positioned at the leading edge of the cell in order 
to ensure directed molecule and vesicular transport which is essential for migration 
(Watanabe, Noritake, and Kaibuchi 2005). The dynein-dynactin motor complex 
involved in vesicular trafficking is also located at the leading edge of cells (Hubbert et 
al. 2002). HDAC6 has been shown to colocalise with the P150Glued domain of 
dynactin (Hubbert et al. 2002) and recently it was discovered that ARL3 directly 
interacts with p150Glued domain and that this interaction dissociates the dynein-
dynactin complex and leads to cargo unloading during vesicular trafficking (Jin et al. 
2014). Overexpression of WT HDAC6 in NIH3T3 cells increased cell migration 
(Valenzuela-Fernández et al. 2008), likely through increased deactylation of 
microtubules which decreases microtubule stability  and increases cell motility 
(Wadsworth 1999). Additionally cells lacking ARL13B have been shown to have a 
defect in cell migration and have increased levels of stable microtubules (Pruski et al. 
2016). Therefore, a mechanism by which ARL3 activates HDAC6 and regulates 
release of cargo from vesicles at the leading edge of cells could contribute to cellular 
migration in vivo. Nevertheless, it should be noted that the migration phenotype 
reported in RodARL3Q71L mice was variable between founder lines and the level of the 
migration defect correlated with level of transgene expression (Z. C. Wright et al. 
2016) and the Arl3 -/- had no reported cell migration phenotype (Schick et al., 2006).  
In Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas no obvious cell migration defect was 
detected suggesting that the cell migration phenotype reported in RodARL3Q71L mice 
may be attributed to overexpression or tagging of ARL3 Q71L rather than increased 
levels of ARL3-GTP. Examination of younger retinas may be required to observe 
whether some photoreceptors have migration defects. Still this serves as an example 
of another mechanism which may be regulated only by ARL3 and not RP2.  
Another interesting comparison highlighting differential mechanisms which may be 
regulated by RP2 and ARL3 is the comparison of the Arl3 -/- mouse and the previously 
published Rp2h knockout mice. Arl3 -/- mice have a severe ciliopathy like phenotype 
with pancreatic lesions, failure of OS development and death by P.21 due to kidney 
disease (Schrick et al. 2006). Other groups have reported Arl3 -/- mice to be an 
embryonic lethal (Hanke-Gogokhia et al. 2016) and in my CRISPR screen no Arl3 null 
mice survived to genotyping. Rp2h knockout mice on the other hand have normal 
retina development followed by retinal degeneration with no other adverse 
phenotypes (L. Li et al. 2013; Houbin Zhang et al. 2015). This demonstrates that 
complimentary mechanisms must exist to compensate for loss of RP2 function in non-
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ocular tissues. As ARL3 has been shown to regulate the activity of STAT3 in vivo 
ARL3 may also have roles in regulating other transcription factors which control cell 
survival. This could further explain the differences in phenotype which were observed 
between Rp2h DEL26/Y, Rp2h E135G/Y and Arl3 Q71L/+ and Arl3 Q71L/Q71L and 
may reveal other mechanisms which may contribute to cell death in vivo.  
This result also has significant consequences in terms of potential treatment options 
as reintroduction of STAT3 signalling was shown to be  protective against 
photoreceptor cell death in a model of inherited retinal degeneration (K. Jiang et al. 
2014). Therefore, treatments designed to increase STAT3 signalling in the retina may 
prove ineffective in patients with RP2 mutations if levels of STAT3 expression and 
activation are not affected. In order to confirm if loss of STAT3 signalling causes 
photoreceptor cell death in vivo WT mice would be treated with STAT3 inhibitors and 
examined for development of retinal degeneration. Rp2h DEL26/Y or Rp2h E135G/Y 
could also be treated with STAT3 inhibitors and examined to determine whether their 
retinal degeneration becomes much more severe.  
6.4 OS Sink Hole Hypothesis 
 
A common feature in animal models and human patients with RP is normal 
photoreceptor function at birth and progressive reduction in function over time 
followed by photoreceptor cell death. In Rp2h DEL26/Y and Rp2h E135G/Y retinas 
M/L opsin, rhodopsin and GRK1 were initially localised normally. Rp2h -/- mice have 
a similar phenotype with mislocalisation of PDE6 observed at 1 month of age 
however, the majority of PDE6 is localised to the OS with a minor fraction localised to 
the IS (Houbin Zhang et al. 2015). This data demonstrates that despite the hypothesis 
that RP2 is required for the trafficking of these proteins mechanisms exist which can 
facilitate trafficking to the OS in the absence of RP2. Even in the Pde6δ knockout 
mouse (Pde6δ -/-) proteins trafficked by PDE6δ are still initially localised to the OS 
but become mislocalised overtime (H Zhang et al. 2007) demonstrating another 
mechanism must exist which enables trafficking in the absence of the RP2-ARL3-
PDE6δ pathway.  
A study by Baker et.al demonstrated that the outer segment is the default destination 
for transmembrane proteins in the photoreceptor (Baker et al. 2008). Using R9AP as 
an example of an OS localised protein and syntaxin 3 as an example of an IS localised 
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protein they demonstrated that only syntaxin 3 had a sequence specific targeting motif 
that facilitated exclusion from the OS. No sequence specific moiety required for OS 
localisation was detected and the only requirement for OS targeting was a 
transmembrane domain of sufficient length (Baker et al. 2008). This finding may help 
to explain why in Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+, Arl3 Q71L/Q71L and 
in published models some proteins are localised normally to the OS before they 
become mislocalised.  
In mice the OS discs first develop at p10 and are fully developed by p14 (Salinas et 
al. 2017) whereas pups do not open their eyes until roughly p17, therefore there are 
a few days after OS development before OS function is required. During this time 
proteins could be expressed and localised to the OS by this default mechanism. 
Perhaps after eyes open the functional demand on OS proteins, specifically those 
involved in phototransduction, cannot be maintained by this default trafficking 
pathway thus alternative trafficking mechanisms have evolved. This hypothesis may 
help to explain why in Rp2h deficient mice and in XLRP patients with RP2 mutations 
proteins are initially localised normally but become mislocalised over time. For 
example, the default trafficking pathway is able to maintain trafficking of OS proteins 
enough initially facilitate function, however, over time other trafficking mechanisms 
such as the RP2-ARL3-PDE6δ pathway are required for maintenance of OS protein 
load. In the absence of this pathway proteins gradually become mislocalised, 
photoreceptor function declines and ultimately photoreceptors die.  
This “OS sink hole” hypothesis suggests that proteins may be able to freely diffuse to 
the OS providing an attractive mechanism to explain how proteins can still be 
trafficked to the OS despite loss of the trafficking pathway that shuttles them there. 
Knockout of RP2 is hypothesised to lead to increased levels of ARL3-GTP and 
aberrant release of cargo from PDE6δ, and if proteins are able to freely diffuse into 
the OS these proteins could end up in the OS regardless. However, this is not what 
is observed as GRK1 was lost from the OS in Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 
Q71L/+, Arl3 Q71L/Q71L and in Rp2h -/- mice (Houbin Zhang et al. 2015). Also PDE6 
was observed in punctate structures in the IS in Rp2h -/- mice (Houbin Zhang et al. 
2015). This may be explained by considering that the OS is a modified cilia and 
proteins cannot freely diffuse into the cilia due to the presence of the cilia diffusion 
barrier (Q. Hu and Nelson 2011). The ciliary diffusion barrier is localised to the 
transition zone and consists of the ciliary necklace (two rows of particles which are 
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connected to the basal body by appendages), the Y-link that connects the ciliary 
necklace to the microtubules, a septin cytoskeleton and multiple protein complexes 
(Q. Hu and Nelson 2011). Photoreceptor OS are separated from the IS via the CC 
which contains transition zone proteins implying proteins cannot freely diffuse to the 
OS (Besharse et.al1999).  
If proteins can be trafficked to the OS without any sequence specific targeting 
information but cannot arrive there by diffusion, these proteins may co-opt vesicles 
which contain proteins which do have sequence specific targeting information. For 
example, rhodopsin and cone opsins contain the (Valine X Proline X) VXPX ciliary 
targeting sequence which is required for OS targeting. Rhodopsin mutants lacking the 
VXPX sequence are mislocalised and human mutations in rhodopsin’s C-terminus 
which contains this sequence cause autosomal dominant Retinitis Pigmentosa 
(ADRP) (Deretic et al. 2005). However when rhodopsin lacking the VXPX targeting 
sequence was expressed with WT rhodopsin the majority of rhodopsin molecules 
were localised to the OS with only a small fraction observed in the ER and other 
cellular compartments (Sung et al. 1994; T. Li et al. 1996; Green et al. 2000). This 
suggests that rhodopsin lacking VXPX may still able to traffic to the OS in vesicles 
containing rhodopsin with the VXPX domain.  
If this model is applied to a situation where RP2 is absent it may explain why an 
accumulation of mislocalised proteins is observed in the IS and ONL of 
photoreceptors. Using GRK1 as an example, it can be hypothesized that in WT 
photoreceptors during development proteins are trafficked to the OS in vesicles 
containing proteins with sequence specific OS targeting motifs- default trafficking 
pathway. After eyes open and photoreceptor function is required the default pathway 
cannot maintain sufficient levels of GRK1 in the OS so PDE6δ is then required to 
extract GRK1 from the ER and traffic it to the OS. When RP2 is mutated and levels of 
ARL3-GTP increased, GRK1 is still extracted from the ER by PDE6δ, therefore can 
no longer co-opt vesicles destined to the OS. PDE6δ is converted to the closed 
conformation by ARL3-GTP releasing GRK1 into the cytoplasm which ultimately leads 
to photoreceptor cell stress and apoptosis.  
This model can also be applied to Arl3 Q71L/+ and Arl3 Q71L/Q71L mice where M/L 
opsin is localised normally at one month but becomes mislocalised with aging. In Arl3 
Q71L/+ rhodopsin is initially localised normally but becomes mislocalised over time 
however in Arl3 Q71L/Q71L mice rhodopsin is mislocalised from one month of age. 
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As 1 month of age was the youngest age I examined it is not possible to conclude 
whether Arl3 Q71L/Q71L mice ever have normally localised rhodopsin. Similarly 
GRK1 is mislocalised in Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas at 1 month of age 
so it is not possible to conclude whether Arl3 Q71L mice have normally localised 
GRK1 at birth. In order to assess whether GRK1 is localised normally earlier ages 
could be analysed. If GRK1 or rhodopsin is never localised normally in Arl3 Q71L 
mice, but it is initially localised normally in Rp2h DEL26/Y and Rp2h E135G/Y retinas, 
it would demonstrate that the extremely elevated levels of ARL3-GTP in Arl3 Q71L 
mice is capable of disrupting the pathway that traffics GRK1 to the OS in the absence 
of RP2.  
6.5 Implications for Therapeutic Approaches for X-linked Retinitis Pigmentosa 
 
Retinitis Pigmentosa is not a disease attributed to defects in the visual cycle as 
patients can see throughout their early lives, the key pathogenic defect is onset of 
photoreceptor cell death (Travis 1998). Rp2h DEL26/Y and Rp2h E135G/Y mice 
model this aspect of the disease as photoreceptors remain functional for some time 
before photoreceptor cell death occurs. The hypothesis that RP2 mutations cause 
increased levels of ARL3-GTP and therefore mislocalisation of OS proteins trafficked 
by PDE6δ and UNC119 and activation of apoptosis through ER stress is somewhat 
supported by my data however my results suggest that increased levels of ARL3-GTP 
may not fully explain the cell death phenotype which occurs in these mice. Increased 
levels of ARL3-GTP were undetectable in Rp2h DEL26/Y and Rp2h E135G/Y tissues 
compared to WT demonstrating that if levels of ARL3-GTP are increased it is not 
substantially greater than WT. As Rp2h DEL26/Y retinas have a more severe retinal 
degeneration than Rp2h E135G/Y retinas this suggests that functions of RP2 
independent of ARL3 contribute to photoreceptor cell death. Furthermore Arl3 Q71L/+ 
and Arl3 Q71L/Q71L not Rp2h DEL26/Y or Rp2h E135G/Y eyes had reduced STAT3 
activation which may contribute to cell death providing evidence that photoreceptor 
apoptosis may not be driven by the same mechanisms in vivo. Overall, my results 
indicate that targeting levels of ARL3-GTP may not be the best approach to treat 
XLRP patients with RP2 mutations, as although trafficking defects may be alleviated 
the as yet unknown functions of RP2 which are independent of ARL3 would not be 
addressed and therefore cell death may still occur. Ultimately, further research is 
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required into the alternative roles of RP2 in the retina and how these contribute to 
photoreceptor survival so that effective treatment strategies can be developed. 
Although my study suggests that ARL3 may not be an ideal drug target for the 
treatment of XLRP patients it suggests that targeting of RP2 itself may be the most 
effective strategy. Gene therapy is an attractive therapeutic option for diseases of 
inherited retinal degeneration. The eye is an attractive tissue for the application and 
validation of gene therapy based approaches as it is an encapsulated organ so the 
risk of systemic exposure of the transgene to the rest of the body is reduced and in 
the event of an adverse outcome, such as  cancer development, eyes can be treated 
or ultimately removed from patients without risk to life (Whiting et al. 2015). 
Effectiveness of therapy is easily assessed by non-invasive approaches which 
measure increased visual acuity and the patients untreated eye serves as an ideal 
control to assay treatment effectiveness (Whiting et al. 2015).  
In October 2017 the first gene therapy to treat inherited retinal degeneration achieved 
FDA approval. Luxturna, the commercial name for the therapy, is a drug that 
reintroduces RPE65 into patients who suffer from Leber Congenial Amaurosis (LCA) 
caused by mutation in RPE65. Previous clinical trials have demonstrated that 
reintroduction of RPE65 into young patients improved visual acuity however after 3 
years of follow up despite improved vision retinal degeneration still persisted in 
patients (Cideciyan et al. 2013). This example highlights the issues associated with 
timing and efficacy of therapies as if a therapy is administered after initiation of 
photoreceptor degeneration restoration of gene function may not prevent cell death, 
as loss of some photoreceptors can trigger secondary death in others due to changes 
in oxygen tension (Campochiaro and Mir 2018). Similarly if only a small percentage 
of photoreceptors express the re-introduced gene, cell death may still occur 
secondary to death of other non- transgene expressing photoreceptors. The 
mechanisms which drive photoreceptor degeneration in LCA patients treated with 
RPE65 gene therapy are currently unknown therefore further investigation is required 
so that innovative treatments such as this can provide maximum benefit to patients. 
Despite the issues associated with RPE65 gene therapy, its success in restoring vison 
has spurred on the development of gene therapies for other inherited retinal 
degenerations. Gene therapy approaches for XLRP caused by RPGR mutations are 
under development. A recent update of this approach in X-linked Progressive Retinal 
Atrophy 2 (XLPRA2) dogs, which contain a naturally occurring frameshift mutation in 
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RPGRORF15, demonstrated that treatment with human codon optimised RPGRORF15 
driven by the GRK1 promotor restored vision and protected against retinal 
degeneration 2 years post treatment (Beltran et al. 2012). A phase 1 trial for AAV 
administered RPGR in XLRP is due to be completed in 2020 
(https://clinicaltrials.gov/ct2/show/study/NCT03252847).  
The development of gene therapy approaches for RP2 patients has also begun, AAV 
administration of RP2 to the Rp2null mouse rescued the M/L opsin mislocalisation 
phenotype, improved ERG response of cone photoreceptors and protected against 
cone degeneration suggesting this could be a therapeutic option for patients in the 
future (Mookherjee et al. 2015). Patients which contain nonsense mutations may also 
be applicable for treatment with translational read through drugs to reintroduce 
expression of the full-length protein in cells. Administration of translational read 
through drugs in RPE cells derived from patient derived iPSCs (induced pluripotent 
stem cells) restored sufficient RP2 expression to reduce the cellular phenotypes of 
Golgi fragmentation and IFT20 dispersion associated with RP2 mutation (Schwarz et 
al. 2015). Recently antisense oligonucleotides have been used to correct the splicing 
defect which results from human the c.2991+1655A>G intronic mutation in CEP290 
which causes Leber Congenital Amaurosis (LCA). QR-110 (the antisense 
oligonucleotide) restored full length CEP290 expression in patient derived iPSC 
retinal organoids and when injected into the eyes of mice and rabbits QR-110 
localised to all retinal layers. Antisense oligonucleotide approaches are an attractive 
option for patients with splice site mutations and a major benefit from this approach is 
that the final result is restoration of WT protein levels avoiding overexpression of 
proteins, the effect of which for many genes including RP2 is unknown (Dulla et al. 
2018).    
Gene therapy approaches are promising for RP2 patients which harbour null, 
nonsense or missense mutations which lead to an unstable protein product but for 
patients that harbour RP2 point mutations such as RP2 E135G, RP2 R118H, RP2 
R211L, which affect a specific aspect of RP2 function, gene replacement therapies 
may be ineffective. In these cases cell based therapies may be a viable option. Cell 
therapies involve the introduction of a healthy stem cell population to the retina in the 
hopes they will differentiate to healthy photoreceptors or RPE cells to replace those 
lost in disease. A study in patients with Macular Degeneration (MD) and Stargardt’s 
disease demonstrated that transplantation of human ESCs (Embryonic Stem Cells) 
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was safe and potentially affective (Schwartz et al. 2015) however the use of human 
embryos to derive human ESCs is controversial and holds the possibility of the 
recipient rejecting the donor tissue. An alternative approach involves using the 
patient’s own fibroblasts to generate iPSCs which could be transplanted into the eye 
with no fear of rejection. Patients own fibroblasts will contain pathogenic mutations 
that would first have to be corrected before cells could be used for therapeutic 
purposes. The advent of CRISPR technology facilitates the correction of human 
pathogenic point mutations. A proof of principal study demonstrated that correction of 
a pathogenic point mutation in RPGR is possible by CRISPR editing of patient derived 
iPSC (Bassuk et al. 2016). An issue with cell therapies is the difficulty in encouraging 
stem cell populations to differentiate into photoreceptor cells, therefore restoration of 
damaged RPE cells by stem cell therapies to promote photoreceptor survival is a 
strategy which could benefit patients with RP. In the rhodopsin knockout (rho -/-) 
mouse transplantation of bone marrow derived stem cells into the retina resulted in 
preservation of photoreceptors by restoring healthy RPE at the transplant site 
(Arnhold et al. 2007). For patients with MD which is caused by defects in the RPE, 
cell based therapy may be widely available in the future as remarkable sight 
restoration has been achieved in a  patient with Wet MD after treatment with RPE 
cells engineered from stem cells (Da Cruz et al. 2018). Recently differentiation of rod 
photoreceptors was achieved through a two-step reprogramming of Muller glia cells. 
The resulting rods have functional outer segments with disc structures and expression 
of rhodopsin and other outer segment proteins and were capable of generating a 
calcium gradient upon light stimulation (Yao et al. 2018). Although this achievement 
is no doubt exciting if this method was to be applied in a therapeutic context, a 
mechanism to repair the pathogenic mutation in patient cells would be required, 
otherwise rods generated from patient Muller glial cells would still containing the 
pathogenic mutation and would degenerate once again.  
6.6 ZDHHC5 Traffics RP2 to the Cell Membrane in Vitro 
 
ZDHHC5 was identified as a novel interactor of RP2 in my BIO ID analysis. Using 17-
ODYA incorporation as a measure of RP2 palmitoylation I demonstrated that 
ZDHHC5 is likely not soley responsible for RP2 palmitoylation in vitro. Overexpression 
of ZDHHC5 was able to rescue the mistrafficking of RP2 mutants, RP2 C3S and RP2 
G2A, independently of its catalytic activity suggesting that ZDHHC5 may have a role 
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in trafficking RP2. Knockdown of endogenous ZDHHC5 in HeLa cells caused RP2-
V5 to be mislocalised from the plasma membrane to intracellular membranes 
suggesting that it may be required for trafficking of WT RP2 in vivo and this may could 
play a role in trafficking of lipid modified OS proteins in photoreceptors. I also tested 
whether ARL3 is palmitolyated and demonstrated that ARL3 is palmitolyated and 
mutation of C158, C118 and C174 reduced palmitoylation of ARL3 in cells, suggesting 
ARL3 is palmitolyated at multiple residues to facilitate membrane associations which 
may be required for interaction with its regulator proteins RP2 and ARL13B. 
ZDHHC5 overexpression was able to rescue the mistrafficking of RP2 C3S and G2A 
which are not palmitolyated or myristolated respectively (Chapple et al. 2000). These 
mutations are human pathogenic mutations which are presumed to be mislocalised 
in vivo this finding suggests that the pathogenesis of these mutants may not be purely 
due to mislocalisation as ZDHHC5 is expressed in photoreceptors (D. Murphy et al. 
2016). It is possible that other interactions of RP2 are perturbed when palmitoylation 
or myristolation is blocked as it has been demonstrated that palmitoylation can 
regulate protein -protein interactions for example palmitoylation of cysteine residues 
on tetraspanin is essential for its interaction with integrins which is essential for 
function (X. Yang et al. 2004). As overexpression of ZDHHC5 was required for rescue 
of mistrafficking it may be that in vivo endogenous levels of ZDHHC5 are not sufficient 
to rescue trafficking of RP2 C3S and RP2 G2A thus these mutants are mislocalised. 
Increased ZDHHC5 expression in the photoreceptor could be an interesting avenue 
for therapeutic intervention in patients with RP2 C3 and RP2 G2 mutations as this 
may be able to rescue the trafficking defect. 
Knockdown of ZDHHC5 by siRNAs demonstrated that ZDHHC5 expression was 
required for RP2-V5 localisation to the plasma membrane. This finding suggests that 
ZDHHC5 may be involved in trafficking RP2 to the membrane in vivo independently 
of its catalytic activity (Figure 6.1).  As ARL3 was identified as being palmitolyated in 
HeLa cells the effect of ZDHHC5 overexpression on ARL3 palmitoylation or 
localisation could be investigated this would provide more information into the 
regulation of RP2 and ARL3 and whether they share common mechanisms of 
regulation. As RP2 and ARL3 are involved in the trafficking of lipid modified proteins 
it suggests ZDHHC5 may be another player in this pathway, which may have a dual 
role in trafficking and palmitoylation of OS proteins in the photoreceptor. ZDHHC5 and 
ZDHHC2 are enriched in photoreceptors compared to other ZDHHC’s suggesting 
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Schematic of ZDHHC5 and RP2 trafficking to the plasma membrane. RP2 may be 
trafficked from the plasma membrane into membrane bound vesicles by an 
unknown mechanism or newly synthesised RP2 is packaged into vesicles destined 
for the plasma membrane. RP2 and ZDHCC5 interact in membrane bound vesicles 
and are trafficked to the plasma membrane where RP2 is palmitolyated by an as 
yet unidentified palmitolyltransferase and anchors to the plasma membrane.  
they may have specific roles in photoreceptors which other ZDHHC’s cannot 
compensate for (D. Murphy et al. 2016). Furthermore, as mislocalisation of lipid 
modified proteins is a phenomenon common to X-linked Retinitis Pigmentosa, 
demonstrated through the study of Rp2h and Rpgr knockout mice (L. Li et al. 2013; 
F. Liu et al. 2015; Hong et al. 2000),  further study of this protein may be relevant do 
















6.7 Future Work  
 
By studying the phenotype of Rp2h DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 
Q71L/Q71L mice I demonstrated that high levels of ARL3-GTP is a driver of retinal 
degeneration in mice and that mutation of Rp2h and increased levels of ARL3-GTP 
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DEL26/Y, Rp2h E135G/Y, Arl3 Q71L/+ and Arl3 Q71L/Q71L retinas all displayed 
defects in rhodopsin trafficking which indicates a novel role for RP2 and ARL3 in the 
trafficking of opsins in vivo. I demonstrated that RP2 might have functions that are 
important in the retina which are not related to GAP activity on ARL3 as Rp2h 
DEL26/Y mice have a more severe retinal degeneration than Rp2h E135G/Y mice. I 
demonstrated that Arl3 Q71L/+ and Arl3 Q71L/Q71L mice have substantially  
increased levels of ARL3-GTP compared to WT, Rp2h DEL26/Y and Rp2h E135G/Y 
demonstrating that mechanisms exist which regulate the levels of ARL3-GTP  in the 
eye in the absence of RP2.  Finally I showed that only Arl3 Q71L/+ and Arl3 
Q71L/Q71L eyes and not Rp2h DEL26/Y or Rp2h E135G/Y eyes had reduced STAT3 
activation at one month of age which may contribute to retinal degeneration. This 
finding suggests that mutations of RP2 and increased levels of ARL3-GTP may not 
promote retinal degeneration by the same mechanisms. 
Along with the further experiments discussed throughout this chapter and my results 
chapters the key questions which remain unanswered from this study and that require 
further investigation are:  
6.7.1 How are levels of ARL3-GTP regulated in the absence of RP2?  
 
In order to address this question and search for an alternative GAP for ARL3, novel 
interactors of ARL3 could be examined through an Immunoprecipitation and Mass 
spectrometry (IP/Mass Spec) approach in RPE cells. Alternatively, a BIO-ID assay for 
ARL3 could be utilised as this may better facilitate the capture of transient interactions 
in RPE cells. This assay could also be carried out in RP2 null RPE cells in order to 
identify interactors that interact with ARL3 in the absence of RP2. In order to identify 
a retina specific GAP IP/Mass spec proteomics from the retinas of ARL3 Q71L/Q71L 
retinas could be attempted, since GAPs should preferentially bind to the GTP bound 
form this approach would enrich for potential gaps for ARL3. Attempting to identify 
GAPs from eye tissue might identify a second retina specific GAP not found in other 
tissues and hence not previously identified as all other studies have been carried out 
in cell culture systems. In order to assess whether levels of ARL3-GTP may be 
regulated by the GEF ARL13B the level of expression of ARL13B could be assessed 
in WT, Rp2h DEL26/Y and Rp2h E135G/Y eyes. The GEF activity of ARL13B for 
ARL3 could be measured, by measuring the presence of ARL3-GTP in cells using an 
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antibody specific for ARL3-GTP, in WT RPE cells and in RP2 null RPE cells in order 
to establish if GEF activity is affected by the absence of RP2.  
6.7.2 What functions does RP2 have that are Independent of ARL3?  
 
In order to address RP2 functions which are independent of ARL3, that are relevant 
to disease pathogenesis in vivo, a BIO-ID assay on WT RP2 and RP2 E135G 
expressing RPE cells could be performed to identify interactors which are present 
when interaction with ARL3 is lost. In order to infer whether these interactors are 
important to disease pathogenesis the findings could be compared to BIO-ID analysis 
of other non-destabilising pathogenic point mutations, such as R211L, to assess 
whether they may represent molecular mechanisms which could underlie disease 
pathogenesis in these cases. After identification of interesting hits, the relevance of 
these hits in vivo could be assessed in Rp2h DEL26/Y and Rp2h E135G/Y mice. 
6.7.3 How does mutation of RP2 stimulate Photoreceptor Cell Death?  
 
There are likely multiple mechanisms that drive photoreceptor cell death in Rp2h 
mutant mice. As Rp2h mutants have mislocalised OS proteins it is possible that 
accumulation of mislocalised proteins causes ER stress which leads to apoptosis. In 
order to evaluate whether Rp2h DEL26/Y and Rp2h E135G/Y mice have increased 
ER stress, RNA sequencing of retinas could be analysed and analysis of expression 
levels of genes associated with ER stress and UPR could be compared to WT retinas. 
This experiment could also be performed in Arl3 Q71L/+ and Arl3 Q71L/Q71L mice in 
order to ascertain whether these retinas also suffer from ER stress. As it was 
established that GRK1 is degraded it may be that degradation of mislocalised proteins 
protects against ER stress. As some evidence exists, which suggests RP2 may have 
a role in the DNA damage response (Yoon et al. 2006) and as other models of 
inherited retinal degeneration have been shown to have increased levels of oxidative 
stress induced DNA damage (Ahuja-Jensen et al. 2007) this hypothesis could be 
investigated further. Whether RP2 has roles in the DNA damage response could be 
addressed through in vitro assays in RP2 null RPE cells. WT and RP2 null RPE cells 
could be treated with hydrogen peroxide or UV to induce DNA damage and the 
survival of RP2 knockout cells assessed. It would be expected that if RP2 had a role 
in DNA damage response then RP2 null RPE cells would be unable to repair their 
DNA efficiently and may undergo growth arrest or apoptosis as a result. In order to 
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identify which proteins RP2 interacts with post-DNA damage a time course IP/Mass 
spec experiment could be performed in which WT RPE cells and RP2 null RPE cells 
are exposed to a DNA damaging agent and cells lysed at various times after DNA 
damage. Alternatively, this same approach could be combined with the BIO-ID system 
such that RP2 null RP2 BIRA RPE cells are treated with a DNA damaging agent and 
biotin to facilitate labelling of proximal proteins, cells could be lysed at different times 
after exposure to the DNA damaging agent to examine RP2’s interactors during DNA 
repair. Any interesting interactors identified could be validated in vivo in Rp2h 
DEL26/Y and Rp2h E135G/Y mice.  
6.7.4 How is RP2 Palmitoylation Regulated in Vivo and does ZDHHC5 have an 
Important Function in the Eye?  
 
In order to examine whether multiple ZDHHC’s are required for palmitoylation of RP2 
in vivo knockdown of multiple ZDHHC’s in cells followed by an assessment of RP2’s 
17-ODYA incorporation could be undertaken. In order to assess whether the RP2-
ZDHHC5 interaction has an important function in vivo the residues which are required 
for this interaction could first be investigated through targeted deletions of RP2 and 
assay of ZDHHC5 interaction. Once the residues required for this interaction were 
established mutations of these residues could be introduced into mice via CRISPR 
genome editing. Whether these mice have retinal degeneration could be confirmed 
by histology and ERG analysis. An interesting observation may be whether these mice 
have mislocalisation of proteins known to be trafficked by RP2 and ARL3 which would 
infer that the RP2-ZDHHC5 interaction has a functional role in vivo. Generation of a 
ZDHHC5 null mouse could also be invaluable in assessing the role of ZDHHC5 in the 
eye. The previously published DHHC5 gt/gt mouse carried a hypomorphic null allele 
(Yi Li et al. 2010) therefore in order to cleanly assess the role of ZDHHC5 in the retina 
a new model could be generated by CRISPR cas9. The localisation of RP2 could be 
investigated in these mice to establish whether ZDHHC5 is required for RP2 
localisation in vivo. As knockdown of ZDHHC5 caused ciliogenesis defects in RPE 
cells the development of the photoreceptor CC and OS could be investigated in order 
to determine whether ZDHHC5 plays a role in photoreceptor ciliogenesis in vivo. 
Overall, further work in in vivo models is required in order to determine whether 
ZDHHC5 is involved in photoreceptor function and whether this is relevant to 
pathogenesis of XLRP caused by RP2 mutations.  
224 
 
6.8 Concluding Remarks 
 
Retinitis Pigmentosa is the leading cause of inherited blindness worldwide and 
currently limited treatment options and no cures are available. 15% -20% of cases of 
XLRP are caused by mutations in RP2 a gene that’s function is still not well 
understood. As RP2 is known to have GAP activity for ARL3 it is hypothesised that 
mutation of RP2 causes increased levels of ARL3-GTP which leads to mislocalisation 
of OS proteins in photoreceptors leading to cell death. My PhD research aimed to 
ascertain whether the pathogenesis of XLRP in cases of RP2 mutation is attributed 
solely to dysregulation of ARL3. In order to do this new mouse models were generated 
by CRISPR including a new RP2 null model, Rp2h DEL26/Y and a  mouse with GAP 
activity deficient RP2, Rp2h E135G/Y. The phenotype of these mice was compared 
to mice harbouring a constitutively activating mutation in ARL3, Arl3 Q71L/+ and Arl3 
Q71L/Q71L. Discrepancies in the phenotypes of these mice imply that pathogenesis 
of XLRP caused by RP2 mutation cannot be fully explained by increased levels of 
ARL3-GTP. My results validated a role for RP2 and ARL3 in protein trafficking but 
highlighted that cell death may not be activated by the same mechanisms in Rp2h 
mutants and Arl3 Q71L mice. As blindness in RP results from cell death of 
photoreceptors this is an important finding which sheds new light on disease 
pathogenesis in patients. This finding highlights the need for further research into 
mechanisms which stimulate photoreceptor cell death in vivo so that effective 
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